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The ubiquitin-proteasome system is responsible for the targeted degradation of proteins within 
the cell. The 26S proteasome, which is the protease of this system, is a high molecular weight 
complex consisting of 33 subunits that arrange to form two smaller complexes the 19S regulatory 
particle (RP) and the 20S core particle (CP). The 19S RP can bind one or both ends of the 20S 
CP and is responsible for recognizing the ubiquitinated substrates. After recognition, the 19S RP 
will subsequently deubiquitinate, unfold, and translocate the substrates into the proteolytic 20S 
CP. The 20S CP consists of seven unique α and seven unique β subunits that arrange into four 
stacked rings, with two α rings capping two β rings. Assembly of the α1-7β1-7β1-7α1-7 structure 
begins with the formation of an α ring and proceeds through specific assembly intermediates. 
This process is assisted by assembly chaperone proteins that promote on pathway interactions to 
efficiently construct the 20S CP. In this dissertation, three new findings are described which 
further characterize the proteasome assembly pathway. First, novel non-canonical complexes 
comprised of proteasome subunit α4 were identified in vivo, revealing proteasome subunits can 
assemble into complexes outside of the proteasome. Second, Hsp70 proteins, Ssa1/2, were 
shown to assist in the assembly of 20S CPs, adding to the growing list of proteins guiding 
proteasome assembly. Third, a novel complex was identified which is believed to represent a 
new proteasome assembly intermediate. 
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CHAPTER 1. INTRODUCTION 
1.1 Ubiquitin-Proteasome System Overview 
Proteasomes are proteases that help maintain protein homeostasis, which is essential for 
cellular function. Proteasomes are found throughout the eukaryotic and archaeal domains and 
within a few bacterial lineages. In eukaryotes, the proteasome is an essential component of the 
ubiquitin-proteasome system. This well characterized system is responsible for the targeted 
degradation of proteins. Proteins destined for degradation are first ubiquitinated through an 
enzymatic cascade consisting of three enzymes E1 (ubiquitin activating enzyme), E2 (ubiquitin 
conjugating enzyme), and E3 (ubiquitin ligase) (reviewed by (Hershko & Ciechanover, 1998; 
Hochstrasser, 1996; Jentsch, 1992). In this cascade, the 76 amino acid protein, ubiquitin, is 
initially activated by the E1 enzyme in an ATP dependent manner where ubiquitin’s C-terminus 
is covalently attached to a cysteine residue within the active site of E1, forming an E1-ubiquitin 
thioester. Next, ubiquitin is transferred to a cysteine on E2. Then by E2 alone or in combination 
with E3, the ubiquitin is transferred to a lysine on the substrate forming an isopeptide bond. 
Ubiquitin has seven endogenous lysines that may undergo ubiquitination. Several subsequent 
rounds of ubiquitination results in the formation of a polyubiquitin chain. These chains are 
characterized according to the lysine residues chosen for polyubiquitination. Proteins tagged with 
K48 and K11 specific chains are deubiquitinated, unfolded, and degraded by the proteasome 
(Chau et al., 1989; Lu, Lee, King, Finley, & Kirschner, 2015; Meyer & Rape, 2014; Xu et al., 
2009).  
The 26S proteasome is a large multi-subunit complex that consists of a 20S core particle 
(CP; also known as the 20S proteasome), which is the protease of the complex, and a 19S 
regulatory particle (RP) that may cap one or both ends of the 20S CP (DeMartino & Slaughter, 
1999). The 19S RP recognizes, deubiquitinates, unfolds, and feeds substrates into the proteolytic 
20S CP. The 26S proteasome and the 20S CP are the best characterized of the proteasome 
complexes; however, several proteasome sub-types exist. These sub-types appear to house 
unique functions. Some sub-types are formed by the capping of alternative activator complexes. 
Other sub-types are composed of specialized 20S CP subunits or an alternative arrangement of 
canonical subunits. Despite considerable progress in elucidating the structure and function of the 
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proteasome, how this intricate structure is assembled is not completely understood. Proper and 
efficient assembly of proteasomes is vital for cellular homeostasis. By better understanding the 
proteasome assembly pathway, therapies can be designed to target the pathway. This dissertation 
will focus on 20S CP assembly. Work over the last decade has supported the idea of a canonical 
linear assembly pathway for the 20S CP. Growing evidence suggests that 20S CP assembly is not 
simply a linear process, but likely occurs through multiple pathways and through a variety of 
intermediates. 
1.2 26S Proteasome Structure 
The eukaryotic 26S is approximately 2.5 MDa. It contains two main sub-complexes, a 
20S core particle (CP) and a 19S regulatory particle (RP). The 19S RP can cap one or both ends 
of the 20S CP (DeMartino & Slaughter, 1999). The 20S CP (~730 kDa) is the proteolytic center 
of the 26S proteasome and consists of 14 unique subunits, seven distinct α and β subunits, that 
assemble into four stacked hetero-heptameric rings: α1-7β1-7β1-7α1-7 (Groll et al., 1997). The 
proteolytic activity is sequestered within the central hollow chamber formed by the stacked rings. 
Three of the seven β subunits (β1, β2, and β5) contain propeptides that are cleaved upon 20S CP 
assembly, exposing a catalytically active threonine residue (Thr1) (Groll et al., 1997). This 
catalytic activity is shielded from the cellular environment by α subunit N-terminal tails covering 
the opening to the central pore. To allow for substrate entry, these gating N-terminal tails are 
displaced by activator proteins, such as the 19S RP (Groll et al., 1997).  
The 19S RP (~700 kDa) is made up of 19 subunits that are classified as Rpt (Regulatory 
Particle AAA-ATPase) or Rpn (Regulatory Particle non-AAA-ATPase) subunits. These subunits 
assemble into two sub-components, a base and a lid (Glickman et al., 1998). The terms lid and 
the base are still used, but are quite misleading in light of published 26S cryo-EM structures (X. 
Huang, Luan, Wu, & Shi, 2016b; Lander et al., 2012; Schweitzer et al., 2016). The base of the 
19S RP is made up of six homologous AAA-ATPase subunits (Rpt1-6) (Tomko, Funakoshi, 
Schneider, Wang, & Hochstrasser, 2010) and four non-ATPase subunits Rpn1, Rpn2, Rpn10, 
and Rpn13. Rpn1 binds UBL (ubiquitin-like) domains, while Rpn10 and Rpn13 bind ubiquitin 
directly (Elsasser et al., 2002; Husnjak et al., 2008; Saeki, Sone, Toh-e, & Yokosawa, 2002). The 
Rpt subunits form a hexameric ring that is responsible for unfolding substrates in an ATP 
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dependent manner, opening the α ring gate, and feeding substrate into the 20S CP (Rabl et al., 
2008; Smith et al., 2007). The Rpt ring opens the α ring gate through the C-terminal extensions 
of Rpt2, 3, and 5. These three Rpt subunits contain a C-terminal HbYX motif, which is a tri-
peptide motif consisting of a hydrophobic (Hb) residue followed by a tyrosine (Y), then any 
amino acid (X). These C-terminal extensions will bind to the intersubunit pockets of the α ring. 
The carboxylate group on the ‘X’ residue of these Rpt subunits will form a salt bridge with a 
conserved lysine found at the base of 6 of the 7 α intersubunit pockets (Rabl et al., 2008; Smith 
et al., 2007).  
The lid is made of nine non-ATPase subunits, one of which, Rpn11, is essential in 
deubiquitination of substrates (Verma et al., 2002; T. Yao & Cohen, 2002). Both the 20S CP and 
the 19S RP have been shown to assemble in distinct pathways that involve specific chaperone 
proteins (Funakoshi, Tomko, Kobayashi, & Hochstrasser, 2009; Hirano et al., 2005; 
Kusmierczyk, Kunjappu, Funakoshi, & Hochstrasser, 2008; Kusmierczyk, Kunjappu, Kim, & 
Hochstrasser, 2011; Le Tallec et al., 2007; Le Tallec, Barrault, Guerois, Carre, & Peyroche, 2009; 
X. Li, Kusmierczyk, Wong, Emili, & Hochstrasser, 2007; Roelofs et al., 2009; Saeki, Toh, Kudo, 
Kawamura, & Tanaka, 2009; Yashiroda et al., 2008). A detailed review of 26S assembly can be 
found here (Howell, Tomko, & Kusmierczyk, 2017). 
Figure 1.1 Cryo-EM 26S proteasome yeast 
The 19S RP and 20S CP components of the 26S proteasome are indicated. Image modified from 
Bai Luan et al 2016.  
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1.3 20S Conservation 
Proteasomes are found throughout the archaeal and eukaryotic domains; however, in the 
bacteria it is only found in the Actinomycete (De Mot, Nagy, Walz, & Baumeister, 1999) and 
Nitrospirales lineages (De Mot, Schoofs, & Nagy, 2007). These bacterial proteasomes are 
thought to have been acquired through a lateral gene transfer event (Lupas et al., 1997; Volker & 
Lupas, 2002). Regardless of origin, all 20S CPs have the same barrel like structure with a 
catalytically active central hollow chamber gated by α subunit N-terminal tails. While this 
dissertation is focused on proteasomes, it is worth noting that bacteria contain a variety of 
proteases that appear to maintain cellular homeostasis, and several bacterial species use a 
combination of proteases: Lon, ClpAP, HslV, and proteasome (Gille et al., 2003). The HslV 
protease in particular has striking similarities to the 20S CP (Bochtler, Ditzel, Groll, & Huber, 
1997).  
HslV is considered a distant relative to the proteasome. HslV’s protease component 
shares some sequence and structural similarity to the catalytically active β subunits of the 20S 
proteasome (Bochtler et al., 1997; Chuang, Burland, Plunkett, Daniels, & Blattner, 1993; Gille et 
al., 2003). Moreover, like the proteasome, HslV is a multi-subunit complex consisting of rings 
and employs an N-terminal threonine nucleophile for catalytic activity (Bochtler et al., 1997; 
Bochtler, Song, Hartmann, Ramachandran, & Huber, 2001; Groll et al., 1997). In addition to 
HslV, a bioinformatic study in 2008 identified two other new groups of ancient hypothetical 
bacterial proteasomes (Valas & Bourne, 2008). One group, Anbu (ancestral beta subunit), is 
found in some cyanobacteria, and the other group, BPH (β-proteobacteria proteasome 
homologue), is found exclusively within a few β-proteobacteria (Valas & Bourne, 2008). Since 
that initial bioinformatic study, Anbu was crystalized and shown to form a dodecameric open 
ring complex (Fuchs et al., 2017). The authors’ bioinformatic analysis of Anbu places it at the 
early stages of proteasome evolution and suggests that Anbu’s open rings might have descended 
from an evolutionary precursor stage in the development of a closed ring, self-
compartmentalizing, protease (Fuchs et al., 2017). This same study tested several substrates, but 
unfortunately no substrates for Anbu were identified; to date no catalytic activity has been 
described for Anbu (Fuchs et al., 2017). 
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1.4 Proteasome Tagging Systems and Activators 
In all domains of life, the essential function of the proteasome is to degrade proteins. 
Both archaea and bacteria employ tagging systems and activators with proteasomes that are 
reminiscent of the ubiquitin-proteasome system. 
1.4.1 Bacteria: Modifier Pup and Activators ARC, Mpa and PafE/Bpa 
Bacterial proteasomes utilize a modifier protein called Pup (prokaryotic ubiquitin-like 
protein) that functions as a part of the Pup-proteasome system (PPS) (Pearce, Mintseris, 
Ferreyra, Gygi, & Darwin, 2008). This modifier protein attaches to substrates in a unique manner 
called pupylation. The C-terminus of the Pup protein contains a glutamine. In the first step of 
pupylation, this glutamine is deamidated by an enzyme called Dop (deamidase of Pup) to form a 
glutamate (Pearce et al., 2008; Striebel et al., 2009). Through the action of another enzyme, Pup 
ligase PafA, the glutamate side chain on Pup is covalently linked to a lysine on the target protein 
(Guth, Thommen, & Weber-Ban, 2011). There are exceptions to this method of tagging. For 
instance, in Streptomyces coelicolor, Pup is synthesized with a glutamate, and oddly still 
contains the Dop enzyme, even though Pup does not require deamidation (Bentley et al., 2002; 
Compton, Fernandopulle, Nagari, & Sello, 2015). One explanation for this is that Dop has an 
additional function besides deamidation. Two different groups described this new enzymatic 
activity for Dop, depupylation (Burns et al., 2010; Imkamp et al., 2010). Depupylation is the 
removal of Pup from substrates which is analogous to deubiquitination observed in eukaryotes 
(Burns et al., 2010; Imkamp et al., 2010). 
In addition to having a tagging system, bacterial species containing proteasomes also 
have activator proteins that bind to the α ring of 20S CPs and stimulate degradation. Two types 
of activators have been identified in bacteria. The first activator was identified in Rhodococcus 
erythropolis and is referred to as ARC (AAA ATPase Ring-shaped Complex) (Wolf et al., 1998). 
A homologue of ARC was identified in Mycobacterium tuberculosis, Mpa (mycobacterium 
proteasome ATPase) (Darwin, Ehrt, Gutierrez-Ramos, Weich, & Nathan, 2003; Darwin, Lin, 
Chen, Li, & Nathan, 2005; Striebel, Hunkeler, Summer, & Weber-Ban, 2010). The second type 
activator was identified by two different groups at around the same time. One group called the 
activator Bpa (bacterial proteasome activator), and the other group referred to it as PafE 
(proteasome accessory factor E) (Delley et al., 2014; Jastrab et al., 2015). Both of these 
6 
 
activators contain a penultimate tyrosine and are suspected to use a similar gate opening 
mechanism as the eukaryotic 19S RP (Delley et al., 2014; Imkamp, Ziemski, & Weber-Ban, 
2015; Jastrab et al., 2015; Striebel et al., 2010) Mpa/ARC is an ATP dependent activator that 
unfolds and degrades puplylated substrates (Striebel et al., 2010). Bpa/PafE is an ATP 
independent activator, and a recent Cryo-EM analysis of Bpa-20S suggests that this activator is 
structurally similar to the eukaryotic 11S (PA28 activators) (Bolten et al., 2016). 
1.4.2 Archaea: Modifier SAMP and Activators PAN, Cdc48, and AMA 
Ubiquitin like proteins, SAMP1, SAMP2, and SAMP3 (small archaeal modifier protein 1, 
2, and 3) and an E1 like enzyme, UbaA (ubiquitin-like activating protein of Archaea) were 
described in archaeal species Haloferax volcanii (Humbard et al., 2010; Miranda et al., 2014; 
Miranda et al., 2011). UbaA activates the SAMP proteins through an E1-like mechanism 
(Miranda et al., 2011). All three SAMPs can form isopeptide bonds via their C-terminal glycine 
residues and lysine residues on the target proteins (Hepowit et al., 2012; Humbard et al., 2010; 
Miranda et al., 2014; Miranda et al., 2011). SAMP2, but not SAMP1, was shown to form a 
SAMP2 chain, by forming an isopeptide bond to itself (Humbard et al., 2010). SAMP3 was 
shown to form chains of SAMP3, but whether these chains are attached to substrates still needs 
to be determined (Miranda et al., 2014). 
Archaeal 20S CP contains a closed α ring gate (Benaroudj, Zwickl, Seemuller, Baumeister, 
& Goldberg, 2003; Smith et al., 2005; H. Zhang et al., 2009). By in vitro methods, three 
proteasome activators have been identified in archaea PAN, proteasome activating nucleotidase 
(Wilson, Ou, Aldrich, & Maupin-Furlow, 2000; Zwickl, Ng, Woo, Klenk, & Goldberg, 1999), 
Cdc48 (Barthelme & Sauer, 2012; Forouzan et al., 2012), and AMA (Archaeoglobus and 
methanogenic archaea) (Djuranovic, Rockel, Lupas, & Martin, 2006; Summer, Bruderer, & 
Weber-Ban, 2006). All three activators are AAA ATPases (Forouzan et al., 2012). PAN is an 
archaeal homologue of eukaryotic 19S RP AAA ATPase (Wilson et al., 2000; Zwickl, Voges, & 
Baumeister, 1999). PAN is found sporadically throughout archaea, and of the PAN proteins 
identified, only some contain a HbYX motif (Reuter, Kaczowka, & Maupin-Furlow, 2004; Yu et 
al., 2010). Despite lacking a HbYX motif or PAN all together, all archaeal genomes sequenced 
encode 20S CP α and β subunits (Maupin-Furlow, 2013).  
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The archaeal species lacking PAN may employ Cdc48 and/or AMA as proteasome 
activators. Cdc48 from Thermoplasma acidophilim can interact with 20S CPs in an ATP-
dependent manner to stimulate degradation (Barthelme & Sauer, 2012). AMA is only found in 
Archaeoglobus and methanogenic archaea (Djuranovic et al., 2006; Summer et al., 2006). It was 
first shown to have unfoldase activity (Djuranovic et al., 2006), and was later shown to stimulate 
20S CP activity (Forouzan et al., 2012); however, the AMA-20S complex has not been isolated 
in vivo or in vitro. 
1.5 Canonical 20S CP Assembly 
While the overall structure of the 20S proteasome is highly conserved. The paths by 
which these proteasomes assemble are distinct between the three domains. The assembly 
pathway in eukaryotes is much more complicated than archaeal or bacterial pathways due to the 
fact it is made up of seven unique α and β subunits that occupy specific locations within the 
assembled structure. Data collected from several studies has shed light on what is likely the 
canonical or preferred assembly pathway in eukaryotes. 
The current view of eukaryotic assembly begins with the formation of an α ring. This α 
ring acts as a scaffold for incoming β subunits (Hirano et al., 2005), and its formation appears to 
be essential for assembly. The β subunits bind to the α ring in the following order: β2, β3, β4, β5, 
β6, β1, and β7 (Hirano et al., 2008). To date three α/β subunit intermediates have been 
characterized in eukaryotes: the 13S complex, containing one α ring with β2, β3, and β4; the 
15S (also known as the -β7 half-mer), consisting of a full α ring plus all of the β subunits, except 
β7; and the half-proteasome, which is one full α ring and one full β ring. Once two half-
proteasomes are assembled, they will dimerize to form a pre-holoproteasome (PHP)(X. Li et al., 
2007). At the PHP stage in assembly, the propeptides on β1, β2, and β5 are auto-catalytically 
cleaved, exposing a catalytically active threonine residue (Thr1), creating the degradation 
component of the 26S proteasome, the holoproteasome (HP) (Figure 1.2) (Chen & Hochstrasser, 
1995; Heinemeyer, Fischer, Krimmer, Stachon, & Wolf, 1997). 
Initial reports of eukaryotic assembly demonstrated that it mimicked archaeal assembly 
(Frankenberg, Hsu, Yakota, Kim, & Clark, 2001; Groll, Brandstetter, Bartunik, Bourenkow, & 
Huber, 2003; Zwickl, Kleinz, & Baumeister, 1994). Archaeal proteasomes also appear to 
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assemble via an α ring dependent pathway, with α ring formation being an essential first step for 
assembly. However, a study looking at recombinantly expressed archaeal subunits demonstrated 
that an alternative α ring independent pathway is also possible. Mutations were made to the α 
subunits to disrupt α ring formation. When these non-ring forming α subunits where mixed with 
β subunits, proteasomes still assembled, indicating that proteasomes can assemble through the 
initiation of α/β subunit interactions. This alternative pathway is redolent of the bacterial 
pathway (discussed below), where fully formed α rings are not a necessary first step to initiate 
assembly (Panfair, Ramamurthy, & Kusmierczyk, 2015). 
Bacterial 20S subunits, like eukaryotic and archaeal subunits, arrange into four 
heptameric rings α7β7β7α7 (Tamura et al., 1995; Voges, Zwickl, & Baumeister, 1999). One 
major difference between eukaryotic and bacterial assembly occurs at the first step. Eukaryotic 
assembly initiates through α ring formation (Hirano et al., 2005). Bacterial assembly initiates 
through the interaction of α and β subunits, possibly α/β dimers. These dimers were suggested to 
arrange into a half-proteasome intermediate, which consists of one α ring and one β ring 
(Sharon, Witt, Glasmacher, Baumeister, & Robinson, 2007; Zuhl, Seemuller, Golbik, & 
Figure 1.2 Canonical 20S CP assembly pathway 
α and β subunits assemble to form the 20S CP. At least four assembly intermediates have been 
isolated: 13S, 15S, half proteasome, and pre-holoproteasome. Assembly is aided by assembly 
chaperones Ump1, Pba1-Pba2, Pba3-Pba4. 
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Baumeister, 1997). Two half-proteasomes will dimerize forming a pre-holoproteasome. Upon 
maturation, like in eukaryotes, the β subunit propeptide will autocatalytically cleave producing a 
catalytically active 20S proteasome (Zuhl et al., 1997).  
1.5.1 Chaperoned 20S CP Assembly 
Each subunit of the eukaryotic 20S CP occupies a specific position in the final quaternary 
structure. To achieve proper assembly, this process must be well regulated within the cell. 
Assembly chaperone proteins function to ensure proper 20S CP assembly by preventing off 
pathway interactions and aiding in assembly kinetics. Chaperones can be either extrinsic or 
intrinsic. Extrinsic chaperones are proteins that participate in assembly but are independent from 
the 20S CP components and do not take part in the assembled 20S CP. There are five dedicated 
eukaryotic 20S CP assembly chaperone proteins Ump1, Pba1, Pba2, Pba3 and Pba4. There is 
also evidence to suggest that Blm10, a 20S CP activator, may also participate in 20S CP 
assembly. Intrinsic chaperones include features of specific subunits, such as N-terminal or C-
terminal extensions, that help guide assembly. While bacterial and archaeal proteasomes are less 
complex than their eukaryotic counterpart, some of these regulatory features appear to be 
evolutionarily conserved. 
1.5.2 Pba1-Pba2 (PAC1-PAC2) 
Pba1 and Pba2 (PAC1 and PAC2 in mammals) form a heterodimer associated with early 
proteasomal intermediates in both yeast (X. Li et al., 2007) and mammals (Hirano et al., 2005). 
While yeast lacking Pba1-Pba2 are still viable (Kusmierczyk et al., 2011), knockout of PAC1, 
the mammalian homolog of Pba1, in mice results in embryonic lethality (Sasaki et al., 2010). 
This heterodimer participates throughout entire assembly process. It likely has several functions; 
some of the functions described for this chaperone include, preventing premature 19S RP 
binding (Wani, Rowland, Ondracek, Deeds, & Roelofs, 2015) and stabilizing the formation of 
α rings (Hirano et al., 2005; Kusmierczyk & Hochstrasser, 2008; Le Tallec et al., 2007; Wani et 
al., 2015). Furthermore, these proteins were crystalized with mature 20S, which may also suggest 
a role outside of assembly (Stadtmueller et al., 2012).  
Pba1 and Pba2 have functional C-terminal HbYX motifs (Kusmierczyk et al., 2011). The 
exact binding pockets were identified through a crosslinking strategy (Tian et al., 2011) and 
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confirmed in the 20S-Pba1-Pba2 crystal structure (Stadtmueller et al., 2012). The Pba1 C-
terminus binds to the α5-α6 intersubunit pocket, while the Pba2 C-terminus binds to the α6-α7 
intersubunit pocket (Stadtmueller et al., 2012). This heterodimer interacts with the same α ring 
surface as 20S CP activators, such as the 19S RP, but has a higher affinity for α rings containing 
intermediates than α rings that are associated with mature 20S CPs (Wani et al., 2015).  
Recently, single particle electron microscopy (EM) in combination with crosslinking 
mass spectrometry (CX-MS) were used to determine the structure of Pba1-Pba2 bound to a 15S 
intermediate (Kock et al., 2015). This analysis demonstrated that the α rings in intermediates are 
much broader than the mature 20S CP. Pba1-Pba2 sit within this broad opening making 
substantial contacts with several α subunits. Upon maturation, the Pba1-Pba2 heterodimer is 
squeezed out the pore opening and sits on top of the α ring (Kock et al., 2015). Pba1-Pba2 stay 
bound to the α ring until the β subunits are processed. It has been hypothesized that Pba1-Pba2 
binding is regulated by allosteric signaling between the maturing β subunits and the Pba1-Pba2 
binding sites. This hypothesis was initially formed by the observation that archaeal orthologs of 
Pba1-Pba2, PbaA and PbaB (discussed below) in Methaoncoccus maripaludis, bound 
exclusively to the archaeal 20S that contained β propeptides but not to mature 20S CP 
(Kusmierczyk et al., 2011). Again this mechanism was suggested by Wani et al., (2015) who 
pointed out that β7 makes direct contact with α6 and α7, which are the α subunits that Pba1-
Pba2 bind (Stadtmueller et al., 2012), and this direct interaction could be used to induce a 
conformational change to the α ring during maturation (Wani et al., 2015).  
 In contrast to the above hypotheses, Stadmueller et al indicated through binding kinetics 
that the Pba1-Pba2 heterodimer can bind to the mature 20S CP, suggesting that the Pba1-Pba2 
heterodimer may also have a functional role with mature 20S CP (Stadtmueller et al., 2012). 
However, it is important to note that this binding was observed under non-physiological (low) 
salt conditions. When the salt concentration was increased Pba1-Pba2 binding affinity decreased, 
therefore it is unclear if the binding observed is functionally relevant. 
1.5.2.1 Archaeal Orthologs PbaA and PbaB 
Archaeal orthologs of Pba1 and Pba2, PbaA and PbaB, were first identified in 
Methanococcus maripaludis (Kusmierczyk et al., 2011). These two proteins contain C-terminal 
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HbYX motifs and interact with proteasomal precursors. PbaA’s HbYX motif, but not PbaB’s, is 
essential for binding to proteasome intermediates (Kusmierczyk et al., 2011). 
Another group looking at archaeal homologs PbaA and PbaB in Pyrococcus furiosus, 
revealed PbaB forms a homotetramer, binds preferentially to the mature 20S, and can act as a 
proteasomal activator (Kumoi et al., 2013). This same study noted that PbaA in Pyrococcus 
furiosus has a C-terminal HbYX motif, but does not bind 20S CP (Kumoi et al., 2013). To 
elucidate its function this same group crystalized PbaA (Sikdar, Satoh, Kawasaki, & Kato, 2014). 
PbaA forms a homopentamer, where the C-terminus is buried within the structure (Sikdar et al., 
2014). 
There is still much to learn regarding the functional roles of PbaA and PbaB. In 
Methanococcus maripaludis PbaA appears to be functionally related to the eukaryotic 
proteasome assembly chaperone Pba1-Pba2, while PbaB’s function is not clear (Kusmierczyk et 
al., 2011). In Pyrococcus furiosus PbaB acts as an activator, while PbaA’s function is still 
unknown (Kumoi et al., 2013; Sikdar et al., 2014).  
1.5.2.2 Bacterial Orthologs 
A bioinformatic study in 2008 revealed that Mycobacterium tuberculosis contained two 
orthologs to PAC2, Rv2125 and Rv2714 (Iyer, Burroughs, & Aravind, 2008). Both proteins 
crystalized as trimers (L. Bai et al., 2017; Grana et al., 2009). Structural features of Rv2714 hint 
that it may function in a biosynthetic pathway (Grana et al., 2009). A recent study examined 
Rv2125 and Rv2724 in relationship to proteasomes. Immunoprecipitation studies revealed that 
neither ortholog interacted with open gate M. tuberculosis 20S CP (L. Bai et al., 2017). 
Furthermore, disruption of the Rv2125 in M. tuberculosis had no obvious phenotype (L. Bai et 
al., 2017), and proteomic analysis of the mutant strain showed no major differences in protein 
expression levels when compared to wild type (L. Bai et al., 2017). The authors of this study 
concluded that Rv2125 and Rv2714 are not proteasome assembly chaperones and likely do not 
participate in proteasome biology (L. Bai et al., 2017). 
Rv2125 and Rv2714 lack a C-terminal HbYX motif, which is the mechanism by which 
Pba1 and Pba2 bind to eukaryotic 20S CPs (Kusmierczyk et al., 2011; Stadtmueller et al., 2012; 
Tian et al., 2011); and one of the primary roles described for Pba1-Pba2 is stabilization of α 
rings (Hirano et al., 2005; Wani et al., 2015) which prokaryotic proteasomes do not form. 
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However, there is considerable evidence demonstrating this class of chaperones also has non-
HbYX mediated interactions with assembling 20S proteasomes (Howell et al., 2017). For 
instance, Pba1-Pba2 interact with a subset of α subunits in yeast (Kusmierczyk et al., 2008; Le 
Tallec et al., 2007) and mammalian cells (Hirano et al., 2005). Furthermore, Pba1-Pba2 were 
shown to make substantial contacts with several α subunits while sitting within the α ring of a 
15S intermediate (Kock et al., 2015); it is possible that these Pba2 homologues may have non-
HbYX interactions with proteasome intermediates. Disrupting Rv2125 in M. tuberculosis had no 
obvious growth defects (L. Bai et al., 2017), yet similar observations were made in yeast: pba1∆, 
pba2∆, and pba1∆pba2∆ had no obvious growth defects (X. Li et al., 2007). Rv2125 did not 
bind to mature 20S proteasomes (L. Bai et al., 2017), but whether Rv2125 or Rv2714 interact 
with assembling proteasomes remains to be elucidated. 
1.5.3 Pba3-Pba4 (PAC3-PAC4) 
Pba3 and Pba4 were identified and characterized by several different groups at roughly 
the same time. The mammalian homolog of Pba3, PAC3, was initially identified bound to 
proteasomal intermediates in mammalian cells. PAC3 was shown to form a dimer and bind 
exclusively to one α subunit, α2, and to several β subunits (Hirano et al., 2006). Knockdown 
experiments suggested that PAC3 is involved in α ring formation (Hirano et al., 2006). Shortly 
after the characterization of PAC3, its yeast ortholog (Poc3) was discovered and found to form a 
40 kDa heterodimer with Poc4, the ortholog of mammalian PAC4 (Le Tallec et al., 2007). Two 
other groups independently described the functionality of this heterodimer. These groups 
identified these proteins as Dmp1-Dmp2 (Yashiroda et al., 2008) and Pba3-Pba4 (Kusmierczyk 
et al., 2008); for simplicity these chaperones will be referred to as Pba3-Pba4. The Pba3-Pba4 
heterodimer ensures that the α3 subunit is incorporated in the α ring in-between α2 and α4 
(Kusmierczyk et al., 2008). It has also been suggested that this heterodimer ensures the 
incorporation of α4 into the α ring (Takagi et al., 2014). One study which looked at pba4∆ cells 
identified an off pathway complex in which α2 had replaced α4 in the α ring (Takagi et al., 
2014). Pull down experiments done independently by two different labs indicated that this 
heterodimer associates with α5 (Kusmierczyk et al., 2008; Yashiroda et al., 2008), and a crystal 
structure of Pba3-Pba4-α5 was solved (Yashiroda et al., 2008). Furthermore, Pba3 and Pba4 
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were shown to interact with α6 (Yashiroda et al., 2008) and somewhat with α1 (Kusmierczyk et 
al., 2008). 
1.5.4 Ump1 (POMP) 
Ump1was the first proteasome assembly chaperone to be characterized (Ramos, 
Hockendorff, Johnson, Varshavsky, & Dohmen, 1998). Ump1 is intrinsically disordered (Sa-
Moura, Simoes, et al., 2013; Uekusa et al., 2013) and is found bound to one of the earliest 20S 
CP intermediates, the 13S complex (X. Li et al., 2007). This chaperone stays associated with the 
assembling 20S CP until two half-proteasomes dimerize. This results in Ump1 being 
encapsulated in the newly formed PHP, and once the β subunits are processed Ump1 becomes 
the first proteasomal substrate (X. Li et al., 2007; Ramos et al., 1998).  
When UMP1 is deleted in yeast cells there are fewer 20S CPs and 26S proteasomes; 
additionally, there is a buildup of proteasomal precursors. Oddly, these precursors contained 
chymotrypsin-like activity, which is normally associated with processed β5, suggesting that 
Ump1 may normally inhibit the autocatalytic activity of β5 (Ramos et al., 1998). Another 
hypothesis proposed that the role of Ump1 is to ensure that β7 is in place before the two half-
proteasomes dimerize (X. Li et al., 2007). It has been suggested that both hypotheses are likely to 
be correct. Ump1’s N-termini and C-termini may each be fulfilling one of these functions 
(Howell et al., 2017). A recent study looking at electron microscopy with crosslinking and mass 
spectrometry argued that Ump1 interacts within the interior α/β subunit interface of the 15S 
intermediate (Kock et al., 2015). The C-terminus is likely important for these contacts, (Burri et 
al., 2000; Howell et al., 2017), and may be responsible stabilizing incoming β subunits (Howell 
et al., 2017), including β5. The N-terminus of Ump1 is near β6 and is likely extending outside of 
the β ring (Kock et al., 2015). Thus, the N-terminus is probably well positioned to block 
premature dimerization and also to detect β7 incorporation, which would then presumably 
relieve the Ump1-dependent block (Howell et al., 2017).  
1.5.5 Blm10 
A sixth possible assembly chaperone, Blm10, was first described as a proteasomal 
activator (Schmidt et al., 2005). Blm10 can bind to the 20S CP α ring and stimulate peptide 
hydrolysis in an ATP independent manner (Schmidt et al., 2005; Ustrell, Hoffman, Pratt, & 
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Rechsteiner, 2002). However, unlike the 19S RP which uses multiple C-termini to bind the α 
intersubunit pockets, Blm10 is a large protein (~250 kDa) that folds to form a dome over the α 
ring, binding to the α5-α6 intersubunit pocket via a single C-terminus (Sadre-Bazzaz, Whitby, 
Robinson, Formosa, & Hill, 2010). Blm10 binds to this pocket via a C-terminal HbYX motif 
(Dange et al., 2011). Blm10 localizes to the nucleus and has been implicated in DNA repair 
(Blickwedehl et al., 2008; Blickwedehl et al., 2007; Doherty et al., 2012; Ustrell et al., 2002), 
mitochondrial function (Sadre-Bazzaz et al., 2010), and spermatogenesis (L. Huang, Haratake, 
Miyahara, & Chiba, 2016; Khor et al., 2006; Qian et al., 2013). 
Shortly after its original characterization, Blm10 was identified associating with 
proteasomal precursors in a yeast strain over expressing β7. The amount of precursors associated 
with Blm10 increased when the propeptide of β5 was deleted (X. Li et al., 2007). While a 
BLM10 deletion had only a modest effect on proteasome assembly at low temperatures, a BLM10 
deletion combined with a truncation of the β7 C-terminal extension (β7∆C19) had a severe 
growth defect that was not observed in the single β7∆C19 (Marques, Glanemann, Ramos, & 
Dohmen, 2007). This double mutant accumulated proteasomal precursors, had reduced peptidase 
activity, and contained unprocessed β2 in the 20S and 26S proteasomes (Marques et al., 2007). 
These results strongly advocate that Blm10 contributes to the stabilization and maturation of 20S 
CP, although the mechanism of this interaction is unknown. 
1.5.6  β Subunit Propeptides 
Subunits β1, β2, β5, β6, and β7 are synthesized with cleavable propeptides. The 
proteolytic subunits β1, β2, and β5 undergo autocatalytic processing of their propeptides, 
exposing a N-terminal threonine nucleophile (Huber et al., 2016). These propeptides protect 
Thr1 from deactivation by N-terminal acetylation (Arendt & Hochstrasser, 1999; Groll et al., 
1999; Jager, Groll, Huber, Wolf, & Heinemeyer, 1999).  
Deletion of the β5 propeptide in yeast,  β5∆pro, is lethal (Chen & Hochstrasser, 1996). 
To further characterize assembly events, Li et al. carried out a high copy suppressor screen with 
 β5∆pro and with β5 propeptide mutants that have an assembly defect. They discovered that high 
copy expression of β7 (β7HC) suppressed the assembly defect observed in the β5 propeptide 
mutants. Moreover, the β7HC suppressed the lethal phenotype of the  β5∆pro . When a  β5∆pro 
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subunit variant is co-expressed with wild type β5, the β5∆pro is incorporated into the 20S poorly. 
However, if β7 is overexpressed at the same time, the  β5∆pro variant incorporates into the 
assembling 20S more readily (X. Li et al., 2007). The authors suggest that the β5 propeptide and 
β7 likely assist a common step in assembly after 15S formation (X. Li et al., 2007). Furthermore, 
the β7HC suppression of  β5∆pro was shown to be dependent on the β7 C-terminal tail (see 
below). When the last 15 residues of the β7 C-terminal tail were deleted, the high copy 
suppression of  β5∆pro was abolished (X. Li et al., 2007). β7’s C-terminus and the β5 propeptide 
have overlapping functions (X. Li et al., 2007; X. Li, Li, Arendt, & Hochstrasser, 2016). The 
function of the β5 propeptide has also been linked to Ump1 because an UMP1 deletion can also 
suppress the lethality of  β5∆pro (Ramos et al., 1998). In addition to elucidating the roles of 
β5pro and β7, proteasomes purified and analyzed from the strain containing β5∆pro with β7 
(β7HC) over expression accumulated 15S intermediates and an unidentified low molecular weight 
species (below the 15S) (X. Li et al., 2007).  
Unlike β5 the propeptide, β1 and β2 propeptides are not essential for viability in yeast; 
however, deletion of β2’s propeptide, or mutating the threonine nucleophile to an alanine, results 
in a growth defect (Arendt & Hochstrasser, 1997; Jager et al., 1999). When both β1 and β2’s 
propeptides are deleted a more severe growth defect is seen than in the β2∆pro alone (Arendt & 
Hochstrasser, 1999). Very little is known about β7’s propeptide besides that it is not essential in 
yeast and is partially processed by β2 during assembly (Groll et al., 1999). β6’s propeptide 
appears to have a functional role in assembly. Comparable to the β5 propeptide, deletion of the 
β6 propeptide is lethal and may be rescued by an UMP1 deletion (X. Li et al., 2007).  
1.5.6.1 β Propeptide Function in Bacterial 20S 
While no proteasome chaperones have been identified in bacterial species to date, 
intrinsic features of the subunits themselves are important for assembly. Depending on the 
bacterial species, the same intrinsic features appear to have different roles. In Rhodococcus 
erythropolis the β subunit propeptide is important for promoting assembly, but it is not essential 
for viability (Kwon, Nagy, Adams, Baumeister, & Jap, 2004; Zuhl et al., 1997). In contrast, the 
M. tuberculosis proteasome β subunit propeptide has an inhibitory effect on assembly and 
maturation (D. Li et al., 2010). 
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1.5.7 C-terminal Tails of β subunits 
 In addition to propeptides, the C-terminal extensions of β7 and β2 are important for 20S 
assembly. The β7 extension extends from one half-proteasome and inserts into the other half-
proteasome upon dimerization. The β2 extension wraps around the β3 subunit within the same β 
ring (Groll et al., 1997). When the last 19 residues of β7 are truncated (β7∆C19), there is an 
accumulation of half-proteasome complexes, implicating the last 19 residues of β7 as an 
essential component for efficient half-proteasome dimerization (Ramos, Marques, London, & 
Dohmen, 2004). When the last 30 residues of the yeast β2 C-terminal tail were truncated, the 
yeast were no longer viable (Ramos et al., 2004). 
1.5.8 Intrinsic Features of α Subunits 
α subunits and β subunits share similar tertiary structures (Lowe et al., 1995); however, α 
subunits have N-terminal extensions. These extensions serve as a gating mechanism for the fully 
assembled 20S (Rabl et al., 2008; Saeki & Tanaka, 2007; Smith et al., 2007), and they contain a 
conserved α-helix (H0) which is important for assembly (Zwickl et al., 1994). This feature of α 
subunits allows them to form stable rings, whereas β subunits lack an H0 helix and do not form 
stable rings on their own (Zwickl et al., 1994). In addition to the H0 helix there are likely unique 
α subunit functions in regard to assembly. The Fub1 (function of boundary 1) protein has been 
shown to interact with 20S CP subunits (Hatanaka et al., 2011). Double deletion of FUB1 and 
PBA4 in yeast results in lethality, which can be suppressed by the additional deletion of α3 
(Yashiroda et al., 2015). Interestingly, N-terminal deletion of α7 also suppressed this lethality, 
but not the N-terminal deletion of α3 (Yashiroda et al., 2015). While the focus of this study was 
on Fub1, it does shed light on the possibility that the α7 subunit’s N-terminus has a functional 
role outside of 20S CP gating (Yashiroda et al., 2015).  
1.6 General Chaperones Involved in Assembly 
The TRC/GET protein pathway (transmembrane recognition complex (TRC)/guided entry 
of tail-anchored (GET)) has been implicated in 20S CP assembly. The TRC (mammals)/GET 
(yeast) pathway mediates the insertion of tail-anchored (TA) proteins into the ER. Its 
involvement in proteasome assembly was initially determined through a genetic screen for 
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mutants that showed synthetic growth defects with nas6∆ in yeast (Nas6 is an RP assembly 
factor) (Akahane, Sahara, Yashiroda, Tanaka, & Murata, 2013). The nas6∆ screen identified a 
growth defect in strains lacking GET3. Further examination of GET1, GET2, and GET3 deletions 
in combination with deletions involved in proteasome assembly (UMP1, NAS6, or HSM3) each 
yielded a synthetic growth defect (Akahane et al., 2013). 
 In addition to studies done in yeast, the mammalian homolog of GET3, TRC40, was 
examined. TRC40 knockdown in HEK293T cells resulted in an accumulation of ubiquitinated 
proteins, and a reduction in proteasomal peptidase activity, which suggested that the TRC 
pathway (similar to GET), may also be involved in proteasome assembly (Akahane et al., 2013). 
Furthermore, a deletion of the most upstream component of the TRC pathway, Bag6, a 
multifunctional chaperone, was shown to hinder proteasome assembly. Specifically, the Bag6 
knockdown induced an accumulation of proteasomal intermediates and caused a defect in RP 
assembly (Akahane et al., 2013). These results suggested that membrane insertion of some 
unknown TA protein, along with Ump1 and the propeptides of the β subunits, might be 
responsible for efficient assembly of β subunits on α rings (Akahane et al., 2013). These results 
are consistent with a previous study done in mammals which demonstrated that early 20S CP 
assembly intermediates bound by POMP (mammalian homolog of Ump1) are associated with the 
ER membrane (Fricke, Heink, Steffen, Kloetzel, & Kruger, 2007). 
 Heat shock proteins (Hsps) of the Hsp70 family have been routinely detected in high 
throughput mass spectrometry studies looking at purified proteasomes (Gong et al., 2009; 
Guerrero, Milenkovic, Przulj, Kaiser, & Huang, 2008; Verma et al., 2000). Interpreting this data 
is difficult because on the one hand, Hsp70 proteins are very abundant and frequently 
represented in collections of non-specific proteins routinely detected by mass spectrometry 
(Mellacheruvu et al., 2013). On the other hand, Hsp70 proteins have well established roles in the 
ubiquitin-proteasome system, which include enhancing substrate ubiquitination and delivery of 
substrates to the proteasome (Arndt, Rogon, & Hohfeld, 2007; Huyer et al., 2004; Kettern, 
Dreiseidler, Tawo, & Hohfeld, 2010; Metzger, Maurer, Dancy, & Michaelis, 2008; Plemper, 
Bohmler, Bordallo, Sommer, & Wolf, 1997; Shiber & Ravid, 2014). However, no role in 
proteasome assembly has been ascribed to these proteins. Recently a study that examined both 
20S intermediates and intact 20S CP in yeast via native PAGE and subsequent mass 
spectrometry, revealed that the yeast Hsp70 proteins, Ssa1/2, associated with early 20S CP 
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intermediates, but not the fully assembled 20 CP (Hammack, Firestone, Chang, & Kusmierczyk, 
2017). When these proteins were deleted in yeast cells the intermediates they associated with 
were greatly reduced, suggesting Ssa1/2 are important for stabilizing these intermediates. Other 
Hsp proteins have been identified interacting specifically with assembling proteasomes. Hsp90 
was shown to be important for 26S assembly (Yamano et al., 2008). 
1.7 Alternative Proteasomes 
In eukaryotes the canonical 20S CP is ubiquitous. Variations of this structure allow for 
cellular adaptation or tissue specific function. The alternative assemblies identified to date 
include the α4-α4 proteasome, described in yeast and in mammalian cells, the 
immunoproteasome and thymoproteasome, found in vertebrates, and the testis specific 20S CP 
represented in Drosophila and in mammals. 
1.7.1 α4-α4 Proteasomes 
The α4-α4 proteasome was first described by Velichutina et al (2004). In yeast, α3 is the 
only non-essential 20S CP subunit, and through a crosslinking strategy it was determined that 
when α3 is deleted, α4 readily takes its place on the α ring (Velichutina, Connerly, Arendt, Li, & 
Hochstrasser, 2004). The deletion of Pba3-Pba4 chaperone also induces the formation of these 
alternative proteasomes (Kusmierczyk et al., 2008) The Pba3-Pba4 chaperone is important for α 
ring assembly, ensuring α3 is incorporated in-between α2 and α4. Furthermore, yeast expressing 
these alternative proteasomes can tolerate heavy metal stress better than wild type yeast cells 
(Kusmierczyk et al., 2008). This might be due to the alternative α ring gate formed in the 
absence of α3. Deletion of α3’s N-terminus results in an opening of the 20S CP α ring gate 
(Groll et al., 2000). Recently this alternative proteasome was described in mammalian cells, and 
the levels of this alternative proteasome are regulated by PAC3-PAC4, the mammalian homologs 
of Pba3-Pba4 (Padmanabhan, Vuong, & Hochstrasser, 2016). 
1.7.2 Immunoproteasome and Thymoproteasome 
The immunoproteasome (iCP), iCP sub-types, and thymoproteasome (tCP) are 20S CP 
variants that work as part of the immune system in vertebrates. The iCP was first characterized 
by Aki et al (1994) when they examined the effect of interferon-γ (IFNγ) on proteasomes. In the 
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iCP, instead of the β1, β2, and β5 subunits, these proteasomes contain paralogs β1i, β2i, and β5i. 
In addition to being induced by IFNγ, they are also induced by tumor necrosis factor (TNF) (Aki 
et al., 1994; Tanaka, 1994). These proteasomes are important for adaptive immunity, since they 
produce peptides that bind to the major histocompatibility complex (MHC), which is important 
for antigen presentation (Gaczynska, Rock, & Goldberg, 1993; Kincaid et al., 2011; Rock & 
Goldberg, 1999).  
Sub-types of iCPs have been described in HeLa cells exposed to INFγ (Klare, Seeger, 
Janek, Jungblut, & Dahlmann, 2007), cancer cell lines, and in human tissues (Guillaume et al., 
2010). Guillaume et al (2010) identified two iCP sub-types, one where β5i was the only 
immuno-subunit and another where only β5i and β1i were present. These were identified in 
cancer cell lines not exposed to INFγ and in some normal human tissues including liver, small 
bowel, colon, and monocyte-derived dendritic cells (Guillaume et al., 2010). The levels of sub-
type iCPs were highly variable between individual tissue samples, and the authors suggested that 
this may be due to the variability in an individual’s inflammatory response (Guillaume et al., 
2010). The tCP, like the iCP contains β1i and β2i, but instead of β5i it has a specialized β5t 
subunit. β5t is only expressed in thymic epithelial cells. This alternative proteasome is important 
for the development of CD8 T cells in the thymus (Murata et al., 2007). 
1.7.3 Assembly of the Immunoproteasome and Thymoproteasome 
The immuno-subunits assemble into CPs more readily than β1, β2, and β5 (Griffin et al., 
1998). This is likely due to alternative assembly pathway(s) employed by the immuno-
proteasome subunits. During iCP assembly β1i and β2i are the first two subunits to bind to the α 
ring, with β1i binding first (M. Bai et al., 2014; Griffin et al., 1998; Groettrup, Standera, 
Stohwasser, & Kloetzel, 1997; Nandi, Woodward, Ginsburg, & Monaco, 1997), which differs 
from canonical assembly where β2, β3, and β4 bind first to the α ring (Hirano et al., 2008). 
Furthermore, β5i will bind immediately after β3, which again deviates from the normal CP 
assembly, which requires β4 to incorporate before β5 (M. Bai et al., 2014). The assembly 
mechanisms of the immunoproteasome sub-types β5i and β5i β1i have not been elucidated. 
While the assembly roles of β5 with Ump1 have been well established (X. Li et al., 2007; 
Ramos et al., 1998), there are conflicting reports regarding β5i’s role in iCP biogenesis (M. Bai 
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et al., 2014; Heink, Ludwig, Kloetzel, & Kruger, 2005; Jayarapu & Griffin, 2004; Witt et al., 
2000). Bai et al suggested the mature portion of β5i is responsible for early incorporation during 
iCP assembly. This was concluded by testing the incorporation of β5 modified with the β5t 
propeptide and the β5i propeptide. The construct with the β5t propeptide incorporated more 
rapidly than wild type β5, whereas the construct with the β5i propeptide assembled in to CPs at 
the same rate as wild type (M. Bai et al., 2014). Regarding β5i, Witt et al similarly suggested that 
while β5i’s propeptide promoted correct incorporation and maturation it was not essential for 
iCP incorporation, since β5i∆pro incorporated into iCPs (Witt et al., 2000). A report by Heink et 
al argued that β5i and its propeptide are important for iCP biogenesis. Through yeast two-hybrid 
screens and pull down assays, β5i and UMP1 interactions were illustrated as being essential for 
the rapid biogenesis of iCPs (Heink et al., 2005). UMP1 contacted both β5i’s propeptide and 
mature form, but had a higher affinity for the proform for β5 (Heink et al., 2005). Another yeast 
two-hybrid screen detected UMP1 interactions with β1i, β1, β5, β6, and β7, but not β5i 
(Jayarapu & Griffin, 2004). 
The tCP follows a similar assembly pathway to the iCP, except β5t incorporates instead of 
β5i. Even though both β5t and β5i are transcriptionally expressed in thymo epithelial cortical 
cells, nearly all CP species are tCP. Bai et al’s work described the importance of β5t’s propeptide 
for early incorporation on to the tCP. 
A recent study revealed that the β5i, β1i, and β5t were highly enriched for variation 
amongst the public human genome sequence databases. β5t appeared to be the most enriched for 
predicted damaging variations (Nitta et al., 2017). Some of these β5t variations were examined 
in mice and showed impaired CD8 T cell development in vivo, suggesting that β5t 
polymorphisms influence T cell development which may contribute to an individual’s 
predisposition to autoimmunity (Nitta et al., 2017).  
Even though these proteasomes are specialized, the canonical 20S CP assembly chaperones 
and activators participate in the biogenesis and function of these proteasomes. Assembly 
chaperones, UMP1, PAC1-PAC2, and PAC3-PAC4, function during iCP and tCP biogenesis (M. 
Bai et al., 2014; Heink et al., 2005). The presence of UMP1 appears to be critical for the early 
incorporation β1i and β2i on to the α ring (M. Bai et al., 2014), while UMP1 β5i interactions are 
important for accelerated immunoproteasome biogenesis (Heink et al., 2005). 
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1.7.4 Immunoproteasome Activators 
Activators that bind the iCP include the 19S regulatory particle (PA700), Blm10 (PA200), 
and 11S (PA28/REG αβ, and γ) . Both the 19S and Blm10 were discussed in previous sections 
1.2 and 1.5.5, respectively. The 19S RP can bind the iCP making a 26S immunoproteasome; in 
vitro this iCP has the highest rate of degradation (Cascio, Hilton, Kisselev, Rock, & Goldberg, 
2001; Raule, Cerruti, & Cascio, 2014) and has the most potential for generating peptides that are 
the appropriate size for MHC presentation directly or after trimming (Cascio, 2014). While 
Blm10 has been shown to increase the peptidase activity of the iCP (Pickering & Davies, 2012), 
so far there is no evidence of Blm10 producing peptides for antigen presentation. The PA28αβ 
activator (Dubiel, Pratt, Ferrell, & Rechsteiner, 1992; Ma, Slaughter, & DeMartino, 1992) is 
induced by IFNγ (Ahn et al., 1995; Realini, Dubiel, Pratt, Ferrell, & Rechsteiner, 1994), and is 
found throughout the cytoplasm of jawed vertebrates (Fort, Kajava, Delsuc, & Coux, 2015). 
PA28αβ is made up of two subunits, PA28α and PA28β, that form a heteroheptameric ring, 
PA28α4β3 (Huber & Groll, 2017; Z. Zhang et al., 1999). This activator is presumed to promote 
antigen presentation (Groettrup et al., 1996). 
PA28α and PA28β form homo-heptameric complexes when expressed recombinantly 
(Huber & Groll, 2017; Knowlton et al., 1997; Wilk, Chen, & Magnusson, 2000). PA28α7, 
PA28β7, and PA28α4β3 can each stimulate peptide hydrolysis of proteasomes (Huber & Groll, 
2017). PA28α7 and PA28α4β3 can bind both 20S CP and iCP, but in vivo binding has only been 
demonstrated for iCP (Ahn et al., 1995; J. Li & Rechsteiner, 2001; Pickering & Davies, 2012). 
Since PA28α4β3 is the most stable and active of the PA28 species identified, it is likely the 
relevant species in vivo (Huber & Groll, 2017).  
There are conflicting reports surrounding PA28αβ and iCP formation. One study looking 
at mouse knockouts for PA28α and PA28β, saw less iCP and concluded that PA28αβ is 
necessary for efficient iCP assembly (Preckel et al., 1999). Another study looking at 
PA28αβ deficient mice indicated that PA28αβ is not required for iCP assembly or antigen 
processing, but appears to be important for the processing of specific antigens (Murata et al., 
2001). Interestingly, both PA28αβ and 19S can simultaneously bind a 20S CP creating a 
PA28αβ-20S CP-19S proteasome hybrid (Hendil, Khan, & Tanaka, 1998; Tanahashi et al., 
2000). PA28αβ appears to modify the catalytic activity of the 26S proteasome such that it 
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enhances the variability of epitopes produced (Cascio, Call, Petre, Walz, & Goldberg, 2002). 
This activator reduces the size of peptides produced by the iCP. Other studies tested activator 
binding and activity under oxidative stress in mammalian cells, and showed that PA28αβ is 
induced under oxidative stress and in vitro stimulates both immunoproteasome and 20 CP 
degradation of oxidized substrates (Pickering & Davies, 2012). 
Another activator that can bind immunoproteasomes is PA28γ, which is a homolog of 
PA28αβ. This activator is not induced by INFγ, forms a homohepatmeric ring, and is localized to 
the nucleus (Masson, Andersson, Petersen, & Young, 2001; Rechsteiner, Realini, & Ustrell, 
2000). PA28γ is found throughout metazoans, but is not present in yeast and plants (Masson et 
al., 2001).  
The precise function of PA28γ is still under investigation. Mice deficient for PA28γ show 
mild phenotypes, such as slow growth and a ~10% reduction in size compared to wild type 
(Murata et al., 1999; Z. Zhang & Zhang, 2008). A study in Drosophila revealed that PA28γ 
increases the trypsin-like activity of the proteasome (Masson et al., 2001). Studies in mammalian 
cells have suggested roles that include regulating apoptosis (Barton et al., 2004; Z. Zhang & 
Zhang, 2008), cell proliferation (Z. Zhang & Zhang, 2008), immunity (Barton et al., 2004), 
oxidative stress (Pickering & Davies, 2012) and possibly spermatogenesis (L. Huang et al., 
2016). 
1.7.4.1 PA28γ homologue in Trypanosoma brucei 
Proteasomes were identified and purified from Trypanosoma brucei which is a parasitic 
protozoan that causes African sleeping sickness (Hua, To, Nguyen, Wong, & Wang, 1996). 
Shortly after its identification, a 26kDa protein (PA26) was found associating with active 20S 
(To & Wang, 1997). Further analysis showed that PA26 readily forms a hexameric ring when 
expressed recombinantly, and PA26 can bind rat 20S CP and stimulate peptide hydrolysis 
activity while recombinant human PA28α did not affect 20S from T. brucei (Y. Yao, Huang, et 
al., 1999). Yeast lack a PA28 homologue, yet the recombinantly expressed T. brucei PA26 can 
bind yeast 20S and stimulate peptide hydrolysis, as can recombinantly expressed human 
PA28αβ (Masters, Pratt, Forster, & Hill, 2005). 
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1.7.5 Testis Specific Proteasome  
Very little is known about testis specific proteasomes. They were first identified in 
Drosophila melanogaster and were characterized as having a unique α type subunit, the testis 
specific isoform Prosα6T, that is important for male fertility (Zhong & Belote, 2007). A testis 
specific proteasome (“spermatoproteasome”) was later described in mammals (Qian et al., 2013; 
Uechi, Hamazaki, & Murata, 2014). This proteasome contains a unique α4 subunit called α4s 
(Qian et al., 2013). This novel α4s has ~82-85% amino acid sequence identity with wild type α4 
and is only expressed in the testis, where the α4s CP is the predominant proteasome species 
(Qian et al., 2013; Uechi et al., 2014). Between the two studies that have characterized the α4s 
CP, there is some disagreement as to whether the immuno-β subunits are part of α4 CP. Qian et 
al., (2013) indicated that the immuno-β subunits are part of the α4s CP, while Uechi et al (2014) 
carried out IPs with α4s and did not pull down any immuno-β subunits. The activator PA200 
(Blm10) was associated with α4s CP more so than any other activator, suggesting α4s CP 
preferentially interacts with Blm10. Deletion of BLM10 in mice disrupted spermatogenesis (Qian 
et al., 2013).  
In addition to spermatoproteasomes, a 20S CP assembly chaperone ZPAC (zygote 
proteasome assembly chaperone), was described in mouse gonads and zygotes (Shin et al., 
2013). ZPAC was discovered when researchers were looking into the maternal-to-zygote 
transition during which maternal proteins are degraded by proteasomes and new proteins are 
transcribed and translated from the zygote’s genome. Further characterization of ZPAC revealed 
that it forms a complex with Ump1 that associates with 20S CP intermediates, and knockdown of 
ZPAC in embryos caused abnormal development (Shin et al., 2013). Another group looked at 
ZPAC’s role in mouse spermatogenesis. ZPAC was argued to be involved in germline survival 
and apoptosis (Shimizu et al., 2014). More work still needs to be done to elucidate the functional 
roles of ZPAC. 
1.8 Non-canonical Structures Formed by Proteasome Subunits 
Some proteasomal α subunits can readily form high molecular weight complexes. Gerards 
et al demonstrated that when human α7 is expressed recombinantly in E.coli, it forms a high 
molecular weight complex. This complex is a double ring structure with each ring consisting of 
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seven subunits (Gerards et al., 1997). This double ring structure was reminiscent of a complex 
observed with recombinantly expressed α subunits form archaea. When archaeal α and β 
subunits are recombinantly coexpressed they readily form proteasomes; however, when human 
α7 was coexpressed with β7, or β1 (both are the immediate neighbors of α7 within the adjacent 
β ring), no proteasome-like structures were formed (Gerards et al., 1997). When α7 was 
coexpressed with its α ring neighbors, α1 or α6, the α subunits assembled into heterogeneous 
complexes (Gerards, de Jong, Bloemendal, & Boelens, 1998). Recently, Ishii et al crystalized the 
α7 double ring structure. Consistent with the work done by Gerards and colleagues, this group 
demonstrated that the presence of α6 disrupts the formation of the α7 tetradecamer by forming 
smaller complexes consisting of α7 and α6 (Ishii et al., 2015). 
 To date no high molecular weight complexes of α7, α7-α1, or α7-α6 have been 
identified in vivo. We recently identified a non-canonical complex in yeast that consists of 
proteasome subunit α4 and Ssa1/2 (Hammack & Kusmierczyk, 2017). While no structural 
studies have been performed on this complex, our crosslinking strategy argues that this complex 
forms oligomers that we hypothesize to be α4 rings. The formation of this complex opens the 
door toward the possibility of extra-proteasomal roles for proteasome subunits. Experiments are 
currently underway to further characterize this complex. 
1.9 Proteasomes as Therapeutic Targets  
The proteasome degrades regulatory proteins within the cell. Proteasome inhibition has 
been shown to accumulate regulatory proteins such as cell cycle progression proteins (Cusack et 
al., 2001; S. A. Shah et al., 2001) and oncoproteins (Dietrich, Bartsch, Schanz, Oesch, & Wieser, 
1996). This accumulation sensitizes cells to apoptosis (reviewed by (Adams, 2004)). This 
apoptotic sensitivity is greater in malignant cells which makes proteasome inhibition a promising 
target for cancer therapy (Hideshima et al., 2001). There are three proteasome inhibitors 
currently on the market, and several others are in clinical trials (Manasanch & Orlowski, 2017). 
A recent study has suggested that miRNA may also be advantageous for proteasome inhibition 
(Zhang et al 2015).  
In addition to cancer therapy, targeting bacterial proteasomes may have therapeutic 
applications. Zeroing in on Mycobacterium tuberculosis proteasomes may be an effective 
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strategy for treating tuberculosis. Also, understanding the Pup-proteasome’s role in producing 
different types of metabolites, including antibiotic and antifungal compounds, in actinomycete 
Streptomyces coelicolor may be a useful in isolating new antibiotic and antifungal compounds.  
1.9.1 Proteasome Inhibitors 
Three proteasome inhibitors Velcade (brotezomib), Kyprolis (carfilzomib), and Ninlaro 
(ixazomib) have been approved for the treatment multiple myeloma (Kane, Bross, Farrell, & 
Pazdur, 2003; Kubiczkova, Pour, Sedlarikova, Hajek, & Sevcikova, 2014; Kuhn et al., 2007; 
Moreau et al., 2016; L. A. Raedler, 2016; Richardson & Anderson, 2003; Siegel, 2012). 
Brotezomib has also been approved to treat mantle-cell lymphoma (Holkova & Grant, 2012; L. 
Raedler, 2015). These inhibitors work by inhibiting the chymotrypsin activity of β5. Brotezomib 
was the first proteasome inhibitor used to treat multiple myeloma (Kane et al., 2003). It is a 
reversible dipeptide boronate inhibitor that targets both β5 and β5i and also interacts with β1 to a 
lesser extent (Demo et al., 2007). In addition to treating multiple myeloma and mantle-cell 
lymphoma, bortezomib shows promise in the treatment of atopic dermatitis (Kim, Cho, Cheon, 
& Kim, 2017). A study in mice showed brotezomib to increase the expression levels of claudin 1 
and ameliorate the symptoms of atopic dermatitis (Kim et al., 2017).  
Carfilzomib entered the market in 2012 (Thompson, 2013). It is an irreversible inhibitor 
belonging to the epoxyketone family and is based on the natural product epoxomicin (Groll, 
Koguchi, Huber, & Kohno, 2001; Harshbarger, Miller, Diedrich, & Sacchettini, 2015). 
Opozomib, an oral analogue of carfilzomib, is being tested in clinical trials and shows anti-
myeloma activity and is well tolerated (Hari et al., 2014; J. Shah et al., 2015). Ixazomib was 
approved by the FDA as the first orally administered proteasome inhibitor for the treatment of 
multiple myeloma (Moreau et al., 2016; L. A. Raedler, 2016). While the development of each 
new drug has improved patient outcomes, severe side effects are still observed and resistance can 
eventually develop.  
1.9.2 Endogenous Inhibitor MicroRNA-101 
MicroRNAs regulate gene expression by binding to target mRNA molecules. This 
binding suppresses translation of the mRNA transcript. Early studies looking at MicroRNA-101 
(miR-101) demonstrated that it was downregulated in cancer cell lines, and ectopic expression of 
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miR-101 suppressed tumor growth (Su et al., 2009; Varambally et al., 2008). Zhang et al 2015 
demonstrated that miR-101 acts as an endogenous proteasome inhibitor by targeting and down 
regulating the expression of proteasome assembly chaperone POMP (mammalian UMP1). 
Unlike the aforementioned inhibitors, miR-101 works by disrupting proteasome assembly (X. 
Zhang et al., 2015). Moreover, POMP suppression, by either miR-101 or by POMP siRNA, was 
able to re-sensitize cells resistant to bortezomib (X. Zhang et al., 2015). This work sheds light on 
how the assembly machinery may be targeted for cancer pharmacotherapy. 
1.9.3 Targeting Bacterial Proteasomes for Human Therapeutics 
In addition to targeting proteasomes for cancer therapy, bacterial proteasomes also serve 
as useful targets for the development of antibiotics and treatment of tuberculosis (TB). TB is a 
major global health problem. Per the World Health Organization, in 2015 there were 10.4 million 
new cases of TB; 1.4 million of those cases resulted in death (Global Tuberculosis Report, 
2016). The proteasome in M. tuberculosis appears to be a promising target for the development 
of therapeutic agents (Bibo-Verdugo, Jiang, Caffrey, & O'Donoghue, 2017; Samanovic & 
Darwin, 2016). One hypothesis is that nitric oxide (NO) is important for controlling bacterial 
growth, such as M. tuberculosis in humans (Choi, Rai, Chu, Cool, & Chan, 2002; Nicholson et 
al., 1996; Wang et al., 1998). A 2003 study screened 10,100 transposon mutants in M. 
tuberculosis for sensitivity to nitric oxide and other reactive nitrogen intermediates. Five mutants 
that displayed sensitivity were proteasome associated genes (Darwin et al., 2003). Furthermore, 
they demonstrated that treating wild type M. tuberculosis with proteasome inhibitor sensitizes it 
to reactive nitrogen intermediates (Darwin et al., 2003). Proteasomes inhibitors that target M. 
tuberculosis may prove to be useful treatments (Bibo-Verdugo et al., 2017), but targeting other 
unique aspects of the bacterial proteasome system, such as pupylation (Samanovic & Darwin, 
2016) or assembly may also be worthwhile. 
Another actinomycete, S. coelicolor, has potential implications for human therapeutics. 
This group of actinomycetes produces several different types of metabolites including antibiotic 
and antifungal compounds (Chater, Biro, Lee, Palmer, & Schrempf, 2010; Chater & Chandra, 
2008; Flardh & Buttner, 2009). Understanding how this actinomycete regulates its metabolism 
and maintains protein homeostasis is important for understanding the development of these 
compounds. A few groups have looked at the Pup-proteasome system in relationship to S. 
27 
 
coelicolor’s protein homeostasis and secondary metabolite production. Disruption or deletion of 
the Pup-ligase or the Pup-proteasome system results in sensitivity to cumene hyperoxide 
(Compton et al., 2015). Strains with a Pup deletion were also shown to be sensitive to hydrogen 
peroxide, have impaired spore formation, and produce less secondary metabolites (Boubakri et 
al., 2015; Mao et al., 2014). Furthermore, Boubarki and colleagues identified two Pup targets 
that are involved in antibiotic production, OsaA (Bishop, Fielding, Dyson, & Herron, 2004) and 
FtsI (Bennett et al., 2009). While this is the first published evidence of Pup being involved in S. 
coelicolor’s antibiotic production, another group suggested this role for Pup previously (Liu, 
Chater, Chandra, Niu, & Tan, 2013).  
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CHAPTER 2. NON-CANONICAL COMPLEXES 
Chapter 2 along with Appendix A were originally published in Biochemical and 
Biophysical Research Communications (BBRC). 
Hammack, L. J., & Kusmierczyk, A. R. (2017). Assembly of proteasome subunits into non-
canonical complexes in vivo. Biochem Biophys Res Commun, 482(1), 164-169. 
doi:10.1016/j.bbrc.2016.11.024 
2.1 Abstract 
Proteasomes exist in all domains of life. In general, they are comprised of a 
compartmentalized protease whose activity is modulated by one or more regulatory complexes 
with which it interacts. The quaternary structure of this compartmentalized protease, called the 
20S proteasome, is absolutely conserved and consists of four heptameric rings stacked coaxially. 
The rings are made of structurally related α and β subunits. In eukaryotes, assembly factors 
chaperone the α and β subunits during 20S biogenesis. Here we demonstrate that proteasome 
subunits can assemble into structures other than the canonical 20S proteasome in vivo. 
Specifically, the yeast α4 subunit forms high molecular weight complexes whose abundance 
increases when proteasome function is compromised. Results from a disulfide crosslinking 
approach are consistent with these complexes being ring-shaped. Though several eukaryotic α 
subunits can form rings when expressed recombinantly in bacteria, this is the first evidence that 
such noncanonical complexes exist in vivo. 
2.2 Introduction 
The 26S proteasome comprises two major sub assemblies: the 20S proteasome, also known 
as the core particle (CP), and a 19S regulatory particle (RP) (Beck et al., 2012; da Fonseca, He, 
& Morris, 2012). The CP consists of four heptameric rings built up from two structurally related 
subunits, α and β, in an α7β7β7α7 arrangement (Groll et al., 1997; Hu et al., 2006; Lowe et al., 
1995). In eukaryotes, the α and β rings contain seven different subunits, and peptide hydrolysis 
activity resides within the β1, β2, and β5 subunits. Assembly of the CP is guided by structural 
features intrinsic to the CP subunits and by extrinsic factors in the form of dedicated assembly 
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factors (reviewed in (Kunjappu & Hochstrasser, 2014)). There are five such factors in 
eukaryotes, Ump1 and Pba1–4 (called PAC1–4 in mammals). 
 Assembly of the CP begins with the formation of α rings which serve as a platform for 
the subsequent entry of β subunits until a half-proteasome (i.e. α7β7) intermediate is formed 
(Hirano et al., 2008). Two half-proteasomes dimerize to give rise to the CP, a process that 
coincides with the autocatalytic removal of propeptides on the enzymatically active β subunits 
(Chen & Hochstrasser, 1996). The assembly factors perform several functions, including: 
ensuring the correct placement of subunits within the rings (Kusmierczyk et al., 2008), 
performing key checkpoint functions (X. Li et al., 2007), preventing non-desirable interactions 
between CP subunits themselves (Hirano et al., 2005; Takagi et al., 2014) and preventing binding 
of RP to immature CP species (Wani et al., 2015). The end result is a fully functional CP with all 
subunits occupying a defined position. However, evidence has been mounting that the structure 
of the CP need not be considered fixed.  
 In the yeast Saccharomyces cerevisiae, the α3 subunit is not essential for viability; in 
α3∆ yeast cells, an alternative CP is formed in which a second copy of α4 occupies the position 
normally held by α3 (Velichutina et al., 2004). These “α4–α4 proteasomes”, so-called because 
their α rings now contain two neighboring α4 subunits, also arise in yeast when the Pba3-Pba4 
assembly factor is absent (Kusmierczyk et al., 2008) even though α3 is still present. Recently, 
α4–α4 proteasomes were shown to exist in mammalian cells, arguing that formation of this 
alternative CP is evolutionarily conserved (Padmanabhan et al., 2016).  
 Here we present additional evidence that the CP structure need not be considered 
immutable. In addition to enabling the formation of α4–α4 proteasomes, we find that α4 
assembles into high molecular weight complexes (HMWCs) that are most likely rings of α4 
subunits. Some eukaryotic α subunits can form non-canonical rings when expressed 
recombinantly in bacteria but the relevance of these structures was not clear (Gerards et al., 
1998; Gerards et al., 1997; Ishii et al., 2015; Y. Yao, Toth, et al., 1999). This is the first report of 
such structures existing in wild type cells in vivo, raising the possibility of functional 
significance. 
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2.3 Materials and Methods 
2.3.1 Strains and Yeast Culture 
Yeast strains are listed in Supplementary Table 1. The α2HF strain (MATa) was 
generated by backcrossing to the wild type the α2HF strain (MATα) kindly provided by Mark 
Hochstrasser. The crosslinkable α4 (α4CC) was engineered as described (Velichutina et al., 
2004), except we employed a C-terminal Flag tag. One liter yeast cultures were grown in YPD at 
30 °C to mid-log phase. Yeast cells were harvested by centrifugation at 4,000 x g and the pellets 
washed with 40 ml of H2O prior to storage at –80 °C. 
2.3.2 Yeast Lysis and Flag Purification 
Yeast cell pellets were thawed in cold water and gently resuspended in 48 ml of Buffer A 
(40 mM Hepes-NaOH pH 7.5, 10% (v/v) glycerol, 350 mM NaCl, 0.1% (v/v) Tween-20 
supplemented with yeast protease inhibitors (Sigma) according to manufacturer’s instructions). 
The suspension was transferred to a 50 ml bead beater lysis chamber along with 0.5 mm glass 
beads (BioSpec). The yeast cells were lysed via bead beating with cycles of 1 minute bead 
beating followed by one minute of rest/cooling for a total of 15 cycles. Total lysates were 
centrifuged at 11,000 rpm for 1 hour at 4 °C in a Beckman J2-21M centrifuge using a JA-20 
rotor. The supernatant (soluble lysate) was transferred to a fresh 50 ml conical tube and the 
protein concentration was measured via Bradford Assay (ThermoScientific) or BCA Protein 
Assay Kit (ThermoScientific). When processing parallel samples, equal amounts of protein from 
the soluble lysate were incubated with 200 µl of anti-Flag agarose resin (Sigma) overnight at 4 
°C. The anti-Flag agarose resin was collected in a 30 ml gravity column (Bio-Rad) and washed 
with 60 ml of Buffer A. The resin was then transferred to a fresh microcentrifuge tube and 
centrifuged for 30 seconds at 4,000 × g. Excess Buffer A was aspirated, and the Flag-tagged 
proteins were eluted with 300 µl of Flag peptide (Sigma), at a concentration of 5 µg/µl in Tris-
buffered saline (TBS), for 30 minutes at 4 °C. The eluted proteins were collected by transferring 
the resin mixture to a Pierce Micro-spin column (ThermoScientific) and centrifuging at 10,000 × 
g for 3 minutes.  
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2.3.3 Electrophoresis 
 Samples were subjected to SDS-PAGE and native PAGE as previously described 
(Kusmierczyk et al., 2011) except 4–15% non-denaturing polyacrylamide gradient gels, as well 
as 10%, 12% and 11–15% step gradient SDS-PAGE gels were used as indicated. For all gels, the 
migration of molecular size standards is indicated to the left of each gel image in the figures. The 
4–15 % gradient gels were precast Mini-PROTEAN TGX (Bio-Rad) while all others were 
poured in lab. For native PAGE, purified protein (20 µg) was mixed with 5× non-denaturing 
sample buffer (0.5 M Tris-HCl, pH 8.8, 50% (v/v) glycerol, traces of bromophenol blue). Non-
denaturing gels were run at 60 V for 10 hours at 4 °C. Substrate overlay assay was carried out as 
described (Kusmierczyk et al., 2011). The native gels were stained with Imperial Protein Stain 
(ThermoScientific). Loading control samples were run on reducing 12% SDS-PAGE. All SDS-
PAGE gels were stained with GelCode blue (ThermoScientific).  
 For Western blotting, samples were run on 10% SDS-PAGE gels and transferred to 
PVDF membrane for 1 hour at 15 V using a GENIE Electrophoretic Transfer (Idea Scientific). 
The membrane was blocked overnight with 5% (w/v) non-fat milk in TBS. The membrane was 
incubated with primary anti-Flag antibody (Sigma), diluted 1:2000 in 5% (w/v) non-fat milk in 
TBS, for 1 hour at room temperature with gentle rocking. The membrane was washed 3 times 
with TT Buffer (0.1 % (v/v) Tween-20 in TBS) for 5 minutes and then incubated for 1 hour at 
room temperature with gentle rocking in TT buffer containing secondary goat anti-mouse IgG1 
antibody (SouthernBiotech) diluted 1:5000. The membrane was again washed 3 times as above 
before adding ECL substrate (ThermoFisher) and exposing to film. 
2.3.4 Disulfide Crosslinking  
 Disulfide crosslinking was performed as described (Kusmierczyk et al., 2011). 
Crosslinked and noncrosslinked samples were mixed with 2 x SDS sample buffer without DTT 
and loaded onto 11-15% SDS PAGE step gradient gels. Where indicated, a 25 µl aliquot of each 
sample was reduced with 2 µl of 1M DTT at room temperature for 15 minutes.  
2.3.5 Depletion Assay  
 Yeast cell pellets were lysed and CP purified with anti-Flag agarose resin as above. 
Aliquots of the Flag eluates were subjected to depletion via immobilized-cobalt affinity resin 
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(ICAR) as described (Panfair et al., 2015),with the following modifications. The samples were 
applied to 150 µl of resin (TALON resin; Clontech) for 1 hour at 4 °C with gentle rocking. The 
flow through from the first ICAR purification was subjected to a second round of ICAR using a 
fresh 150 µl of resin.  
2.3.6 Mass Spectrometry Analysis 
 Slices were cut from indicated gels and submitted to the Indiana University School of 
Medicine Proteomics Core Facility (IUSM-PCF) to identify proteins by LC-MS/MS. 
Summarized and annotated data describing the identified proteins are presented in table format 
throughout the manuscript and supplementary information. The data analysis files provided by 
IUSM-PCF in Microsoft Excel format, can be found in the accompanying Data In Brief article 
(L. Hammack & A. R. Kusmierczyk, 2016). 
2.4 Results 
Initially, we set out to study the formation and function of α4–α4 proteasomes in yeast. 
We employed a crosslinking strategy (Velichutina et al., 2004) using an engineered α4 subunit 
(α4CC) with a C-terminal Flag epitope (Figure 2.1A). When α4–α4 proteasomes are present, the 
α4CC subunit gives rise to a diagnostic α4 dimer on non-reducing SDS-PAGE under mildly  
oxidizing conditions. This dimer was readily observed when CP was purified from α3∆ 
yeast. However, the α4 dimer was not observed in the wild type sample (lane 2) consistent with 
previous observations that α4-α4 proteasomes are not detectable (at least using this approach) in 
wild type yeast cells (Kusmierczyk et al., 2008; Velichutina et al., 2004).  
 Interestingly, additional bands appeared near the top of the SDS-PAGE gel under non-
reducing conditions. Like the α4 dimer, these species required the presence of α4CC and 
disappeared under reducing conditions (Figure 2.1B); they also failed to form in the absence of 
added oxidant (Figure 2.1C). This argues that these slowly migrating species were the result of 
the engineered disulfide crosslink. However, unlike the α4 dimer, these species were also present 
in wild type cells, albeit at lower levels compared to α3∆ cells (Figure 2.1B, lanes 2 versus 4). 
LC-MS/MS which confirmed the presence of α4 (not shown) consistent with the slowly 
migrating species being a multimer (or multimers) of α4 crosslinked to itself.  
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To determine if the slowly migrating species represented actual α4-containing high 
molecular weight complexes (HMWCs), we analyzed Flag-purified CP samples by native 
PAGE. The major complex in each sample, migrating near the 670 kDa size standard, was the 
CP (Appendix A, Supplementary Figure 1). Species migrating slower than the CP were likely 
complexes of CP and Blm10; these were more abundant in the α3∆ samples because CP lacking 
α3 are constitutively open and Blm10 preferentially binds to CP with an open (or disordered) 
gate (Lehmann, Jechow, & Enenkel, 2008). Species migrating faster than the CP were also 
observed, some of which were likely CP assembly intermediates (Appendix A, Supplementary 
Figure 1, bracket); if α4 HMWCs were present, they would likely be found among them. To 
better visualize these faster migrating species, all of our subsequent native PAGE gels were 
loaded with an excess of protein (Figure 2.2A). 
We excised several of these faster migrating species and submitted them for analysis by 
LC-MS/MS (Appendix A, Supplementary Figures 2 to 7, and see also (L. Hammack & A. R. 
Kusmierczyk, 2016)). As expected, all six bands analyzed suggested the presence of CP 
assembly intermediates. For example, band 1 contained all α subunits, all β subunits except β7, 
as well as the assembly factors Ump1, and Pba1-Pba2 (Figure 2.2A and Appendix A, 
Figure 2.1 Detection of novel α4-containing species 
(A) Schematic of crosslinkable α4 subunit (α4CC) and the resulting crosslink from 
adjacent α4’s with an α ring. (B) Flag-purified CP from the indicated yeast strains were 
treated with CuCl2 to initiate crosslinking. Samples were subjected to SDS-PAGE under 
non-reducing (lanes 1 to 4), or reducing (lanes 5 to 8) conditions. White arrowhead 
denotes position of α4–α4 dimer. Black arrowheads denote slow-migrating novel α4 
species. Asterisk denotes migration of the α3 subunit, or its absence in α3∆ strains. 
Bracket denotes subunits of the CP. Migration of molecular size standards is indicated on 
the left. (C) Analysis as in (B) except the samples were not crosslinked.  
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Supplementary Figure 2). This is consistent with band 1 containing the 15S assembly 
intermediate of the CP (Kunjappu & Hochstrasser, 2014) (alternatively known as the “–β7 half-
mer” (X. Li et al., 2007)). Interestingly, the composition of band 3 argued it too contained the 
15S (Appendix A, Supplementary Figure 4). Yet band 3 migrated slightly slower than that band 
1, and was also more intense.   
 
 
Figure 2.2 Analysis of putative α4-containing HMWCs by native PAGE 
(A) Native PAGE of Flag-purified CP from the indicated yeast strains (top panel). Arrowheads 
denote migration of CP and of CP assembly intermediates (1-6). No protein was loaded in lanes 
labeled “blank” to minimize effect of spillover between samples. To verify equal loading of 
proteins, aliquots of the Flag-purified material were subjected to SDS-PAGE (bottom panel). (B) 
Contents of bands 1-6 in (A) were analyzed by LC-MS/MS. Graphs indicate the total count of 
PSMs (peptide spectral matches) for peptides derived from individual α subunits. Numbers 
below each subunit represent the actual number of peptides identified by LC-MS/MS for that 
subunit.   
 
Band 3 was derived from a wild type yeast strain containing α4CC whereas band 1 was 
derived from an isogenic strain containing (non-crosslinkable) α4. Hence, the difference in their 
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electrophoretic mobility can be accounted for in two, not mutually exclusive, ways. On the one 
hand, to generate α4CC, two amino acids with non-ionizable sidechains were replaced by 
cysteines, which can be appreciably ionized at the pH of the resolving gel; this could affect the 
charge of α4CC-containing species and hence contribute to a migration difference of 15S in 
Figure 2.3 Depletion analysis confirms novel α4 complexes 
(A) Aliquots of Flag-purified CP from the indicated yeast strains were subjected to 
native PAGE (lanes 1 to 3). The remainder of the Flag-purified material was depleted of 
his-tagged proteins via two rounds of binding to immobilized-cobalt affinity resin 
(ICAR). Aliquots of the flow through from the second binding to ICAR were loaded on 
the same native PAGE gel (lanes 4-6). Arrowheads denote the position of CP and two 
faster migrating species (7 and 8) that remain following depletion. Contents of bands 7 
are shown at right. (B) Aliquots of samples in (A) were also analyzed by SDS-PAGE. 
(C) Depletion analysis was repeated to demonstrate that wild type yeast strains also 
possess the novel α4 complexes.  
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band 1 versus band 3. On the other hand, the increased intensity of band 3 could represent a 
novel species not found in band 1 i.e. the sought-after α4 HMWCs. Consistent with the later 
scenario, we observed an excess of spectral counts for peptides derived from the α4 subunit, 
compared to those derived from other α subunits, in band 3 (Figure 2.2B). This vast excess was 
observed for all bands from samples containing α4CC (bands 3-6) and argued that these bands 
contained considerably more α4 than the other subunits. The simplest explanation was that bands 
3 through 6 included, not only CP assembly intermediates but also comparably sized HMWCs 
consisting of α4CC (Appendix A, Supplementary Figures 2 to 7). The subunit composition of 
bands 1 through 6, including the excess of α4 in bands 3 to 6, was reproducible (Appendix A, 
Supplementary Figure 8).  
To confirm the existence of these novel α4-containing HMWCs as independent species, 
we pursued a depletion approach (Appendix A, Supplementary Figure 9). Initially, we chose to 
do this in an α3∆ background because our data suggested these HMWCs are more abundant 
when α3 is deleted (Figures 2.1B and 2.2). We employed a strain in which α2 was C-terminally 
tagged with a tandem epitope consisting of a hexahistidine tag (his tag) and a Flag tag (α2HF). 
We crossed α2HF and α4CC α3∆ yeast to generate the α4CC α3∆ α2HF experimental depletion 
strain. We prepared lysates from cultures of the experimental depletion strain, and its two 
parental strains as controls (α4CC α3∆ and α2HF), and isolated all Flag-tagged species. We 
subjected the Flag eluates to both native and SDS-PAGE (Figures 2.3A and 2.3B, lanes 1 to 3). 
The CP was the major species in all the samples and faster migrating species were also observed. 
The faster migrating species in the two α4CC containing strains (Figure 2.3A, lanes 1 and 3) 
were the equivalent of bands 5 and 6 in Figure 2.2A. As expected, these two bands were absent 
in the α2HF strain (Figure 2.3A, lane 2) because this strain did not contain Flag-tagged α4; it is 
not possible to isolate any α4 HMWCs from this strain. The Flag eluates were depleted of any 
his-tagged proteins via two rounds of binding to immobilized cobalt affinity resin (ICAR) 
(Appendix A, Supplementary Figures 9 and 10). Protein complexes not containing his-tagged 
components would remain in the second “flow through” (Figures 2.3A and 2.3B, lanes 4 to 6).  
 The his flow through of the sample from the α4CC α3∆ parental control looked like its 
corresponding Flag eluate; since no α2HF was present, none of the species were retained on the 
ICAR (Figures 2.3A and 2.3B, lane 4; Appendix A, Supplementary Figure 10, lane 1). The his 
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flow through of the α2HF parental control strain was nearly completely empty; since the only 
Flag tagged protein in this strain was also his-tagged, all Flag-containing species were depleted 
by ICAR (Figures 2.3A and 2.3B, lane 5), though a tiny amount of CP did escape depletion. In 
the his flow through of the experimental strain, nearly all of the CP was depleted, except for the 
tiny amount also present in the α2HF sample (Figure 2.3A, lane 6). Importantly, the two species 
migrating faster than CP were recovered in considerable amounts (bands 7 and 8), consistent 
with these species containing Flag-tagged α4 but not his-Flag-tagged α2. LC-MS/MS analysis 
confirmed the dominant species in each band was α4, though a considerable amount of the 
closely related Hsp70 paralogs, Ssa1p and Ssa2p, were present in band 8. The LC-MS/MS 
results were corroborated by SDS-PAGE showing α4 as the major species and a weaker Hsp70-
containing band (Figure 2.3B, lane 6). We repeated the depletion analysis and included the wild 
type (i.e. non α3∆) yeast strain for comparison, which confirmed that these α4 HMWCs are also 
present in wild type cells (Figure 2.3C).  
Figure 2.4 Quaternary structure of α4 HMWCs 
(A) Aliquots of the α4 HMWCs isolated by depletion analysis, as in Figure 2.3, were incubated in 
the presence or absence of CuCl2 to induce crosslinking. Samples were subjected to SDS-PAGE 
under non-reducing and reducing conditions. (B) Increasing amounts of α4 HMWCs were 
subjected to SDS-PAGE under non-reducing conditions (2, 4, and 8 µl), or reducing conditions (8 
µl + DTT), followed by Western blotting with anti-Flag antibody. Arrowheads denote position of 
crosslinked products containing increasing copies of α4. The position of the monomer is denoted 
by α4CC. 
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 Finally, we subjected aliquots of the his flow through from the α4CC α3∆ α2HF 
depletion strain (containing α4 HMWCs) to SDS-PAGE under reducing and non-reducing 
conditions; prior to electrophoresis, the samples were either treated (or not treated) with CuCl2 to 
initiate crosslinking (Figure 2.4A). Under non-reducing conditions, all the α4 migrated as 
distinct species near the top of the resolving gel. This confirmed that the α4 HMWCs isolated in 
the depletion analysis were the same slowly migrating α4 species initially observed by non-
reducing SDS-PAGE (Figure 2.1B), and consisted of α4 crosslinked to itself. This was further 
verified by Western blotting which demonstrated an expected α4 laddering pattern (Figure 2.4B); 
this occurs when some of the α4 HMWCs in the sample are not completely crosslinked. It is 
notable that CuCl2 was not required to observe the α4 HMWCs in Figure 2.4, unlike in Figure 
2.1B. We have shown before that protracted purification protocols, especially involving ICAR, 
are sufficiently oxidizing to allow crosslinking to occur even in the absence of exogenous 
oxidant (Panfair et al., 2015) (see also Appendix A, Supplementary Note). 
2.5 Discussion 
We provide evidence that the α4 subunit exists in high molecular weight complexes 
(HMWCs) outside of the CP in vivo (Figures 2.1B and 2.3). These non-canonical species are 
likely ring-shaped because their discovery was enabled by a cross-linking strategy developed to 
detect the placement of two α4 subunits within the same α-ring (Velichutina et al., 2004) and 
because we observed a distinctive α4 laddering pattern that would be expected if these were 
rings (Figure 2.4B). The seven crosslinked bands observed in the laddering pattern could be 
evidence for an octameric ring, though it is possible that two of the bands (presumably the two 
highest bands) each contain seven copies of α4. This would occur if one band is derived from a 
completely crosslinked (i.e. closed) heptameric ring and one band is derived from a heptameric 
ring with one crosslink missing (i.e. an open chain of 7 subunits). Circular and linear topologies 
of a protein can migrate differently on SDS-PAGE (Iwai & Pluckthun, 1999). 
 Non-canonical rings containing different combinations of α subunits have been observed 
before, but only when the α subunits were recombinantly produced in bacteria (Gerards et al., 
1998; Gerards et al., 1997; Ishii et al., 2015; Y. Yao, Toth, et al., 1999). Thus, it was not clear if 
their recombinant existence was relevant physiologically. This is the first evidence that such 
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complexes exist in vivo, in wild type cells. The two species we observed on native PAGE (Figure 
2.3A, bands 7 and 8) could be single and double α4 rings that exist in equilibrium. There are 
several reasons why these particular α4 HMWCs escaped detection until now, even though the 
α4–α4 crosslinking approach was used before (Kusmierczyk et al., 2008; Velichutina et al., 
2004). First, the previous studies were interested in detecting α4–α4 proteasomes, specifically 
the characteristic α4-α4 dimers. Their analysis was not optimized to detect HMWCs, which 
likely failed to enter the resolving gel. Here, using a lower percentage step gradient gel, we were 
able to detect these HMWCs (Figure 1B) which just barely entered the resolving gel. Second, the 
HMWCs may not be as stable as CP, especially when analyzed by native PAGE; the presence of 
crosslinkable α4 was needed to clearly visualize them (Figure 2.3 and Appendix A, 
Supplementary Figure 8; see also Supplementary Note). Finally, these HMWCs are comparable 
in size to known CP intermediates (such as 13S, 15S, and half-proteasome species) and can thus 
be obscured by them. The excess of spectral counts for α4-derived peptides was consistent with 
this (Figure 2.2B) and our depletion experiments (Figure 2.3) confirmed it. We suggest increased 
vigilance in interpreting native PAGE data for proteasome assembly. 
The purpose of these α4 HMWCs remains to be determined. Recently α4-GFP was found 
localized into puncta in the absence of Pba3-Pba4 chaperone (Takagi et al., 2014). It is not clear 
if these “aggregates” of α4 are related to the α4 HMWCs observed here, but we note that 
HMWCs are already observed in wild type yeast cells. The observation that levels of HMWCs 
can increase, such as when α3 is deleted, suggests their levels could be regulated. This regulation 
might involve Ssa1/Ssa2 proteins, which associate tightly with HMWCs, surviving the extended 
depletion protocol. 
Our data are consistent with HMWCs having a physiological role, though we cannot yet 
rule out the possibility that these are misassembled products destined for removal by the protein 
quality control machinery. However, the recent study which identified α4-α4 proteasomes in 
mammalian cells, using the same crosslinking approach as here, also acknowledged higher 
molecular weight species containing α4 in vivo (Padmanabhan et al., 2016). Though these 
species were not studied further, we note with interest their observation of an α4 laddering 
pattern (for example, Figure 2.2E in reference (Padmanabhan et al., 2016)) similar to what we 
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observed here (Figure 2.4B). This raises the possibility that the formation of α4 HMWCs, like 
the formation of α4-α4 proteasomes, is evolutionarily conserved.  
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CHAPTER 3. SSA1/2 ASSIST IN 20S ASSEMBLY 
Chapter 3 along with Appendix B were originally published in Biochemical and 
Biophysical Research Communications (BBRC). 
Hammack, L. J., Firestone, K., Chang, W., & Kusmierczyk, A. R. (2017). Molecular chaperones 
of the Hsp70 family assist in the assembly of 20S proteasomes. Biochem Biophys Res 
Commun, 486(2), 438-443. doi:10.1016/j.bbrc.2017.03.059 
3.1 Abstract 
The eukaryotic 26S proteasome is a large protease comprised of two major sub assemblies, 
the 20S proteasome, or core particle (CP), and the 19S regulatory particle (RP). Assembly of the 
CP and RP is assisted by an expanding list of dedicated assembly factors. For the CP, this 
includes Ump1 and the heterodimeric Pba1-Pba2 and Pba3-Pba4 proteins. It is not known how 
many additional proteins that assist in proteasome biogenesis remain to be discovered. Here, we 
demonstrate that two members of the Hsp70 family in yeast, Ssa1 and Ssa2, are bona fide CP 
assembly factors. Ssa1 and Ssa2 interact genetically and physically with proteasomal 
components. Specifically, they associate tightly with known CP assembly intermediates, but not 
with fully assembled CP, through an extensive purification protocol. And, in yeast lacking both 
Ssa1 and Ssa2, specific defects in CP assembly are observed. 
3.2  Introduction 
 Protein quality control in eukaryotes is maintained via several evolutionarily conserved 
machineries, including the ubiquitin-proteasome system (UPS) and the molecular chaperone 
network (MCN) (Amm, Sommer, & Wolf, 2014; reference; Tomko & Hochstrasser, 2013). The 
former provides a major route of protein degradation, removing damaged, misfolded, and no-
longer-needed proteins. The latter assists in proteins attaining their native state following 
synthesis, and in returning misfolded proteins to the native state following stress. How the UPS 
and MCN interact is a topic of considerable interest. 
 The MCN is comprised of a number of highly conserved protein families, many of which 
are nucleotide-driven machines. Perhaps the best studied of these include members of the Hsp60, 
Hsp70, and Hsp90 protein families (Houry, 2014). One way in which the MCN can interact with 
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the UPS is via proteins destined for degradation (Shiber & Ravid, 2014). However, MCN 
proteins could also function in the biogenesis of the UPS components themselves, such as the 2.5 
MDa proteasome, yet this role remains underexplored.  
 The 26S proteasome is an intricate assembly of 33 distinct proteins in multiple copies (X. 
Huang, Luan, Wu, & Shi, 2016a; Luan et al., 2016). It can be subdivided into two major sub-
assemblies, the 19S regulatory particle (RP) and the 20S core particle (CP), also known as the 
20S proteasome. The CP consists of four heptameric rings stacked on top of each other. Seven 
distinct α subunits (α1 to α7) make up each outermost ring and seven distinct β subunits (β1 to 
β7) make up the two inner rings (Groll et al., 1997). Proteolytic activity resides in the β1, β2 and 
β5 subunits which are synthesized as proproteins (Arendt & Hochstrasser, 1999; Chen & 
Hochstrasser, 1996). CP assembly begins with the formation of an α ring which becomes a 
platform for the incorporation of β subunits (Hirano et al., 2008; Zwickl et al., 1994). Addition 
of β subunits occurs in stages defined by a number of intermediates: the 13S intermediate (which 
includes β2, β3, and β4); the 15S intermediate (which includes all β subunits except β7); and the 
half-proteasome (which contains a completed β ring) (Hirano et al., 2008; X. Li et al., 2007; 
Marques et al., 2007). Two half-proteasomes dimerize to produce the preholoproteasome (PHP), 
a fleeting species that looks like a CP but whose β subunits retain their propeptides (X. Li et al., 
2007). As the β subunits undergo autocatalytic processing to reveal their N-terminal threonine 
nucleophiles, the PHP matures into the fully functional CP.  
 CP assembly is regulated by features intrinsic to the subunits themselves and by extrinsic 
factors in the form of dedicated assembly chaperones. The latter include Ump1, Pba1-Pba2, and 
Pba3-Pba4 (also known as hUmp1, PAC1-PAC2, PAC3-PAC4 in mammals) (Tomko & 
Hochstrasser, 2013). Whether any additional proteins participate in CP assembly remains an 
open question. Using the yeast Saccharomyces cerevisiae as a model system, we demonstrate 
that members of the Hsp70 family, specifically Ssa1 and Ssa2, are directly involved in CP 
biogenesis.  
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3.3 Materials and Methods 
3.3.1 Yeast Strains and Plasmids 
Yeast strains used are listed in Appendix B, Supplementary Table 2. Plasmids used are 
listed in Appendix B Supplementary Table 3. All yeast manipulations were carried out according 
to established protocols (C. Guthrie, 1991). Dilution series were carried out as described 
(Kusmierczyk et al., 2008). Yeast strain numbers (AKY) are shown in brackets. 
3.3.2 Protein Purification 
The lysis of yeast pellets and subsequent Flag purification was carried out as described 
(Hammack & Kusmierczyk, 2017) except equal amounts of soluble lysate were bound to 150 µl 
of anti-Flag agarose for 3 hours then eluted. For each sample, the 300 µl Flag eluate was divided 
as follows: 100 µl aliquot for native PAGE; 50 µl aliquot for SDS-PAGE; and the remaining 
Flag eluate (150 µl) was subjected to depletion via immobilized-cobalt affinity resin (ICAR). 
Depletion was carried out as described (Hammack & Kusmierczyk, 2017) with the following 
modifications. The samples were applied to 50 μl of cobalt resin (TALON resin; Clontech) for 
1h at 4 C with gentle rocking. The flow through from the first round of ICAR depletion was 
subjected to a second round of ICAR depletion using a fresh 50 μl aliquot of resin. The flow 
through from the second round of ICAR depletion was split into a 100 µl aliquot for native 
PAGE and a 50 µl aliquot for SDS-PAGE. The Flag eluate and the second ICAR flow through 
were analyzed via native PAGE (40 µl), and loading controls were analyzed by reducing SDS-
PAGE (15 µl).  
3.3.3 Electrophoresis and Blotting 
SDS-PAGE, on 12% gels, and native PAGE, on 4–15% Mini-PROTEAN TGX precast 
gradient gels (Bio-Rad) were carried out as described except native gels were electrophoresed for 
11 hours (Hammack & Kusmierczyk, 2017). Native gels were stained with Imperial Protein 
Stain (ThermoScientific) and SDS-PAGE gels were stained with GelCode blue 
(ThermoScientific). Prior to staining, some native gels were subjected to substrate overlay assay 
carried out as described (Kusmierczyk et al., 2011). The migration of size standards is indicated 
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to the left of each gel. Western blotting was carried out as described (Hammack & Kusmierczyk, 
2017) using anti-Express antibodies (Invitrogen). 
3.3.4 Proteomic Analysis 
Gel slices were submitted to the Indiana University School of Medicine Proteomics Core 
Facility (IUSM-PCF) on a fee-for-service basis. Protein contents of the gel slices were identified 
by LC-MS/MS as described (L. J. Hammack & A. R. Kusmierczyk, 2016). Summarized and 
annotated data is presented in the main text and Appendix B. Data discussed in the main text 
refers only to proteins that were identified on the basis of more than one unique peptide in order 
to decrease the likelihood of false-positives (Carr et al., 2004). The original data provided by the 
core facility (Excel files) is provided in supplementary information in Appendix B. 
3.4 Results 
 Our initial interests lay in determining whether additional extrinsic factors existed that 
assisted in proteasome biogenesis. We focused our search on the CP and employed a depletion 
scheme (Hammack & Kusmierczyk, 2017) to enrich for CP assembly intermediates. We 
generated a series of yeast strains: “WT”; “PHP”; and “2/3-PHP” (Appendix B Supplementary 
Figure 11). The PHP strain is the key experimental strain and should allow the isolation of CP 
assembly intermediates up until, and including, the preholoproteasome (PHP). The PHP strain 
expresses all three mutant β subunits β1(T1A), β2(T1A), and β5(T1A), as well as a wild type β5 
to keep the strain alive (Chen & Hochstrasser, 1996). The 2/3-PHP strain expresses two mutant β 
subunits, β1(T1A) and β2(T1A).  
 We prepared soluble lysates from cultures of all three strains, isolated CP species via the 
Flag epitope on β4, and analyzed the purified material by native and SDS-PAGE (Figures 
3.1A,B lanes 1 to 3). We’ve reported the need to overload native gels to visualize assembly 
intermediates (Hammack & Kusmierczyk, 2017) and did so again here. CP was the major species 
in each sample, migrating near the 670 kDa size standard (Figure 3.1) and Appendix B, 
Supplementary Figure 12). Species migrating slower than CP were Blm10-bound CP (Lehmann 
et al., 2008). More Blm10-bound species were present in the 2/3-PHP sample (Figures 1A,B 
asterisk). Species migrating faster than CP were likely assembly intermediates (Figure 3.1A, 
lanes 1 to 3, bands 1 and 2).  
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Next, the hexahistidine tag on the β5 subunit (β5-his) enabled a depletion strategy to 
remove CP via sequential passage of Flag-purified material over two immobilized-cobalt affinity 
resin (ICAR) columns (Hammack & Kusmierczyk, 2017). Aliquots of the second flow-through 
were analyzed by native and SDS-PAGE (Figures 3.1A,B lanes 4 to 6). A number of 
observations were made. First, in the WT and 2/3-PHP samples, the CP band was almost 
completely absent suggesting that the depletion strategy was effective. A small amount of CP 
remained, as judged by a faint residual CP band and weakly detectable activity on the overlay 
assay (Appendix B, Supplementary Figure 12). However, additional rounds of ICAR depletion  
  
Figure 3.1 Depletion analysis to isolate CP assembly intermediates 
(A) Native PAGE analysis of Flag-purified CP (β4-Flag) from the indicated yeast strains (lanes 1 
to 3). The Flag-purified material was subjected to two rounds of depletion by ICAR to remove 
his-tagged proteins. Aliquots of the flow through from the second ICAR round were analyzed on 
the same native PAGE gel (lanes 4 to 6). Arrowheads denote CP and other bands of interest. 
Asterisk denotes position of Blm10-bound CP. (B) Aliquots in (A) analyzed by SDS-PAGE; 
asterisk denotes position of Blm10. 
 
did not reduce this residual CP band further and only decreased the overall yield of protein (not 
shown); we suggest that the residual CP may be due to some β5 subunits losing their his-tag to 
proteolysis post-lysis. Second, the pair of putative assembly intermediates (bands 1 and 2) was 
still present following depletion. Finally, the PHP sample retained a considerable band migrating 
at the position of the CP (band 4). Given that β5(T1A) was not his-tagged, this suggested we 
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were able to isolate the PHP. A fainter band migrating below the putative PHP was also observed 
(band 3). 
Bands 1 to 4 were excised and analyzed by LC-MS/MS (Appendix B, Supplementary Figures 13 
to 20). Band 4 was actually a series of three closely spaced bands (Figure 3.1A, enlarged). It was 
not possible cut these bands apart, thus the analysis of band 4 reflects material from all three 
bands. Band 4 contained all α and β subunits, as well as the assembly factors Ump1 and Pba1-
Pba2 (Table 1). We also recovered peptides from the β5 propeptide (Figure 3.1C). This 
composition is consistent with band 4 containing PHP. Interestingly, band 4 exhibited some 
catalytic activity (Appendix B, Supplementary Figure 12) but the resolution was not sufficient to 
determine which of the three bands was active. Consequently, band 4 must also contain some 
species with wild type β5. We offer a plausible explanation for the three bands in Supplementary 
Figure 21 (Appendix B). Band 3 had identical composition to band 4 (Table 3.1), including 
peptides from the β5 propeptide (not shown) but it displayed no activity (Appendix B, 
Supplementary Figure 12). Band 3 likely represents a half-proteasome.  
 Band 2 migrated similarly across all three samples, as did band 1, suggesting two 
identical species were present. Indeed, band 2 from each sample returned considerable peptide 
Table 3.1 Select composition of excised bands 
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spectral matches (PSMs) from all α subunits plus β2, β3, β4 and the assembly factors Ump1 and 
Pba1-Pba2 (Table 3.1). Some peptides for other β subunits were also recovered. However, these 
were either not uniformly present in all bands, or were present in considerably lower PSMs, 
suggesting they were not stoichiometric components of band 2 which most likely contained the 
13S intermediate. Band 1 was similar to band 2 except that we observed comparatively fewer 
PSMs for α5 and α6 in all three samples, and fewer PSMs for α7 in the 2/3-PHP and WT 
samples (Table 3.1). As above, this suggests that these subunits may not be stoichiometric 
components of the complex in band 1. Furthermore, we recovered no peptides for Pba2. We 
conclude that band 1 likely contains a species we refer to as “sub-13S” (i.e. a 13S intermediate 
lacking Pba2, α5, α6, and probably α7).  
Figure 3.2 Phenotype analysis of ssa mutants 
Dilution series were prepared and the yeast spotted onto SD plates (top). Alternatively, yeast 
from individual colonies were struck out onto YPD plates (bottom). The temperature and 
duration of plate incubation are indicated.  
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 Each of the bands analyzed gave rise to peptides from a number of additional proteins 
(Appendix B, Supplementary Tables 13 to 20). Most of these were not likely candidates for 
assembly factors because they were recovered with only a few peptides, and/or were derived 
from highly abundant metabolic enzymes (e.g. Eno2, Pfk26, Adh1) which are likely 
contaminants. However, two proteins from the Hsp70 family, Ssa1 and Ssa2, emerged as 
possible candidates. We shall refer to these proteins as Ssa1/2 because they share 97% amino 
acid identity, making it difficult to definitively assign all observed peptides to either isoform. 
Ssa1/2 were identified with considerable PSMs in bands 1 and 2 from all three strains, but not in 
the more highly abundant band 4, arguing that they were not just non-specifically binding to CP 
subunits. 
Figure 3.3 Suppressor analysis 
Dilution series of CP mutants (A), and RP mutants (B), transformed with Hsp70-containing 
plasmids, or vector-only controls. Plates were incubated for 3 days. 
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Physical association of Hsp70 proteins with proteasomes has been observed (Gong et al., 
2009; Guerrero et al., 2008; Verma et al., 2000) But these high-throughput studies only 
considered chaperone binding to intact proteasomes (see also Appendix B, Supplementary 
Notes). To strengthen the case for a role in assembly, we first carried out a series of genetic 
experiments. When yeast were grown at 36º C (Figure 3.2), we observed synthetic sick 
interactions between deletion of SSA1, or SSA2, and proteasome mutants that affect assembly of 
CP (pre9∆) and the lid subcomplex of the RP (sem1∆ or rpn12-234∆) (Funakoshi, Li, 
Velichutina, Hochstrasser, & Kobayashi, 2004; Kusmierczyk et al., 2008; Tomko & 
Hochstrasser, 2011) . This was not due to a general decrease in cytoplasmic Hsp70 activity 
because no effects were observed when another Hsp70 gene, SSB1, was deleted (Appendix B, 
Supplementary Figure 22A). No obvious synthetic sick interaction was seen with a mutant 
affecting assembly of the base subcomplex of the RP (nas2∆nas6∆rpn14∆) (Funakoshi et al., 
2009). However, this mutant already grows quite weakly at 36º C (Figure 3.2A); repeating the 
experiment at 33 º C, we instead observed a slight suppression when SSA1 was deleted 
(Appendix B, Supplementary Figure 22B). 
Overexpression of Ssa1 suppressed growth defects of CP, but not RP, assembly mutants 
in the presence of the amino acid analog canavanine (Figure 3.3 and Appendix B, Supplementary 
Notes). This suppression differed from that observed with overexpression of Ssb1, a known 
suppressor of CP mutants (Ohba, 1997). Here, Ssb1 suppressed both CP and RP base defects. 
Western blots verified that protein was expressed (Supplementary Figure 22C and not shown). 
Taken together, the genetic results bolster the link between Ssa1/2 and CP assembly.  
 If Ssa1/2 proteins have a direct role in CP assembly, one should observe assembly defects 
biochemically if these proteins are absent. Since Ssa1 and Ssa2 likely have a redundant role in 
CP assembly (see Discussion), we looked for assembly defects in an ssa1∆ssa2∆ strain. We 
purified proteasomes from wild type and mutant strains, via a Flag-tag on α4, and analyzed them 
by native PAGE (Figure 3.4A). CP was again the major species and two faster migrating bands 
were observed in the WT sample; they were easier to visualize when the gel was overloaded 
(Figure 3.4B). We excised the indicated bands and analyzed them by LC-MS/MS. Because this 
experiment did not involve a depletion, bands 5 and 6 each likely contained a mixture of 
assembly intermediates (see Discussion). Nevertheless, the relevant result is that considerable 
PSMs were observed for Ssa1/2 in bands 5 and 6 but none in bands 7 and 8, corresponding to 
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fully assembled CP (Supplementary Figures 23 to 26). This is consistent with our previous 
results showing Ssa1/2 associating with assembly intermediates (Figure 3.1). Most importantly, 
bands 5 and 6 were greatly reduced in the ssa1∆ssa2∆ mutant. 
 We also observed what appeared to be more doubly-Blm10 capped CP in the 
ssa1∆ssa2∆ mutant (Figure 3.4B asterisk). Blm10 plays an undefined role in CP maturation and 
increased binding of Blm10 to CP can indicate a maturation defect (Marques et al., 2007). 
Consistent with this, we recovered peptides derived from the β2 propeptide from CP in the 
ssa1∆ssa2∆ strain (band 8) but not CP in the wild type strain (band 7). The lack of β2 
propeptide-derived peptides in band 7 was not due to a detection sensitivity issue; we readily 
recovered β2 propeptide-derived peptides from bands 5 and 6 (as expected for CP assembly 
intermediates) despite these two bands being much less abundant than band 7 (Appendix B 
Supplementary Figure 27).  
 Finally, the Ssa1/2 band observed by SDS-PAGE in the purified material from the wild 
type strain (Figure 3.4A) was replaced by a slightly slower migrating doublet in the ssa1∆ssa2∆ 
mutant. LC-MS/MS analysis identified this doublet as containing Ssa3, Ssa4 and Kar2 (not 
shown but see Appendix B, Supplementary Notes).  
 
Figure 3.4 Assembly defects in a mutant lacking Ssa1 and Ssa2 
(A) Equal amounts (8 µg) of Flag-purified CP material (α4-Flag) from the indicated yeast 
strains were analyzed by native PAGE (left). An SDS-PAGE loading control is also shown 
(right). (B) Same native PAGE analysis as in (A) except a larger amount of protein (25 µg) 
was loaded. In all gels, arrowheads denote bands of interest. Asterisk denotes migration of 
Blm10-bound CP (singly and doubly capped).  
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3.5 Discussion 
 We present evidence that Ssa1/2 proteins function as CP assembly factors. First, these 
chaperones associate with assembly intermediates in purifications from four independent yeast 
strains utilizing two different Flag-tagged CP subunits (Table 3.1 and Figure 3.4B). Depletion 
analysis confirms association with the 13S intermediate, and a novel species we refer to as sub-
13S, though Ssa1/2 likely associate with intermediates up to the half-proteasome (Appendix B, 
Supplementary Figures 3-5, 13, 14). Second, the physical association of Ssa1/2 with CP 
intermediates is corroborated by genetic association between SSA mutants and proteasome 
assembly mutants. Moreover, phenotypic suppression often indicates physical interaction, and 
the suppression by SSA1 of CP (but not RP) assembly mutants is entirely consistent with a 
physical role for this chaperone in CP biogenesis. Third, our depletion strategy involves multiple 
purification steps with extensive washing. The ability of Ssa1/2 to remain bound to CP assembly 
intermediates throughout our depletion protocol, and their absence from bands corresponding to 
the PHP and fully assembled CP (Table 3.1, Appendix B, Supplementary Figures 15, 16), argues 
that they dissociate prior to completion of assembly; this is the very definition of an assembly 
factor. Finally, strains lacking Ssa1/2 have greatly reduced levels of assembly intermediates and 
likely exhibit a weak defect in β2 propeptide processing (Figure 3.4). Two previous observations 
are consistent with our findings. First, upregulation of RPN4, encoding the transcription factor 
that regulates expression of proteasome subunits (Xie & Varshavsky, 2001), has been observed 
in an ssa1∆ssa2∆ double mutant (Matsumoto, Akama, Rakwal, & Iwahashi, 2005). A greater 
need for proteasomes would be expected if assembly is impacted by a loss of Ssa1/2. Second, the 
rpn4∆ssa1∆ssa2∆ triple mutant grows worse than the ssa1∆ssa2∆ double mutant (Oling, Eisele, 
Kvint, & Nystrom, 2014). This is reminiscent of the synthetic sick (or lethal) phenotypes that 
result when deletion of RPN4 is combined with a deletion of any CP assembly factor (Le Tallec 
et al., 2007). 
 The precise role of Ssa1/2 in CP assembly remains to be determined. They may help 
stabilize assembly intermediates. For instance, the 13S intermediate contains a full α-ring and 
three out of seven β subunits (β2, β3, β4). Recently we reported that Ssa1/2 bind to high 
molecular weight complexes of α4 in vivo, which are most likely rings (Hammack & 
Kusmierczyk, 2017). Thus, perhaps Ssa1/2 chaperone the formation of α subunit rings, or 
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stabilize them once formed. Also, Ssa1/2 appear to be involved in the formation (or stabilization) 
of a novel complex we call the sub-13S species. This complex probably contains a subset of α 
and β subunits (most likely α1–α4, and β2–β4) but whether or not it is a true assembly 
intermediate remains to be determined. On the one hand, it could be the result of a 13S 
intermediate falling apart during purification and/or electrophoresis. On the other hand, it could 
be a precursor to the 13S intermediate, suggesting the existence of an assembly pathway that 
does not involve an isolated α ring. We’ve demonstrated such α ring independent pathways for 
archaeal proteasomes, which serve as models for eukaryotic proteasome assembly (Panfair et al., 
2015).  
 Regardless of the status of the sub-13S species, it is likely that CP assembly has multiple 
redundancies built in. There is the obvious redundancy between Ssa1 and Ssa2, as evidenced by 
the recovery of peptides for both Ssa1 and Ssa2 from assembly intermediates and by the similar 
synthetic phenotypes observed when deletion of either SSA1 or SSA2 is combined with assembly 
mutants. Consistent with this redundancy, whereas the rpn4∆ssa1∆ssa2∆ triple mutant grows 
worse than the ssa1∆ssa2∆ double mutant (Oling et al., 2014), we observe no obvious 
phenotypes when rpn4∆ is combined with only ssa1∆ or ssa2∆ (Appendix B Supplementary 
Figure 22D). Redundancy is also seen in the ssa1∆ssa2∆ mutant where levels of assembly 
intermediates (bands 5 and 6) are reduced but the overall levels of CP are not. Clearly, the 
subunits are still capable of coming together to form CP species, even if a small fraction of them 
has incompletely matured β2 subunits. Taking a broader view, the simple observation that none 
of the CP or RP assembly factor genes are essential (Tomko & Hochstrasser, 2013) is strongly 
suggestive of assembly redundancy.  
 Although our purification/depletion analysis did not identify additional candidates 
beyond Ssa1/2, the stringency of our method means that weakly/transiently bound assembly 
factors could have been washed away. The existence of redundancy in assembly, which implies 
multiple assembly pathways, makes it more likely that additional factors assisting proteasome 
assembly await discovery. That some of these are likely to be members of the MCN now has 
considerable precedent, given our results here and the proposed, though incompletely understood, 
role of Hsp90 in proteasome biogenesis (Imai, Maruya, Yashiroda, Yahara, & Tanaka, 2003).  
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CHAPTER 4. NOVEL COMPLEX: SUB-13S 
4.1 Abstract 
Efficient assembly of proteasomes is required for cellular homeostasis. Proteasome 
assembly is regarded as a regulated stepwise process. In eukaryotes, a number of assembly 
chaperones and assembly intermediates have been identified. The accepted model of eukaryotic 
proteasome biogenesis depicts a linear pathway that begins with the formation of an α ring 
which serves as a scaffold for the subsequent entry of β subunits. The β subunits bind in the 
following order β2, β3, β4, β5, β6, β1, and β7. In yeast, the earliest intermediate that can be 
stably isolated is the 13S, which consists of a full α ring, plus β2, β3, and β4. Here, we report 
evidence for an earlier intermediate we call sub-13S, consisting of α1, α2, α3, α4, β2, β3, and 
β4. We propose that this intermediate originates from another assembly pathway, an α ring 
independent pathway, that functions alongside the canonical α ring dependent pathway. 
Evidence of this intermediate suggests eukaryotic proteasome biogenesis can initiate through α/β 
subunits interactions.  
4.2 Introduction 
Maintaining protein homeostasis is important for maintaining proper cellular function. In 
eukaryotes several mechanisms contribute to homeostasis. One such mechanism is the ubiquitin-
proteasome system. In this system, proteins are tagged with a modifier protein, ubiquitin, and 
subsequently degraded by the 26S proteasome. The 26S proteasome is comprised of two major 
assemblies, the 19S regulatory particle (RP) and the 20S core particle (CP). The 19S RP is made 
up of ~19 subunits that form two sub-complexes: the base and the lid. This structure recognizes, 
deubiquitinates, unfolds, and feeds substrates into the 20S CP. The 20S CP is the protease of the 
26S proteasome and is comprised of seven unique α and β subunits that assemble into four 
stacked heptameric rings (α1-7β1-7β1-7α1-7) (Groll et al., 1997). β subunits, β1, β2, and β5, are 
catalytically active, and their catalytic activity is sequestered within the central hollow chamber 
formed by the stacked rings (Groll et al., 1997). 
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 Many reports have described proteasome assembly as a linear pathway way containing 
proteasome assembly chaperones and specific intermediates (Funakoshi et al., 2009; Hirano et 
al., 2005; Kusmierczyk et al., 2008; Kusmierczyk et al., 2011; Le Tallec et al., 2007; Le Tallec et 
al., 2009; X. Li et al., 2007; Roelofs et al., 2009; Saeki et al., 2009; Yashiroda et al., 2008). The 
canonical pathway is considered to be an α ring dependent pathway, meaning α ring formation is 
required for assembly to begin (Hirano et al., 2005). While α subunits and β subunits share 
similar tertiary structures (Lowe et al., 1995), only α subunits independently form rings. This 
feature is due, in part, to a conserved α-helix (H0) in α subunits, which allows them to form 
stable rings, whereas β subunits lack an H0 helix and do not form stable rings on their own 
(Zwickl et al., 1994).  
After α ring formation, the assembly process proceeds as follows. β2, β3 and β4 bind the 
α ring creating a 13S intermediate (Hirano et al., 2008). Next, β1, β5, and β6 assemble forming a 
15S intermediate (X. Li et al., 2007; Nandi et al., 1997). Entry of the last β subunit, β7, results in 
a half-proteasome, which contains one full α ring and one full β ring (Hirano et al., 2008; X. Li 
et al., 2007). Two half-proteasomes dimerize creating the pre-holoproteasome intermediate (X. 
Li et al., 2007). Although this intermediate looks like the 20S CP, it is catalytically dead, due to 
the propeptides synthesized on β1, β2, and β5. These propeptides protect the N-terminal 
nucleophile threonine from being acetylated prior to assembly, which would render it inactive 
(Arendt & Hochstrasser, 1997; Groll et al., 1999; Jager et al., 1999). During maturation, the 
propeptides are autocatalytically cleaved forming the fully functional 20S CP. Several proteins 
have been described in assisting proteasome assembly: Pba1-Pba2, Pba3-Pba4, Ump1, and 
possibly Blm10 (Howell et al., 2017). Recently, we added Ssa1/2 to this growing list of assembly 
factors (see Chapter 3; Hammack et al. 2017). Assembly factors most likely function by 
preventing off-pathway interactions and promoting on-pathway interactions. While deletion of 
chaperone proteins results in assembly defects in yeast it does not cause lethality.  
 The 20S CP is conserved throughout archaea and a few bacterial lineages (De Mot et al., 
1999; De Mot et al., 2007). While the overall structure and function is conserved, the archaeal 
and bacterial 20S CPs are far less complex than the eukaryotic 20S CPs. These proteasomes 
consist generally of one to two α and β type subunits (Tamura et al., 1995; Zwickl et al., 1992). 
Archaeal and eukaryotic proteasomes were originally thought to assemble through an α ring 
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dependent pathway (Groll et al., 2003; Hirano et al., 2005; Zwickl et al., 1994). By contrast, 
assembly of bacterial 20S CP was considered to be α ring independent, since assembly initiates 
through α/β subunit interactions, possibly α/β dimers (Sharon et al., 2007; Zuhl et al., 1997). 
Interestingly, an alternate assembly pathway was recently described for archaeal 20S CP (Panfair 
et al., 2015). This pathway initiates through the interaction of α and β subunits, which is 
reminiscent of the assembly pathway observed in bacteria. 
 It is widely accepted that eukaryotic proteasomes readily form through the canonical 
assembly pathway described above. In a previous report we identified a novel species migrating 
faster than the 13S by native PAGE, which we referred to as sub-13S. This species lacked a full 
α ring, contained β subunits, and Hsp70 proteins Ssa1/2 (Hammack et al., 2017). Here, we 
investigate this species as a potential 20S assembly intermediate. Since this species lacks a full α 
ring, it does not fit within the current model for eukaryotic assembly. We propose this species is 
an assembly intermediate within an α ring independent assembly pathway, that works in parallel 
with the canonical, α ring dependent, pathway to assemble proteasomes. 
4.3 Materials and Methods 
4.3.1 Yeast Strains and Manipulations 
Yeast strain used are listed in Supplementary Table 4 in Appendix C. Yeast growth 
conditions and manipulations were carried out according to established protocols (C. Guthrie, 
1991). Dilution series, purifications, depletions and electrophoresis were carried out as 
previously described (Hammack & Kusmierczyk, 2017; Kusmierczyk et al., 2008). 
4.4 Results 
A widely accepted method to study proteasome assembly involves tagging a 20S CP 
subunit with a given epitope (frequently Flag), using it to purify proteasomes, and analyzing the 
purified material via native PAGE. Species migrating faster than the 20S CP are considered 
assembly intermediates. This strategy has been used to identify the 13S, 15S, and half-
proteasome intermediates (Frentzel, Pesold-Hurt, Seelig, & Kloetzel, 1994; Hirano et al., 2008; 
X. Li et al., 2007; Nandi et al., 1997; Schmidtke, Schmidt, & Kloetzel, 1997). We chose to use 
Flag and hexahistidine-Flag (HF) tagged α2, α4, α5, and β4 subunits in our analyses. Of course, 
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it is important that the tags themselves do not result in gross functional deficiencies. One way to 
test for a functional defect in yeast is to look for phenotypes, such as temperature sensitivity. To 
this end, we carried out dilution series of the indicated yeast strains (Figure 4.1A). While all the 
yeast strains examined grew slower under the heat stress (37 ° C), no distinguishable phenotypes 
were observed between α4-Flag, α2-HF, α5-HF, or β4-Flag strains (Figure 4.1A). We also 
tested for temperature sensitivity of strains in which the tagged subunit is combined with a 
deletion of the RPN4 gene. Rpn4 is a transcription factor that regulates the levels of proteasomes 
in the cell through a negative feedback mechanism (Xie & Varshavsky, 2001). Therefore, one 
possibility for not observing temperature sensitivity in the tagged strains is that Rpn4 is able to 
compensate for the defects caused by the subunit tagging. When this compensation mechanism is 
removed, as in an rpn4∆ strain, even weaker perturbations in proteasome function can be 
revealed (Le Tallec et al., 2007). However, even in the context of an RPN4 deletion, no growth 
defects were observed at 37 °C. This lack of a phenotype suggests that these tags on 20S CP 
subunits are not deleterious to function.  
To examine 20S CP assembly in yeast, we purified proteasomes with tags on subunits α2, 
α4, α5, and β4, and subjected the purified material to native PAGE (Figure 4.1B). In each case, 
Figure 4.1 Analysis of yeast strains tagged with different subunits 
(A) Dilution series of strains analyzed by native PAGE at 30° C and 37° C.  
(B) Proteasomes were Flag purified using different 20S CP subunits. Equal amounts of Flag 
purification were analyzed by native PAGE. Species indicated are based on relative molecular 
weight, previous mass spectrometry analysis. Unique species (* and **) along with the other 
intermediate bands have been excised for mass spectrometry analysis to confirm identity. Loading 
control, activity assay, and another 30 µg loaded gel are in Appendix C (Supplementary Figures 
28 and 29). (A) Dilution series of strains analyzed by native PAGE at 30° C and 37° C.  
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the major species was the fully assembled 20S CP. Bands migrating immediately above the 20S 
CP are complexes of CP and Blm10 (Lehmann et al., 2008). Moreover, in the β4-flag 
purification we detected two high molecular weight bands migrating slower than the 20S-Blm10 
species. Interestingly, at least one of these bands (*) has peptidase activity (Appendix C, 
Supplementary Figure 28). This band has been excised and will be sent off for mass 
spectrometry analysis to determine the protein composition. The two species migrating faster 
than the 20S CP in the α4-Flag sample were analyzed in a previous study (Hammack & 
Kusmierczyk, 2017). They were identified as the 13S intermediate and a novel species we 
termed the sub-13S (containing subunits α1-4 and β2-4). By contrast, the α2-HF, α5-HF, and 
β4-Flag stains all produced only a single species migrating faster than the 20S CP. As this 
species migrates at approximately the same position as the 13S intermediate in the α4-Flag 
sample, we presume it to be the 13S intermediate; we will confirm this by mass spectrometry 
analysis.  
Lack of the sub-13S species in the α5-HF strain is understandable as the sub-13S species 
does not contain α5 and thus cannot be isolated from an α5-tagged strain. However, the sub-13S 
species does contain both α2 and β4, yet we do not observe sub-13S in purifications from these 
tagged strains. One possibility for this phenomenon is that tagging α4 with Flag, while not 
disruptive enough to function (as judged by the lack of phenotype in an α4-Flag rpn4∆ strain; 
Figure 4.1A), does perturb assembly sufficiently to allow novel putative assembly intermediates, 
such as the sub-13S, to accumulate. The simplest explanation, given the subunit composition of 
the sub-13S species (α1-α4 and β2-β4), argues that it is a precursor to the 13S, because it only 
lacks α5, α6, and α7. If this is the case, then disrupting the incorporation of one of these three 
missing α subunits should result in the accumulation of more sub-13S species in the α4-Flag 
strain. To this end, a yeast strain bearing a mutation in the DOA5 gene, encoding the α5 subunit, 
was crossed into the α4-Flag strains. This α5 mutation causes an amino acid change from Gly to 
Asp at position 49 and is referred to as doa5-1 (Chen & Hochstrasser, 1995). This Gly residue is 
normally buried within the hydrophobic core and its change to a charged Asp likely causes α5 to 
take longer to reach the native state. This, in turn, should slow the rate at which α5 can assemble 
into a nascent 20S CP. If the sub-13S species is an assembly intermediate and a precursor to the 
13S intermediate, then slowing down the rate at which α5 incorporates (through the doa5-1 
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mutation) should result in the accumulation of more sub-13S species and a decrease in the 13S 
species. We purified proteasomes from α4-Flag and α4-Flag doa5-1 strains and subjected them 
to native PAGE. As expected, the levels of 13S species decreased, while the amount of sub-13S 
species increased, in the presence of the doa5-1 mutation (Figure 4.2A). The result is consistent 
with the sub-13S species being a precursor to the 13S intermediate, at least in the context of an 
α4-Flag strain. But what about the strains in which the sub-13S species is not observed? 
As stated above, it is possible that the ability to observe the sub-13S species in the α4-Flag 
strain, but not in the α2-HF or β4-Flag strains, is due to assembly being perturbed enough in the 
α4-Flag strain to allow sub-13S to become visualized. If this is true, then we should be able to 
use the same genetic manipulation to slow down assembly in one of these two strains. The result 
should be that the sub-13S species would now become sufficiently populated and thus detectable. 
To this end, we introduced the doa5-1 mutation into the α2-HF strain by crossing, purified 20S 
CP from the resulting α2-HF doa5-1 progeny and α2-HF control, and analyzed the purified 
Figure 4.2 Induction of sub-13S with doa5-1 
(A) Equal amounts (25 µg) of Flag purification (α4-Flag) were analyzed by native PAGE. 
Species of interest are indicated by arrow heads. (B) Equal amounts (25 µg) of Flag purification 
(α2-his-Flag (HF)) were analyzed by native PAGE. Species of interest are indicated by arrow 
heads. (C) 12% SDS-PAGE loading controls for native gels (A) and (B). 
 
59 
 
material by native PAGE. While the α2-HF strain again failed to produce the sub-13S species, in 
the α2-HF doa5-1 strain we observed a dramatic accumulation of a faster migrating species, 
likely the sub-13S species, and a drastic reduction in the amount of the 13S intermediate (Figure 
4.2B). Again, to confirm the identities of these species, bands will be excised and their contents 
will be analyzed by mass spectrometry analysis. Nevertheless, the results with the α2-HF strain 
are entirely consistent with those observed in the α4-Flag strain, and argue that the sub-13S 
species is a precursor to the 13S intermediate. 
Since the sub-13S looks like a 13S species lacking α5, α6, and α7, it could be argued that 
observing the sub-13S species is a gel artifact. The argument would be that the 13S intermediate 
 
Figure 4.3 Depletion analysis to test for gel artifact 
(A) Schematic of 13S and sub-13S. (B) Native PAGE analysis of Flag-purified CP (α4-Flag) 
from the indicated yeast strains (lanes 1 to 3). The Flag-purified material was subjected to two 
rounds of depletion by ICAR to remove his-tagged proteins. Aliquots of the flow through from 
the second ICAR round were analyzed on the same native PAGE gel (lanes 4 to 6). Arrowheads 
denote CP and other bands of interest. (C) Aliquots in (B) analyzed by SDS-PAGE. Gel was first 
stained with GelCode Blue then subsequently silver stained to better observe CP subunits and 
Ssa1/2 in depleted samples. 
 
is insufficiently stable during electrophoresis and falls apart to yield the sub-13S species; 
inclusion of the doa5-1 mutation only hastens this break-up because the mutation would also 
weaken the 13S intermediate. To address this possibility, a depletion strategy was employed to 
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determine if the sub-13S is the result of 13S falling apart during electrophoresis. This depletion 
strategy is diagramed in Appendix C, Supplementary Figure 30. In brief, the depletion strategy 
relies on generating an α4-Flag α5-HF strain. This strain, by virtue of the α4-Flag subunit, 
should contain (and does contain) both the 13S intermediate and the sub-13S species when Flag-
purified material is analyzed by native PAGE (Figure 4.3A, lane 3). However, if the Flag-
purified material is first subjected to a depletion via TALON resin prior to native PAGE, this 
will deplete all α5-containing species in the sample, including the 13S intermediate. If the sub-
13S species is a gel artifact resulting from the break-up of the 13S intermediate, then the sub-13S 
species should not be detected in the depleted sample, since the 13S intermediate will have been 
removed by the TALON resin via the hexahistidine tag on α5. Nevertheless, even following 
depletion, we recovered small quantities of the sub-13S species (Figure 4.3B, lane 6). Moreover, 
in the silver stained loading control we see Ssa1/2 in the depleted sample (Figure 4.3C, lane 6) 
which we previously identified associating with sub-13S (Hammack et al., 2017).  
4.5 Discussion and Future Work 
We present evidence that the sub-13S species is an assembly intermediate and a precursor 
to the 13S intermediate. Its existence implies that 20S CP assembly can, at least in yeast, proceed 
via an alternative, α ring independent, pathway that functions in parallel with the canonical α 
ring dependent assembly pathway. We initially described this species in a previous report 
(Hammack et al., 2017). Here, we investigate the formation of the sub-13S species in additional 
yeast strains in which various 20S CP subunits (α2, α4, α5, β4) are epitope tagged (Figure 4.1). 
The tagged strains did not exhibit any growth defects on their own, or in the presence of a 
deletion of the RPN4 gene, which suggests that the tags do not drastically disrupt function. 
Analysis of the various strains revealed the expected 13S intermediate in all of them. However, 
the sub-13S species was present only in the α4-Flag strain; purifications with α2-HF and β4-
Flag did not produce any detectable sub-13S, even though both subunits are part of the sub-13S 
complex. We hypothesized that perhaps tagging the α4 subunit with Flag, while not resulting in 
obvious functional defects, could slow assembly enough to allow the sub-13S species to 
accumulate. Consistent with this, we previously reported existence of the sub-13S species from a 
β4-Flag strain which also contained a hexahistine tag on β5 (Hammack et al., 2017). We propose 
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that like the Flag tag on α4, the additional tag on β5 slows assembly down sufficiently to allow 
sub-13S to accumulate in a β4-Flag strain (that on its own does not accumulate it). Moreover, in 
this study, we showed that we could induce accumulation of the sub-13S species in the α2-HF 
strain by introducing a mutation, doa5-1, that slowed assembly further in this strain (Figure 4.2 
B).  
Introducing the doa5-1 mutation also allowed us to argue that the sub-13S species is part 
of an assembly pathway that leads to the formation of the 13S intermediate. The sub-13S species 
consists of α1, α2, α3, α4, β2, β3, and β4 subunits. Consequently, α5 must be one of the next 
three subunits to incorporate to produce the 13S intermediate. Through the aforementioned α5 
mutation, doa5-1, we were able to slow the rate at which α5 was incorporated. This increased the 
levels of sub-13S (Figure 4.2A) in both α2-HF and α4-Flag strains. More importantly, it also 
resulted in a reduction in the amount of 13S intermediate produced (Figure 4.2A). This coupled 
rise and fall in two closely related species is entirely consistent with a precursor-product 
relationship and strongly suggests that the sub-13S species may be a precursor to the13S 
intermediate.  
A criticism can be raised to the relevance of the sub-13S species, based on the fact that the 
sub-13S species looks similar to the 13S intermediate. It could be argued that the13S 
intermediate is not stable and falls apart, either during lysis (or immediately after), or during 
electrophoresis itself, to give rise to the sub-13S species. We provide the following counter-
arguments. First, we consistently observe the 13S intermediate across all purifications, but only 
observe the sub-13S species in some strains (Figure 4.1B and Chapter 3 Figure 3.1). If the 13S 
intermediate were unstable and falling apart, either prior to or during electrophoresis, it should be 
observed in all purifications that have the 13S intermediate. Second, we designed a depletion 
strategy that clearly demonstrated that the sub-13S species is not the result of dissociation during 
electrophoresis (Figure 4.3 and Supplementary Figure 31). Third, the ability to induce the 
formation of the sub-13S species with the doa5-1 mutation (Figure 4.2) argues that species is 
part of an assembly pathway that feeds into the 13S intermediate. Finally, it bears mention that 
the manner in which protein complexes can be disassembled in vitro is often the reverse of the 
pathway by which they assemble (Levy, Boeri Erba, Robinson, & Teichmann, 2008). Hence 
even if some of the observed sub-13S species did result from the dissociation of the 13S 
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intermediate post lysis, this could still be consistent with sub-13S being a precursor to the 13S 
intermediate.  
The next steps in characterizing the sub-13S species include determining if it feeds into 
higher intermediates and proteasomes. Since the doa5-1 mutation produces a considerable 
amount of the sub-13S species, depletion strains containing doa5-1 will be used to isolate 
significant amounts of this complex. It can then be incubated with yeast lysates, or with 
recombinantly produced 20S CP subunits. The goal is to determine if the sub-13S species can act 
as a precursor for higher intermediates. Lysates from different yeast strains will likely need to be 
tested, since it is not clear if sufficient free 20S CP subunits are present in wild type yeast lysate 
to observe a change in assembly. Lysate from an Rpn4 overexpression strain might be a 
promising candidate. Rpn4 over expression will activate transcription and translation of 20S CP 
subunits (Xie & Varshavsky, 2001) which should increase free subunit availability.  
Demonstrating that the sub-13S species can give rise to the 13S intermediate would 
strongly argue that an alternate pathway of 20S CP assembly is possible. However, we are 
particularly interested in determining if the sub-13S can directly feed into half-proteasomes, by-
passing the 13S and the other α ring dependent intermediates entirely. To test this, α ring 
formation will need to be disrupted in yeast. Disrupting α ring formation will force assembly to 
occur outside of the canonical pathway. In this noncanonical pathway, we propose assembly 
proceeds though the sub-13S to the half-proteasome where two half-proteasomes dimerize to 
form the 20S CP. In summary, we present evidence in support of a novel intermediate that 
participates in an alternative assembly pathway that functions along-side the canonical pathway 
in yeast. Upon completion of the purposed work, we will be able to elucidate the sub-13S species 
as a bona fide assembly intermediate. We anticipate that this work will demonstrate that 
proteasome assembly in eukaryotes, like archaea, occurs though more than one pathway. 
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CHAPTER 5. CONCLUDING REMARKS 
5.1 Overview 
Studies over the past two decades have supported the idea of 20S CP assembly being a 
linear stepwise process, initiating with the formation of an α ring (Hirano et al., 2005). Upon α 
ring formation, the β subunits bind in a specific order creating assembly intermediates (Hirano et 
al., 2008) (discussed in section 1.5) that lead to the formation of the mature 20S CP. Efficient 
assembly requires dedicated assembly chaperones, Ump1, Pba1-2, and Pba3-4, that promote on 
pathway interactions and prevent off pathway interactions (discussed in sections 1.5.1, 1.5.2, 
1.5.3, and 1.5.4). Defects in proteasome function are implicated in a variety of ailments such as 
cancer and neurodegenerative diseases (Schmidt & Finley, 2014). Since better characterization 
of the proteasome assembly pathway may help in the development of future therapeutics, the 
overall aim of this work was to further characterize the proteasome assembly pathway. In this 
dissertation three major contributions to the proteasome assembly field were described: first 
novel high molecular weight complexes comprised of primarily α4 were identified, second 
Ssa1/2 were shown to function as proteasome assembly chaperones, and third a complex of α 
and β subunits, which may be a new assembly intermediate, was identified.  
5.2 α4 Complex 
 While studying conditions that lead to the formation of the alternative α4-α4 proteasome 
in wild type cells, novel high molecular weight complexes consisting primarily of proteasome 
subunit α4 and Hsp70 proteins, Ssa1/2, were identified (Figure 2.3). This was the first report of 
such a complex forming in vivo. Previous reports demonstrated that human proteasome subunit 
α7 readily forms high molecular weight complexes when expressed recombinantly in E.coli 
(Gerards et al., 1997); however, no such complexes had been described in vivo, until now.  
Proteasome subunits were thought to exclusively function as part of the proteasome. 
Identifying these non-canonical complexes in vivo opens the door to the idea of extra-
proteasomal roles for proteasome subunits. While its function is unknown, it is hypothesized that 
these α4 complexes may be one of four things: (1) these complexes may have their own unique 
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function separate from the 20S proteasome; (2) they may serve as α4 reservoirs for efficient 
proteasome assembly; (3) they may act as a scaffold or template for proteasome assembly; or (4) 
they may be nonfunctional dead-end products. Experiments are currently underway to determine 
if these complexes have a unique function. One way to explore this, is by looking for phenotypes 
in a yeast strain where α4 complex formation is disrupted. Phenotypes can give clues to function; 
moreover, once a phenotype is identified a high copy suppressor screen can be implemented. 
Identifying which overexpressed genes suppress an α4 complex disruption phenotype will 
suggest which pathways, or cellular systems, this complex participates within.  
Another possible way to determine function is to identify interacting proteins. Only 
Ssa1/2 were associated with the α4 complexes, but there could be other weakly associated 
proteins that may not have survived the stringent purification protocol that was implemented. To 
look for interacting proteins binding assays with immobilized α4 complexes and yeast lysate will 
be performed. Varying salt concentrations will be tested as well as binding in the presence of 
different nucleotides, since interacting proteins may require nucleotide for binding. Furthermore, 
the α4 complexes are likely comprised of rings (Figure 2.4), these rings may resemble the 
proteasome’s α ring, which can be bound by activator proteins. It will be interesting to see if 
those same activators can also bind α4 complexes.  
Identifying these novel high molecular weight complexes highlights that there is still much 
to learn about cellular homeostasis. These complexes were missed in previous studies. They 
were identified here by resolving SDS-PAGE gels for an extended period of time and by using 
engineered disulfide bonds to stabilize them on native PAGE. While the function of these α4 
complexes is unclear, it is likely that they do serve a function since the levels of these complexes 
appear to be regulated within the cell. 
5.3 Ssa1/2 Function as 20S Assembly Chaperones 
This study sought to determine if any other proteins assisted in 20S CP assembly besides 
the previously described assembly factors, Ump1, Pba1, Pba2, Pba3, and Pba4. The findings 
described in this dissertation suggest that Ssa1/2 participate within 20S CP assembly. Both 
mature 20S CPs and intermediates were examined by native PAGE and subsequent mass 
spectrometry. Ssa1/2 were identified on early assembly intermediates, but not late intermediates 
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or the mature 20S CP (Figure 3.1 and 3.4). This argued that Ssa1/2 may function as assembly 
chaperones, since assembly chaperones, by definition, are only identified on assembly 
intermediates, and not the mature 20S CP. While the precise role of Ssa1/2 in assembly is 
unknown, the data suggests that they may be important for stabilizing assembly intermediates, 
since the levels of intermediates drastically decrease when Ssa1/2 are deleted (Figure 3.4). 
Moreover, this data combined with the findings outlined in Chapter 2, argue that Ssa1/2 may be 
important for stabilizing rings of proteasome subunits, since Ssa1/2 are observed as part of the 
α4 complexes, which are likely rings of α4. To better understand Ssa1/2’s interaction with 
assembly intermediates, structural studies may provide insight into their exact role in proteasome 
assembly.   
 Ssa1/2 are part of the molecular chaperone network and have defined roles within the 
ubiquitin-proteasome system (Arndt et al., 2007; Huyer et al., 2004; Kettern et al., 2010; Metzger 
et al., 2008; Plemper et al., 1997; Shiber & Ravid, 2014). Here Ssa1/2 were added to the growing 
list of general chaperones that participate within the proteasome assembly network. Other 
chaperones that have been implicated in proteasome assembly include, Bag6 (Akahane et al., 
2013) and Hsp90 (Yamano et al., 2008). Other proteins may also participate in proteasome 
assembly. While Ssa1/2 were the only new proteins identified interacting with assembly 
intermediates, there may be other weakly interacting proteins that function as 20S assembly 
factors, that did not survive the extensive purification protocol.  
5.4 Sub-13S 
A depletion strategy was implemented to purify proteasome intermediates and their 
potential binding partners (Figure 3.1 and 4.1B). The purified intermediates were resolved by 
native PAGE. While the canonical intermediates were identified, a novel species containing 
proteasome subunits α1-4 and β2-4 was also identified. This species migrated faster than the 13S 
intermediate on native PAGE, so it was referred to as the sub-13S. The sub-13S is a novel 
species which may be an assembly intermediate belonging to an alternative assembly pathway. 
The sub-13S does not fit within the described assembly pathway for eukaryotes. 
Eukaryotic assembly proceeds through an α ring dependent pathway, which initiates with the 
formation of an α ring (Hirano et al., 2005). This is also the case in archaea, whose proteasomes 
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have long served as models for studying 20S CP assembly (Zwickl et al., 1994). However, a 
recent study uncovered an α ring independent pathway for archaeal proteasomes which initiates 
through the interaction of α and β subunits (Panfair et al., 2015). Since the sub-13S lacks a full α 
ring and contains a subset of α and β subunits, this species may be the first evidence of an α ring 
independent assembly pathway operating in eukaryotes.  
The sub-13S resembles a 13S intermediate lacking α5, α6, and α7. Because of this 
similarity is was hypothesized that sub-13S may be a precursor to the 13S. Moreover, the 13S 
was routinely detected in proteasome purifications, while the sub-13S was only detected in a 
subset of purifications. This observation was attributed to disturbances in assembly caused by 
tagging different subunits. Tagging some subunits may perturb assembly slightly, while other 
tags may have no effect on the assembly process. To test the idea of a precursor product 
relationship between sub-13S and 13S, 13S assembly was perturbed by slowing down the rate at 
which α5 could incorporate by using an α5 mutant. The results were consistent with sub-13S 
being the immediate precursor the 13S. Slowing down assembly in strains that produced sub-13, 
caused more sub-13S accumulate while amount of 13S was reduced (Figure 4.2A). Furthermore, 
slowing down assembly with the α5 mutant induced the formation of sub-13S in strains where it 
was previously not detected (Figure 4.2B). 
The proteasome field describes α ring formation as an essential step for proteasome 
assembly in eukaryotes (Hirano et al., 2005), even though no one has formally described α rings 
in yeast. Experiments are underway to further characterize this complex. The evidence provided 
in this dissertation argues for this novel sub-13S species as being an assembly intermediate that 
participates within an alternative assembly pathway, initiating through the interaction of α and β 
subunits. Perhaps, this novel intermediate is unique to yeast, but it is also possible that 
eukaryotes, like archaea, can use more than one assembly pathway.  
5.5 Concluding Remarks 
Three major contributions to the proteasome assembly field were described in this 
dissertation (Figure 5.1). First, novel non-canonical complexes comprised of proteasome subunit 
α4 and Ssa1/2 were identified. Second, a new proteasome assembly role for molecular 
chaperones Ssa1/2 was described. Third, a novel complex, the sub-13S, was identified and is 
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believed to be an assembly intermediate that participates within an alternative assembly pathway. 
The findings presented in this dissertation suggest that proteasome assembly likely occurs 
through multiple pathways using a variety of assembly factors and intermediates.  
  
 
Figure 5.1 Contributions to the 20S proteasome assembly pathway 
This schematic depicts the canonical 20S proteasome assembly pathway with the findings 
described in this dissertation
68 
 
REFERENCES 
Adams, J. (2004). The development of proteasome inhibitors as anticancer drugs. Cancer Cell, 
5(5), 417-421.  
Ahn, J. Y., Tanahashi, N., Akiyama, K., Hisamatsu, H., Noda, C., Tanaka, K., . . . et al. (1995). 
Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible 
protein activator of the 20S proteasome. FEBS Lett, 366(1), 37-42.  
Akahane, T., Sahara, K., Yashiroda, H., Tanaka, K., & Murata, S. (2013). Involvement of Bag6 
and the TRC pathway in proteasome assembly. Nat Commun, 4, 2234. 
doi:10.1038/ncomms3234 
Aki, M., Shimbara, N., Takashina, M., Akiyama, K., Kagawa, S., Tamura, T., . . . Ichihara, A. 
(1994). Interferon-gamma induces different subunit organizations and functional 
diversity of proteasomes. J Biochem, 115(2), 257-269.  
Amm, I., Sommer, T., & Wolf, D. H. (2014). Protein quality control and elimination of protein 
waste: the role of the ubiquitin-proteasome system. Biochim Biophys Acta, 1843(1), 182-
196. doi:10.1016/j.bbamcr.2013.06.031 
Arendt, C. S., & Hochstrasser, M. (1997). Identification of the yeast 20S proteasome catalytic 
centers and subunit interactions required for active-site formation. Proc Natl Acad Sci U 
S A, 94(14), 7156-7161.  
Arendt, C. S., & Hochstrasser, M. (1999). Eukaryotic 20S proteasome catalytic subunit 
propeptides prevent active site inactivation by N-terminal acetylation and promote 
particle assembly. EMBO J, 18(13), 3575-3585. doi:10.1093/emboj/18.13.3575 
Arndt, V., Rogon, C., & Hohfeld, J. (2007). To be, or not to be--molecular chaperones in protein 
degradation. Cell Mol Life Sci, 64(19-20), 2525-2541. doi:10.1007/s00018-007-7188-6 
Bai, L., Jastrab, J. B., Isasa, M., Hu, K., Yu, H., Gygi, S. P., . . . Li, H. (2017). Structural 
Analysis of Mycobacterium tuberculosis Homologues of the Eukaryotic Proteasome 
Assembly Chaperone 2 (PAC2). J Bacteriol, 199(9). doi:10.1128/JB.00846-16 
Bai, M., Zhao, X., Sahara, K., Ohte, Y., Hirano, Y., Kaneko, T., . . . Murata, S. (2014). Assembly 
mechanisms of specialized core particles of the proteasome. Biomolecules, 4(3), 662-677. 
doi:10.3390/biom4030662 
Barthelme, D., & Sauer, R. T. (2012). Identification of the Cdc48*20S proteasome as an ancient 
AAA+ proteolytic machine. Science, 337(6096), 843-846. doi:10.1126/science.1224352 
Barton, L. F., Runnels, H. A., Schell, T. D., Cho, Y., Gibbons, R., Tevethia, S. S., . . . Monaco, J. 
J. (2004). Immune defects in 28-kDa proteasome activator gamma-deficient mice. J 
Immunol, 172(6), 3948-3954.  
Beck, F., Unverdorben, P., Bohn, S., Schweitzer, A., Pfeifer, G., Sakata, E., . . . Forster, F. 
(2012). Near-atomic resolution structural model of the yeast 26S proteasome. Proc Natl 
Acad Sci U S A, 109(37), 14870-14875. doi:10.1073/pnas.1213333109 
Benaroudj, N., Zwickl, P., Seemuller, E., Baumeister, W., & Goldberg, A. L. (2003). ATP 
hydrolysis by the proteasome regulatory complex PAN serves multiple functions in 
protein degradation. Mol Cell, 11(1), 69-78. doi:S109727650200775X [pii] 
Bennett, J. A., Yarnall, J., Cadwallader, A. B., Kuennen, R., Bidey, P., Stadelmaier, B., & 
McCormick, J. R. (2009). Medium-dependent phenotypes of Streptomyces coelicolor 
with mutations in ftsI or ftsW. J Bacteriol, 191(2), 661-664. doi:10.1128/JB.01048-08 
69 
 
Bentley, S. D., Chater, K. F., Cerdeno-Tarraga, A. M., Challis, G. L., Thomson, N. R., James, K. 
D., . . . Hopwood, D. A. (2002). Complete genome sequence of the model actinomycete 
Streptomyces coelicolor A3(2). Nature, 417(6885), 141-147. doi:10.1038/417141a 
Bibo-Verdugo, B., Jiang, Z., Caffrey, C. R., & O'Donoghue, A. J. (2017). Targeting proteasomes 
in infectious organisms to combat disease. FEBS J, 284(10), 1503-1517. 
doi:10.1111/febs.14029 
Bishop, A., Fielding, S., Dyson, P., & Herron, P. (2004). Systematic insertional mutagenesis of a 
streptomycete genome: a link between osmoadaptation and antibiotic production. 
Genome Res, 14(5), 893-900. doi:10.1101/gr.1710304 
Blickwedehl, J., Agarwal, M., Seong, C., Pandita, R. K., Melendy, T., Sung, P., . . . Bangia, N. 
(2008). Role for proteasome activator PA200 and postglutamyl proteasome activity in 
genomic stability. Proc Natl Acad Sci U S A, 105(42), 16165-16170. 
doi:10.1073/pnas.0803145105 
Blickwedehl, J., McEvoy, S., Wong, I., Kousis, P., Clements, J., Elliott, R., . . . Bangia, N. 
(2007). Proteasomes and proteasome activator 200 kDa (PA200) accumulate on 
chromatin in response to ionizing radiation. Radiat Res, 167(6), 663-674. 
doi:10.1667/RR0690.1 
Bochtler, M., Ditzel, L., Groll, M., & Huber, R. (1997). Crystal structure of heat shock locus V 
(HslV) from Escherichia coli. Proc Natl Acad Sci U S A, 94(12), 6070-6074.  
Bochtler, M., Song, H. K., Hartmann, C., Ramachandran, R., & Huber, R. (2001). The 
quaternary arrangement of HslU and HslV in a cocrystal: a response to Wang, Yale. J 
Struct Biol, 135(3), 281-293. doi:10.1006/jsbi.2001.4413 
Bolten, M., Delley, C. L., Leibundgut, M., Boehringer, D., Ban, N., & Weber-Ban, E. (2016). 
Structural Analysis of the Bacterial Proteasome Activator Bpa in Complex with the 20S 
Proteasome. Structure, 24(12), 2138-2151. doi:10.1016/j.str.2016.10.008 
Boubakri, H., Seghezzi, N., Duchateau, M., Gominet, M., Kofronova, O., Benada, O., . . . 
Pernodet, J. L. (2015). The Absence of Pupylation (Prokaryotic Ubiquitin-Like Protein 
Modification) Affects Morphological and Physiological Differentiation in Streptomyces 
coelicolor. J Bacteriol, 197(21), 3388-3399. doi:10.1128/JB.00591-15 
Burns, K. E., Cerda-Maira, F. A., Wang, T., Li, H., Bishai, W. R., & Darwin, K. H. (2010). 
"Depupylation" of prokaryotic ubiquitin-like protein from mycobacterial proteasome 
substrates. Mol Cell, 39(5), 821-827. doi:10.1016/j.molcel.2010.07.019 
Burri, L., Hockendorff, J., Boehm, U., Klamp, T., Dohmen, R. J., & Levy, F. (2000). 
Identification and characterization of a mammalian protein interacting with 20S 
proteasome precursors. Proc Natl Acad Sci U S A, 97(19), 10348-10353. 
doi:10.1073/pnas.190268597 
C. Guthrie, G. R. F. (1991). Guide to Yeast Genetics and Molecular Biology: Academic Press. 
Carr, S., Aebersold, R., Baldwin, M., Burlingame, A., Clauser, K., Nesvizhskii, A., . . . Protein 
Identification, D. (2004). The need for guidelines in publication of peptide and protein 
identification data: Working Group on Publication Guidelines for Peptide and Protein 
Identification Data. Mol Cell Proteomics, 3(6), 531-533. doi:10.1074/mcp.T400006-
MCP200 
Cascio, P. (2014). PA28alphabeta: the enigmatic magic ring of the proteasome? Biomolecules, 
4(2), 566-584. doi:10.3390/biom4020566 
70 
 
Cascio, P., Call, M., Petre, B. M., Walz, T., & Goldberg, A. L. (2002). Properties of the hybrid 
form of the 26S proteasome containing both 19S and PA28 complexes. EMBO J, 21(11), 
2636-2645. doi:10.1093/emboj/21.11.2636 
Cascio, P., Hilton, C., Kisselev, A. F., Rock, K. L., & Goldberg, A. L. (2001). 26S proteasomes 
and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. 
EMBO J, 20(10), 2357-2366. doi:10.1093/emboj/20.10.2357 
Chater, K. F., Biro, S., Lee, K. J., Palmer, T., & Schrempf, H. (2010). The complex extracellular 
biology of Streptomyces. FEMS Microbiol Rev, 34(2), 171-198. doi:10.1111/j.1574-
6976.2009.00206.x 
Chater, K. F., & Chandra, G. (2008). The use of the rare UUA codon to define "expression 
space" for genes involved in secondary metabolism, development and environmental 
adaptation in streptomyces. J Microbiol, 46(1), 1-11. doi:10.1007/s12275-007-0233-1 
Chau, V., Tobias, J. W., Bachmair, A., Marriott, D., Ecker, D. J., Gonda, D. K., & Varshavsky, 
A. (1989). A multiubiquitin chain is confined to specific lysine in a targeted short-lived 
protein. Science, 243(4898), 1576-1583.  
Chen, P., & Hochstrasser, M. (1995). Biogenesis, structure and function of the yeast 20S 
proteasome. EMBO J, 14(11), 2620-2630.  
Chen, P., & Hochstrasser, M. (1996). Autocatalytic subunit processing couples active site 
formation in the 20S proteasome to completion of assembly. Cell, 86(6), 961-972. 
doi:S0092-8674(00)80171-3 [pii] 
Choi, H. S., Rai, P. R., Chu, H. W., Cool, C., & Chan, E. D. (2002). Analysis of nitric oxide 
synthase and nitrotyrosine expression in human pulmonary tuberculosis. Am J Respir Crit 
Care Med, 166(2), 178-186.  
Chuang, S. E., Burland, V., Plunkett, G., 3rd, Daniels, D. L., & Blattner, F. R. (1993). Sequence 
analysis of four new heat-shock genes constituting the hslTS/ibpAB and hslVU operons 
in Escherichia coli. Gene, 134(1), 1-6.  
Compton, C. L., Fernandopulle, M. S., Nagari, R. T., & Sello, J. K. (2015). Genetic and 
Proteomic Analyses of Pupylation in Streptomyces coelicolor. J Bacteriol, 197(17), 
2747-2753. doi:10.1128/JB.00302-15 
Cusack, J. C., Jr., Liu, R., Houston, M., Abendroth, K., Elliott, P. J., Adams, J., & Baldwin, A. S., 
Jr. (2001). Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: 
implications for systemic nuclear factor-kappaB inhibition. Cancer Res, 61(9), 3535-
3540.  
da Fonseca, P. C., He, J., & Morris, E. P. (2012). Molecular model of the human 26S proteasome. 
Mol Cell, 46(1), 54-66. doi:S1097-2765(12)00263-8 [pii]10.1016/j.molcel.2012.03.026 
Dange, T., Smith, D., Noy, T., Rommel, P. C., Jurzitza, L., Cordero, R. J., . . . Schmidt, M. 
(2011). Blm10 protein promotes proteasomal substrate turnover by an active gating 
mechanism. J Biol Chem, 286(50), 42830-42839. 
doi:10.1074/jbc.M111.300178M111.300178 [pii] 
Darwin, K. H., Ehrt, S., Gutierrez-Ramos, J. C., Weich, N., & Nathan, C. F. (2003). The 
proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. 
Science, 302(5652), 1963-1966. doi:10.1126/science.1091176302/5652/1963 [pii] 
Darwin, K. H., Lin, G., Chen, Z., Li, H., & Nathan, C. F. (2005). Characterization of a 
Mycobacterium tuberculosis proteasomal ATPase homologue. Mol Microbiol, 55(2), 
561-571. doi:10.1111/j.1365-2958.2004.04403.x 
71 
 
De Mot, R., Nagy, I., Walz, J., & Baumeister, W. (1999). Proteasomes and other self-
compartmentalizing proteases in prokaryotes. Trends Microbiol, 7(2), 88-92.  
De Mot, R., Schoofs, G., & Nagy, I. (2007). Proteome analysis of Streptomyces coelicolor 
mutants affected in the proteasome system reveals changes in stress-responsive proteins. 
Arch Microbiol, 188(3), 257-271. doi:10.1007/s00203-007-0243-8 
Delley, C. L., Laederach, J., Ziemski, M., Bolten, M., Boehringer, D., & Weber-Ban, E. (2014). 
Bacterial proteasome activator bpa (rv3780) is a novel ring-shaped interactor of the 
mycobacterial proteasome. PLoS One, 9(12), e114348. 
doi:10.1371/journal.pone.0114348 
DeMartino, G. N., & Slaughter, C. A. (1999). The proteasome, a novel protease regulated by 
multiple mechanisms. J Biol Chem, 274(32), 22123-22126.  
Demo, S. D., Kirk, C. J., Aujay, M. A., Buchholz, T. J., Dajee, M., Ho, M. N., . . . Bennett, M. K. 
(2007). Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome. 
Cancer Res, 67(13), 6383-6391. doi:10.1158/0008-5472.CAN-06-4086 
Dietrich, C., Bartsch, T., Schanz, F., Oesch, F., & Wieser, R. J. (1996). p53-dependent cell cycle 
arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth 
factor-stimulated human fibroblasts. Proc Natl Acad Sci U S A, 93(20), 10815-10819.  
Djuranovic, S., Rockel, B., Lupas, A. N., & Martin, J. (2006). Characterization of AMA, a new 
AAA protein from Archaeoglobus and methanogenic archaea. J Struct Biol, 156(1), 130-
138. doi:10.1016/j.jsb.2006.03.010 
Doherty, K. M., Pride, L. D., Lukose, J., Snydsman, B. E., Charles, R., Pramanik, A., . . . Moore, 
C. W. (2012). Loss of a 20S proteasome activator in Saccharomyces cerevisiae 
downregulates genes important for genomic integrity, increases DNA damage, and 
selectively sensitizes cells to agents with diverse mechanisms of action. G3 (Bethesda), 
2(8), 943-959. doi:10.1534/g3.112.003376 
Dubiel, W., Pratt, G., Ferrell, K., & Rechsteiner, M. (1992). Purification of an 11 S regulator of 
the multicatalytic protease. J Biol Chem, 267(31), 22369-22377.  
Elsasser, S., Gali, R. R., Schwickart, M., Larsen, C. N., Leggett, D. S., Muller, B., . . . Finley, D. 
(2002). Proteasome subunit Rpn1 binds ubiquitin-like protein domains. Nat Cell Biol, 
4(9), 725-730. doi:10.1038/ncb845 
Firestone, K., Awonusi, D., Panfair, D., Roland, D., Ramamurthy, A., & Kusmierczyk, A. R. 
(2016). YPL260W, a high-copy suppressor of a copper-sensitive phenotype in yeast, is 
linked to DNA repair and proteasome function. Plant Gene, 5, 38-48. 
doi:10.1016/j.plgene.2015.11.002 
Flardh, K., & Buttner, M. J. (2009). Streptomyces morphogenetics: dissecting differentiation in a 
filamentous bacterium. Nat Rev Microbiol, 7(1), 36-49. doi:10.1038/nrmicro1968 
Forouzan, D., Ammelburg, M., Hobel, C. F., Stroh, L. J., Sessler, N., Martin, J., & Lupas, A. N. 
(2012). The archaeal proteasome is regulated by a network of AAA ATPases. J Biol 
Chem, 287(46), 39254-39262. doi:10.1074/jbc.M112.386458 
Fort, P., Kajava, A. V., Delsuc, F., & Coux, O. (2015). Evolution of proteasome regulators in 
eukaryotes. Genome Biol Evol, 7(5), 1363-1379. doi:10.1093/gbe/evv068 
Frankenberg, R. J., Hsu, T. S., Yakota, H., Kim, R., & Clark, D. S. (2001). Chemical 
denaturation and elevated folding temperatures are required for wild-type activity and 
stability of recombinant Methanococcus jannaschii 20S proteasome. Protein Sci, 10(9), 
1887-1896. doi:10.1110/ps.ps.05801 
72 
 
Frentzel, S., Pesold-Hurt, B., Seelig, A., & Kloetzel, P. M. (1994). 20 S proteasomes are 
assembled via distinct precursor complexes. Processing of LMP2 and LMP7 proproteins 
takes place in 13-16 S preproteasome complexes. J Mol Biol, 236(4), 975-981.  
Fricke, B., Heink, S., Steffen, J., Kloetzel, P. M., & Kruger, E. (2007). The proteasome 
maturation protein POMP facilitates major steps of 20S proteasome formation at the 
endoplasmic reticulum. EMBO Rep, 8(12), 1170-1175. doi:10.1038/sj.embor.7401091 
Fu, H., Doelling, J. H., Arendt, C. S., Hochstrasser, M., & Vierstra, R. D. (1998). Molecular 
organization of the 20S proteasome gene family from Arabidopsis thaliana. Genetics, 
149(2), 677-692.  
Fuchs, A. C. D., Alva, V., Maldoner, L., Albrecht, R., Hartmann, M. D., & Martin, J. (2017). 
The Architecture of the Anbu Complex Reflects an Evolutionary Intermediate at the 
Origin of the Proteasome System. Structure, 25(6), 834-845 e835. 
doi:10.1016/j.str.2017.04.005 
Funakoshi, M., Li, X., Velichutina, I., Hochstrasser, M., & Kobayashi, H. (2004). Sem1, the 
yeast ortholog of a human BRCA2-binding protein, is a component of the proteasome 
regulatory particle that enhances proteasome stability. J Cell Sci, 117(Pt 26), 6447-6454. 
doi:jcs.01575 [pii]10.1242/jcs.01575 
Funakoshi, M., Tomko, R. J., Jr., Kobayashi, H., & Hochstrasser, M. (2009). Multiple assembly 
chaperones govern biogenesis of the proteasome regulatory particle base. Cell, 137(5), 
887-899. doi:S0092-8674(09)00526-1 [pii]10.1016/j.cell.2009.04.061 
Gaczynska, M., Rock, K. L., & Goldberg, A. L. (1993). Role of proteasomes in antigen 
presentation. Enzyme Protein, 47(4-6), 354-369.  
Gerards, W. L., de Jong, W. W., Bloemendal, H., & Boelens, W. (1998). The human 
proteasomal subunit HsC8 induces ring formation of other alpha-type subunits. J Mol 
Biol, 275(1), 113-121. doi:10.1006/jmbi.1997.1429 
Gerards, W. L., Enzlin, J., Haner, M., Hendriks, I. L., Aebi, U., Bloemendal, H., & Boelens, W. 
(1997). The human alpha-type proteasomal subunit HsC8 forms a double ringlike 
structure, but does not assemble into proteasome-like particles with the beta-type subunits 
HsDelta or HsBPROS26. J Biol Chem, 272(15), 10080-10086.  
Gille, C., Goede, A., Schloetelburg, C., Preissner, R., Kloetzel, P. M., Gobel, U. B., & Frommel, 
C. (2003). A comprehensive view on proteasomal sequences: implications for the 
evolution of the proteasome. J Mol Biol, 326(5), 1437-1448. doi:S0022283602014705 
[pii] 
Glickman, M. H., Rubin, D. M., Coux, O., Wefes, I., Pfeifer, G., Cjeka, Z., . . . Finley, D. (1998). 
A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate 
degradation and related to the COP9-signalosome and eIF3. Cell, 94(5), 615-623. 
doi:S0092-8674(00)81603-7 [pii] 
Global Tuberculosis Report. (2016). Retrieved from 
http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1:  
Gong, Y., Kakihara, Y., Krogan, N., Greenblatt, J., Emili, A., Zhang, Z., & Houry, W. A. (2009). 
An atlas of chaperone-protein interactions in Saccharomyces cerevisiae: implications to 
protein folding pathways in the cell. Mol Syst Biol, 5, 275. doi:10.1038/msb.2009.26 
Grana, M., Bellinzoni, M., Miras, I., Fiez-Vandal, C., Haouz, A., Shepard, W., . . . Alzari, P. M. 
(2009). Structure of Mycobacterium tuberculosis Rv2714, a representative of a duplicated 
gene family in Actinobacteria. Acta Crystallogr Sect F Struct Biol Cryst Commun, 65(Pt 
10), 972-977. doi:10.1107/S1744309109035027 
73 
 
Griffin, T. A., Nandi, D., Cruz, M., Fehling, H. J., Kaer, L. V., Monaco, J. J., & Colbert, R. A. 
(1998). Immunoproteasome assembly: cooperative incorporation of interferon gamma 
(IFN-gamma)-inducible subunits. J Exp Med, 187(1), 97-104.  
Groettrup, M., Soza, A., Eggers, M., Kuehn, L., Dick, T. P., Schild, H., . . . Kloetzel, P. M. 
(1996). A role for the proteasome regulator PA28alpha in antigen presentation. Nature, 
381(6578), 166-168. doi:10.1038/381166a0 
Groettrup, M., Standera, S., Stohwasser, R., & Kloetzel, P. M. (1997). The subunits MECL-1 
and LMP2 are mutually required for incorporation into the 20S proteasome. Proc Natl 
Acad Sci U S A, 94(17), 8970-8975.  
Groll, M., Bajorek, M., Kohler, A., Moroder, L., Rubin, D. M., Huber, R., . . . Finley, D. (2000). 
A gated channel into the proteasome core particle. Nat Struct Biol, 7(11), 1062-1067. 
doi:10.1038/80992 
Groll, M., Brandstetter, H., Bartunik, H., Bourenkow, G., & Huber, R. (2003). Investigations on 
the maturation and regulation of archaebacterial proteasomes. J Mol Biol, 327(1), 75-83.  
Groll, M., Ditzel, L., Lowe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997). 
Structure of 20S proteasome from yeast at 2.4 A resolution. Nature, 386(6624), 463-471. 
doi:10.1038/386463a0 
Groll, M., Heinemeyer, W., Jager, S., Ullrich, T., Bochtler, M., Wolf, D. H., & Huber, R. (1999). 
The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational 
and crystallographic study. Proc Natl Acad Sci U S A, 96(20), 10976-10983.  
Groll, M., Koguchi, Y., Huber, R., & Kohno, J. (2001). Crystal structure of the 20 S 
proteasome:TMC-95A complex: a non-covalent proteasome inhibitor. J Mol Biol, 311(3), 
543-548. doi:10.1006/jmbi.2001.4869 
Guerrero, C., Milenkovic, T., Przulj, N., Kaiser, P., & Huang, L. (2008). Characterization of the 
proteasome interaction network using a QTAX-based tag-team strategy and protein 
interaction network analysis. Proc Natl Acad Sci U S A, 105(36), 13333-13338. 
doi:0801870105 [pii]10.1073/pnas.0801870105 
Guerrero, C., Tagwerker, C., Kaiser, P., & Huang, L. (2006). An integrated mass spectrometry-
based proteomic approach: quantitative analysis of tandem affinity-purified in vivo cross-
linked protein complexes (QTAX) to decipher the 26 S proteasome-interacting network. 
Mol Cell Proteomics, 5(2), 366-378. doi:10.1074/mcp.M500303-MCP200 
Guillaume, B., Chapiro, J., Stroobant, V., Colau, D., Van Holle, B., Parvizi, G., . . . Van den 
Eynde, B. J. (2010). Two abundant proteasome subtypes that uniquely process some 
antigens presented by HLA class I molecules. Proc Natl Acad Sci U S A, 107(43), 18599-
18604. doi:10.1073/pnas.1009778107 
Guth, E., Thommen, M., & Weber-Ban, E. (2011). Mycobacterial ubiquitin-like protein ligase 
PafA follows a two-step reaction pathway with a phosphorylated pup intermediate. J Biol 
Chem, 286(6), 4412-4419. doi:10.1074/jbc.M110.189282 
Hammack, L., & Kusmierczyk, A. R. (2016). Data on the identity of non-canonical complexes 
formed from proteasome subunits in vivo. Data Brief, Submitted.  
Hammack, L. J., Firestone, K., Chang, W., & Kusmierczyk, A. R. (2017). Molecular chaperones 
of the Hsp70 family assist in the assembly of 20S proteasomes. Biochem Biophys Res 
Commun, 486(2), 438-443. doi:10.1016/j.bbrc.2017.03.059 
Hammack, L. J., & Kusmierczyk, A. R. (2016). Data on the identity of non-canonical complexes 
formed from proteasome subunits in vivo. Data Brief, 9, 1130-1137. 
doi:10.1016/j.dib.2016.11.048 
74 
 
Hammack, L. J., & Kusmierczyk, A. R. (2017). Assembly of proteasome subunits into non-
canonical complexes in vivo. Biochem Biophys Res Commun, 482(1), 164-169. 
doi:10.1016/j.bbrc.2016.11.024 
Hari, P. N., Shain, K. H., Voorhees, P. M., Gabrail, N., Abidi, M. H., Zonder, J., . . . Paba Prada, 
C. (2014). Oprozomib and Dexamethasone in Patients with Relapsed and/or Refractory 
Multiple Myeloma: Initial Results from the Dose Escalation Portion of a Phase 1b/2, 
Multicenter, Open-Label Study. Blood, 124(21), 3453-3453.  
Harshbarger, W., Miller, C., Diedrich, C., & Sacchettini, J. (2015). Crystal structure of the 
human 20S proteasome in complex with carfilzomib. Structure, 23(2), 418-424. 
doi:10.1016/j.str.2014.11.017 
Hatanaka, A., Chen, B., Sun, J. Q., Mano, Y., Funakoshi, M., Kobayashi, H., . . . Oki, M. (2011). 
Fub1p, a novel protein isolated by boundary screening, binds the proteasome complex. 
Genes Genet Syst, 86(5), 305-314.  
Heinemeyer, W., Fischer, M., Krimmer, T., Stachon, U., & Wolf, D. H. (1997). The active sites 
of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. 
J Biol Chem, 272(40), 25200-25209.  
Heink, S., Ludwig, D., Kloetzel, P. M., & Kruger, E. (2005). IFN-gamma-induced immune 
adaptation of the proteasome system is an accelerated and transient response. Proc Natl 
Acad Sci U S A, 102(26), 9241-9246. doi:0501711102 [pii]10.1073/pnas.0501711102 
Hendil, K. B., Khan, S., & Tanaka, K. (1998). Simultaneous binding of PA28 and PA700 
activators to 20 S proteasomes. Biochem J, 332 ( Pt 3), 749-754.  
Hepowit, N. L., Uthandi, S., Miranda, H. V., Toniutti, M., Prunetti, L., Olivarez, O., . . . Maupin-
Furlow, J. A. (2012). Archaeal JAB1/MPN/MOV34 metalloenzyme (HvJAMM1) cleaves 
ubiquitin-like small archaeal modifier proteins (SAMPs) from protein-conjugates. Mol 
Microbiol, 86(4), 971-987. doi:10.1111/mmi.12038 
Hershko, A., & Ciechanover, A. (1998). The ubiquitin system. Annu Rev Biochem, 67, 425-479. 
doi:10.1146/annurev.biochem.67.1.425 
Hideshima, T., Richardson, P., Chauhan, D., Palombella, V. J., Elliott, P. J., Adams, J., & 
Anderson, K. C. (2001). The proteasome inhibitor PS-341 inhibits growth, induces 
apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res, 
61(7), 3071-3076.  
Hirano, Y., Hayashi, H., Iemura, S., Hendil, K. B., Niwa, S., Kishimoto, T., . . . Murata, S. 
(2006). Cooperation of multiple chaperones required for the assembly of mammalian 20S 
proteasomes. Mol Cell, 24(6), 977-984. doi:S1097-2765(06)00786-6 
[pii]10.1016/j.molcel.2006.11.015 
Hirano, Y., Hendil, K. B., Yashiroda, H., Iemura, S., Nagane, R., Hioki, Y., . . . Murata, S. 
(2005). A heterodimeric complex that promotes the assembly of mammalian 20S 
proteasomes. Nature, 437(7063), 1381-1385. doi:nature04106 [pii]10.1038/nature04106 
Hirano, Y., Kaneko, T., Okamoto, K., Bai, M., Yashiroda, H., Furuyama, K., . . . Murata, S. 
(2008). Dissecting beta-ring assembly pathway of the mammalian 20S proteasome. 
EMBO J, 27(16), 2204-2213. doi:emboj2008148 [pii]10.1038/emboj.2008.148 
Hochstrasser, M. (1996). Ubiquitin-dependent protein degradation. Annu Rev Genet, 30, 405-439. 
doi:10.1146/annurev.genet.30.1.405 
Holkova, B., & Grant, S. (2012). Proteasome inhibitors in mantle cell lymphoma. Best Pract Res 
Clin Haematol, 25(2), 133-141. doi:10.1016/j.beha.2012.04.007 
75 
 
Houry, W. A. (2014). The Molecular Chaperones Interaction Networks in Protein Folding and 
Degradation. New York: Springer-Verlag. 
Howell, L. A., Tomko, R. J., & Kusmierczyk, A. R. (2017). Putting it all together: intrinsic and 
extrinsic mechanisms governing proteasome biogenesis. Frontiers in Biology, 12(1), 19-
48. doi:10.1007/s11515-017-1439-1 
Hu, G., Lin, G., Wang, M., Dick, L., Xu, R. M., Nathan, C., & Li, H. (2006). Structure of the 
Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl 
boronate. Mol Microbiol, 59(5), 1417-1428. doi:10.1111/j.1365-2958.2005.05036.x 
Hua, S., To, W. Y., Nguyen, T. T., Wong, M. L., & Wang, C. C. (1996). Purification and 
characterization of proteasomes from Trypanosoma brucei. Mol Biochem Parasitol, 78(1-
2), 33-46.  
Huang, L., Haratake, K., Miyahara, H., & Chiba, T. (2016). Proteasome activators, PA28gamma 
and PA200, play indispensable roles in male fertility. Sci Rep, 6, 23171. 
doi:10.1038/srep23171 
Huang, X., Luan, B., Wu, J., & Shi, Y. (2016a). An atomic structure of the human 26S 
proteasome. Nat Struct Mol Biol. doi:10.1038/nsmb.3273 
Huang, X., Luan, B., Wu, J., & Shi, Y. (2016b). An atomic structure of the human 26S 
proteasome. Nat Struct Mol Biol, 23(9), 778-785. doi:10.1038/nsmb.3273 
Huber, E. M., & Groll, M. (2017). The Mammalian Proteasome Activator PA28 Forms an 
Asymmetric alpha4beta3 Complex. Structure. doi:10.1016/j.str.2017.07.013 
Huber, E. M., Heinemeyer, W., Li, X., Arendt, C. S., Hochstrasser, M., & Groll, M. (2016). A 
unified mechanism for proteolysis and autocatalytic activation in the 20S proteasome. 
Nat Commun, 7, 10900. doi:10.1038/ncomms10900 
Humbard, M. A., Miranda, H. V., Lim, J. M., Krause, D. J., Pritz, J. R., Zhou, G., . . . Maupin-
Furlow, J. A. (2010). Ubiquitin-like small archaeal modifier proteins (SAMPs) in 
Haloferax volcanii. Nature, 463(7277), 54-60. doi:10.1038/nature08659 
Husnjak, K., Elsasser, S., Zhang, N., Chen, X., Randles, L., Shi, Y., . . . Dikic, I. (2008). 
Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature, 453(7194), 481-488. 
doi:nature06926 [pii]10.1038/nature06926 
Huyer, G., Piluek, W. F., Fansler, Z., Kreft, S. G., Hochstrasser, M., Brodsky, J. L., & Michaelis, 
S. (2004). Distinct machinery is required in Saccharomyces cerevisiae for the 
endoplasmic reticulum-associated degradation of a multispanning membrane protein and 
a soluble luminal protein. J Biol Chem, 279(37), 38369-38378. 
doi:10.1074/jbc.M402468200 
Imai, J., Maruya, M., Yashiroda, H., Yahara, I., & Tanaka, K. (2003). The molecular chaperone 
Hsp90 plays a role in the assembly and maintenance of the 26S proteasome. EMBO J, 
22(14), 3557-3567. doi:10.1093/emboj/cdg349 
Imkamp, F., Striebel, F., Sutter, M., Ozcelik, D., Zimmermann, N., Sander, P., & Weber-Ban, E. 
(2010). Dop functions as a depupylase in the prokaryotic ubiquitin-like modification 
pathway. EMBO Rep, 11(10), 791-797. doi:10.1038/embor.2010.119 
Imkamp, F., Ziemski, M., & Weber-Ban, E. (2015). Pupylation-dependent and -independent 
proteasomal degradation in mycobacteria. Biomol Concepts, 6(4), 285-301. 
doi:10.1515/bmc-2015-0017 
Ishii, K., Noda, M., Yagi, H., Thammaporn, R., Seetaha, S., Satoh, T., . . . Uchiyama, S. (2015). 
Disassembly of the self-assembled, double-ring structure of proteasome alpha7 homo-
tetradecamer by alpha6. Sci Rep, 5, 18167. doi:10.1038/srep18167 
76 
 
Iwai, H., & Pluckthun, A. (1999). Circular beta-lactamase: stability enhancement by cyclizing 
the backbone. FEBS Lett, 459(2), 166-172.  
Iyer, L. M., Burroughs, A. M., & Aravind, L. (2008). Unraveling the biochemistry and 
provenance of pupylation: a prokaryotic analog of ubiquitination. Biol Direct, 3, 45. 
doi:10.1186/1745-6150-3-45 
Jager, S., Groll, M., Huber, R., Wolf, D. H., & Heinemeyer, W. (1999). Proteasome beta-type 
subunits: unequal roles of propeptides in core particle maturation and a hierarchy of 
active site function. J Mol Biol, 291(4), 997-1013. doi:10.1006/jmbi.1999.2995S0022-
2836(99)92995-9 [pii] 
Jastrab, J. B., Wang, T., Murphy, J. P., Bai, L., Hu, K., Merkx, R., . . . Darwin, K. H. (2015). An 
adenosine triphosphate-independent proteasome activator contributes to the virulence of 
Mycobacterium tuberculosis. Proc Natl Acad Sci U S A, 112(14), E1763-1772. 
doi:10.1073/pnas.1423319112 
Jayarapu, K., & Griffin, T. A. (2004). Protein-protein interactions among human 20S proteasome 
subunits and proteassemblin. Biochem Biophys Res Commun, 314(2), 523-528.  
Jentsch, S. (1992). The ubiquitin-conjugation system. Annu Rev Genet, 26, 179-207. 
doi:10.1146/annurev.ge.26.120192.001143 
Kane, R. C., Bross, P. F., Farrell, A. T., & Pazdur, R. (2003). Velcade: U.S. FDA approval for 
the treatment of multiple myeloma progressing on prior therapy. Oncologist, 8(6), 508-
513.  
Kettern, N., Dreiseidler, M., Tawo, R., & Hohfeld, J. (2010). Chaperone-assisted degradation: 
multiple paths to destruction. Biol Chem, 391(5), 481-489. doi:10.1515/BC.2010.058 
Khor, B., Bredemeyer, A. L., Huang, C. Y., Turnbull, I. R., Evans, R., Maggi, L. B., Jr., . . . 
Sleckman, B. P. (2006). Proteasome activator PA200 is required for normal 
spermatogenesis. Mol Cell Biol, 26(8), 2999-3007. doi:10.1128/MCB.26.8.2999-
3007.2006 
Kim, Y. E., Cho, N., Cheon, S., & Kim, K. K. (2017). Bortezomib, a proteasome inhibitor, 
alleviates atopic dermatitis by increasing claudin 1 protein expression. Biochem Biophys 
Res Commun. doi:10.1016/j.bbrc.2017.08.120 
Kincaid, E. Z., Che, J. W., York, I., Escobar, H., Reyes-Vargas, E., Delgado, J. C., . . . Rock, K. 
L. (2011). Mice completely lacking immunoproteasomes show major changes in antigen 
presentation. Nat Immunol, 13(2), 129-135. doi:10.1038/ni.2203 
Klare, N., Seeger, M., Janek, K., Jungblut, P. R., & Dahlmann, B. (2007). Intermediate-type 20 S 
proteasomes in HeLa cells: "asymmetric" subunit composition, diversity and adaptation. 
J Mol Biol, 373(1), 1-10. doi:10.1016/j.jmb.2007.07.038 
Knowlton, J. R., Johnston, S. C., Whitby, F. G., Realini, C., Zhang, Z., Rechsteiner, M., & Hill, 
C. P. (1997). Structure of the proteasome activator REGalpha (PA28alpha). Nature, 
390(6660), 639-643. doi:10.1038/37670 
Kock, M., Nunes, M. M., Hemann, M., Kube, S., Dohmen, R. J., Herzog, F., . . . Wendler, P. 
(2015). Proteasome assembly from 15S precursors involves major conformational 
changes and recycling of the Pba1-Pba2 chaperone. Nat Commun, 6, 6123. 
doi:10.1038/ncomms7123 
Kubiczkova, L., Pour, L., Sedlarikova, L., Hajek, R., & Sevcikova, S. (2014). Proteasome 
inhibitors - molecular basis and current perspectives in multiple myeloma. J Cell Mol 
Med, 18(6), 947-961. doi:10.1111/jcmm.12279 
77 
 
Kuhn, D. J., Chen, Q., Voorhees, P. M., Strader, J. S., Shenk, K. D., Sun, C. M., . . . Orlowski, R. 
Z. (2007). Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-
proteasome pathway, against preclinical models of multiple myeloma. Blood, 110(9), 
3281-3290. doi:10.1182/blood-2007-01-065888 
Kumoi, K., Satoh, T., Murata, K., Hiromoto, T., Mizushima, T., Kamiya, Y., . . . Kato, K. (2013). 
An archaeal homolog of proteasome assembly factor functions as a proteasome activator. 
PLoS One, 8(3), e60294. doi:10.1371/journal.pone.0060294 
Kunjappu, M. J., & Hochstrasser, M. (2014). Assembly of the 20S proteasome. Biochim Biophys 
Acta, 1843(1), 2-12. doi:10.1016/j.bbamcr.2013.03.008 
Kusmierczyk, A. R., & Hochstrasser, M. (2008). Some assembly required: dedicated chaperones 
in eukaryotic proteasome biogenesis. Biol Chem, 389(9), 1143-1151. 
doi:10.1515/bc.2008.130 
Kusmierczyk, A. R., Kunjappu, M. J., Funakoshi, M., & Hochstrasser, M. (2008). A multimeric 
assembly factor controls the formation of alternative 20S proteasomes. Nat Struct Mol 
Biol, 15(3), 237-244. doi:nsmb.1389 [pii]10.1038/nsmb.1389 
Kusmierczyk, A. R., Kunjappu, M. J., Kim, R. Y., & Hochstrasser, M. (2011). A conserved 20S 
proteasome assembly factor requires a C-terminal HbYX motif for proteasomal precursor 
binding. Nat Struct Mol Biol, 18(5), 622-629. doi:10.1038/nsmb.2027 
Kwon, Y. D., Nagy, I., Adams, P. D., Baumeister, W., & Jap, B. K. (2004). Crystal structures of 
the Rhodococcus proteasome with and without its pro-peptides: implications for the role 
of the pro-peptide in proteasome assembly. J Mol Biol, 335(1), 233-245.  
Lander, G. C., Estrin, E., Matyskiela, M. E., Bashore, C., Nogales, E., & Martin, A. (2012). 
Complete subunit architecture of the proteasome regulatory particle. Nature, 482(7384), 
186-191. doi:nature10774 [pii]10.1038/nature10774 
Le Tallec, B., Barrault, M. B., Courbeyrette, R., Guerois, R., Marsolier-Kergoat, M. C., & 
Peyroche, A. (2007). 20S proteasome assembly is orchestrated by two distinct pairs of 
chaperones in yeast and in mammals. Mol Cell, 27(4), 660-674. doi:S1097-
2765(07)00415-7 [pii]10.1016/j.molcel.2007.06.025 
Le Tallec, B., Barrault, M. B., Guerois, R., Carre, T., & Peyroche, A. (2009). Hsm3/S5b 
participates in the assembly pathway of the 19S regulatory particle of the proteasome. 
Mol Cell, 33(3), 389-399. doi:10.1016/j.molcel.2009.01.010 
Lee do, H., Sherman, M. Y., & Goldberg, A. L. (2016). The requirements of yeast Hsp70 of SSA 
family for the ubiquitin-dependent degradation of short-lived and abnormal proteins. 
Biochem Biophys Res Commun, 475(1), 100-106. doi:10.1016/j.bbrc.2016.05.046 
Lehmann, A., Jechow, K., & Enenkel, C. (2008). Blm10 binds to pre-activated proteasome core 
particles with open gate conformation. EMBO Rep, 9(12), 1237-1243. doi:embor2008190 
[pii]10.1038/embor.2008.190 
Levy, E. D., Boeri Erba, E., Robinson, C. V., & Teichmann, S. A. (2008). Assembly reflects 
evolution of protein complexes. Nature, 453(7199), 1262-1265. doi:10.1038/nature06942 
Li, D., Li, H., Wang, T., Pan, H., Lin, G., & Li, H. (2010). Structural basis for the assembly and 
gate closure mechanisms of the Mycobacterium tuberculosis 20S proteasome. EMBO J, 
29(12), 2037-2047. doi:10.1038/emboj.2010.95 
Li, J., & Rechsteiner, M. (2001). Molecular dissection of the 11S REG (PA28) proteasome 
activators. Biochimie, 83(3-4), 373-383.  
78 
 
Li, X., Kusmierczyk, A. R., Wong, P., Emili, A., & Hochstrasser, M. (2007). beta-Subunit 
appendages promote 20S proteasome assembly by overcoming an Ump1-dependent 
checkpoint. EMBO J, 26(9), 2339-2349. doi:10.1038/sj.emboj.7601681 
Li, X., Li, Y., Arendt, C. S., & Hochstrasser, M. (2016). Distinct Elements in the Proteasomal 
beta5 Subunit Propeptide Required for Autocatalytic Processing and Proteasome 
Assembly. J Biol Chem, 291(4), 1991-2003. doi:10.1074/jbc.M115.677047 
Liu, G., Chater, K. F., Chandra, G., Niu, G., & Tan, H. (2013). Molecular regulation of antibiotic 
biosynthesis in streptomyces. Microbiol Mol Biol Rev, 77(1), 112-143. 
doi:10.1128/MMBR.00054-12 
Lowe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W., & Huber, R. (1995). Crystal structure of 
the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science, 
268(5210), 533-539.  
Lu, Y., Lee, B. H., King, R. W., Finley, D., & Kirschner, M. W. (2015). Substrate degradation 
by the proteasome: a single-molecule kinetic analysis. Science, 348(6231), 1250834. 
doi:10.1126/science.1250834 
Luan, B., Huang, X., Wu, J., Mei, Z., Wang, Y., Xue, X., . . . Wang, F. (2016). Structure of an 
endogenous yeast 26S proteasome reveals two major conformational states. Proc Natl 
Acad Sci U S A, 113(10), 2642-2647. doi:10.1073/pnas.1601561113 
Luders, J., Demand, J., & Hohfeld, J. (2000). The ubiquitin-related BAG-1 provides a link 
between the molecular chaperones Hsc70/Hsp70 and the proteasome. J Biol Chem, 
275(7), 4613-4617.  
Lupas, A., Zuhl, F., Tamura, T., Wolf, S., Nagy, I., De Mot, R., & Baumeister, W. (1997). 
Eubacterial proteasomes. Mol Biol Rep, 24(1-2), 125-131.  
Ma, C. P., Slaughter, C. A., & DeMartino, G. N. (1992). Identification, purification, and 
characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J Biol 
Chem, 267(15), 10515-10523.  
Manasanch, E. E., & Orlowski, R. Z. (2017). Proteasome inhibitors in cancer therapy. Nat Rev 
Clin Oncol, 14(7), 417-433. doi:10.1038/nrclinonc.2016.206 
Mao, X. M., Ren, N. N., Sun, N., Wang, F., Zhou, R. C., Tang, Y., & Li, Y. Q. (2014). 
Proteasome involvement in a complex cascade mediating SigT degradation during 
differentiation of Streptomyces coelicolor. FEBS Lett, 588(4), 608-613. 
doi:10.1016/j.febslet.2013.12.029 
Marques, A. J., Glanemann, C., Ramos, P. C., & Dohmen, R. J. (2007). The C-terminal 
extension of the beta7 subunit and activator complexes stabilize nascent 20 S 
proteasomes and promote their maturation. J Biol Chem, 282(48), 34869-34876. 
doi:M705836200 [pii]10.1074/jbc.M705836200 
Masson, P., Andersson, O., Petersen, U. M., & Young, P. (2001). Identification and 
characterization of a Drosophila nuclear proteasome regulator. A homolog of human 11 S 
REGgamma (PA28gamma ). J Biol Chem, 276(2), 1383-1390. 
doi:10.1074/jbc.M007379200M007379200 [pii] 
Masters, E. I., Pratt, G., Forster, A., & Hill, C. P. (2005). Purification and analysis of 
recombinant 11S activators of the 20S proteasome: Trypanosoma brucei PA26 and 
human PA28 alpha, PA28 beta, and PA28 gamma. Methods Enzymol, 398, 306-321. 
doi:10.1016/S0076-6879(05)98025-7 
 
79 
 
Matsumoto, R., Akama, K., Rakwal, R., & Iwahashi, H. (2005). The stress response against 
denatured proteins in the deletion of cytosolic chaperones SSA1/2 is different from heat-
shock response in Saccharomyces cerevisiae. BMC Genomics, 6, 141. doi:10.1186/1471-
2164-6-141 
Maupin-Furlow, J. A. (2013). Ubiquitin-like proteins and their roles in archaea. Trends 
Microbiol, 21(1), 31-38. doi:10.1016/j.tim.2012.09.006 
Mellacheruvu, D., Wright, Z., Couzens, A. L., Lambert, J. P., St-Denis, N. A., Li, T., . . . 
Nesvizhskii, A. I. (2013). The CRAPome: a contaminant repository for affinity 
purification-mass spectrometry data. Nat Methods, 10(8), 730-736. 
doi:10.1038/nmeth.2557 
Metzger, M. B., Maurer, M. J., Dancy, B. M., & Michaelis, S. (2008). Degradation of a cytosolic 
protein requires endoplasmic reticulum-associated degradation machinery. J Biol Chem, 
283(47), 32302-32316. doi:10.1074/jbc.M806424200 
Meyer, H. J., & Rape, M. (2014). Enhanced protein degradation by branched ubiquitin chains. 
Cell, 157(4), 910-921. doi:10.1016/j.cell.2014.03.037 
Miranda, H. V., Antelmann, H., Hepowit, N., Chavarria, N. E., Krause, D. J., Pritz, J. R., . . . 
Maupin-Furlow, J. A. (2014). Archaeal ubiquitin-like SAMP3 is isopeptide-linked to 
proteins via a UbaA-dependent mechanism. Mol Cell Proteomics, 13(1), 220-239. 
doi:10.1074/mcp.M113.029652 
Miranda, H. V., Nembhard, N., Su, D., Hepowit, N., Krause, D. J., Pritz, J. R., . . . Maupin-
Furlow, J. A. (2011). E1- and ubiquitin-like proteins provide a direct link between protein 
conjugation and sulfur transfer in archaea. Proc Natl Acad Sci U S A, 108(11), 4417-4422. 
doi:10.1073/pnas.1018151108 
Moreau, P., Masszi, T., Grzasko, N., Bahlis, N. J., Hansson, M., Pour, L., . . . Group, T.-M. S. 
(2016). Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. N 
Engl J Med, 374(17), 1621-1634. doi:10.1056/NEJMoa1516282 
Mumberg, D., Muller, R., & Funk, M. (1995). Yeast vectors for the controlled expression of 
heterologous proteins in different genetic backgrounds. Gene, 156(1), 119-122.  
Murata, S., Kawahara, H., Tohma, S., Yamamoto, K., Kasahara, M., Nabeshima, Y., . . . Chiba, 
T. (1999). Growth retardation in mice lacking the proteasome activator PA28gamma. J 
Biol Chem, 274(53), 38211-38215.  
Murata, S., Sasaki, K., Kishimoto, T., Niwa, S., Hayashi, H., Takahama, Y., & Tanaka, K. 
(2007). Regulation of CD8+ T cell development by thymus-specific proteasomes. Science, 
316(5829), 1349-1353. doi:316/5829/1349 [pii]10.1126/science.1141915 
Murata, S., Udono, H., Tanahashi, N., Hamada, N., Watanabe, K., Adachi, K., . . . Chiba, T. 
(2001). Immunoproteasome assembly and antigen presentation in mice lacking both 
PA28alpha and PA28beta. EMBO J, 20(21), 5898-5907. doi:10.1093/emboj/20.21.5898 
Nandi, D., Woodward, E., Ginsburg, D. B., & Monaco, J. J. (1997). Intermediates in the 
formation of mouse 20S proteasomes: implications for the assembly of precursor beta 
subunits. EMBO J, 16(17), 5363-5375. doi:10.1093/emboj/16.17.5363 
Nelson, R. J., Heschl, M. F., & Craig, E. A. (1992). Isolation and characterization of extragenic 
suppressors of mutations in the SSA hsp70 genes of Saccharomyces cerevisiae. Genetics, 
131(2), 277-285.  
Nicholson, S., Bonecini-Almeida Mda, G., Lapa e Silva, J. R., Nathan, C., Xie, Q. W., Mumford, 
R., . . . Ho, J. L. (1996). Inducible nitric oxide synthase in pulmonary alveolar 
macrophages from patients with tuberculosis. J Exp Med, 183(5), 2293-2302.  
80 
 
Nitta, T., Kochi, Y., Muro, R., Tomofuji, Y., Okamura, T., Murata, S., . . . Takayanagi, H. (2017). 
Human thymoproteasome variations influence CD8 T cell selection. Sci Immunol, 2(12). 
doi:10.1126/sciimmunol.aan5165 
Ohba, M. (1994). A 70-kDa heat shock cognate protein suppresses the defects caused by a 
proteasome mutation in Saccharomyces cerevisiae. FEBS Lett, 351(2), 263-266.  
Ohba, M. (1997). Modulation of intracellular protein degradation by SSB1-SIS1 chaperon 
system in yeast S. cerevisiae. FEBS Lett, 409(2), 307-311.  
Oling, D., Eisele, F., Kvint, K., & Nystrom, T. (2014). Opposing roles of Ubp3-dependent 
deubiquitination regulate replicative life span and heat resistance. EMBO J, 33(7), 747-
761. doi:10.1002/embj.201386822 
Padmanabhan, A., Vuong, S. A., & Hochstrasser, M. (2016). Assembly of an Evolutionarily 
Conserved Alternative Proteasome Isoform in Human Cells. Cell Rep, 14(12), 2962-2974. 
doi:10.1016/j.celrep.2016.02.068 
Panfair, D., Ramamurthy, A., & Kusmierczyk, A. R. (2015). Alpha-ring independent assembly 
of the 20S proteasome. Sci Rep, 5, 13130. doi:10.1038/srep13130 
Pearce, M. J., Mintseris, J., Ferreyra, J., Gygi, S. P., & Darwin, K. H. (2008). Ubiquitin-like 
protein involved in the proteasome pathway of Mycobacterium tuberculosis. Science, 
322(5904), 1104-1107. doi:10.1126/science.1163885 
Pfund, C., Huang, P., Lopez-Hoyo, N., & Craig, E. A. (2001). Divergent functional properties of 
the ribosome-associated molecular chaperone Ssb compared with other Hsp70s. Mol Biol 
Cell, 12(12), 3773-3782.  
Pickering, A. M., & Davies, K. J. (2012). Differential roles of proteasome and 
immunoproteasome regulators Pa28alphabeta, Pa28gamma and Pa200 in the degradation 
of oxidized proteins. Arch Biochem Biophys, 523(2), 181-190. 
doi:10.1016/j.abb.2012.04.018 
Plemper, R. K., Bohmler, S., Bordallo, J., Sommer, T., & Wolf, D. H. (1997). Mutant analysis 
links the translocon and BiP to retrograde protein transport for ER degradation. Nature, 
388(6645), 891-895. doi:10.1038/42276 
Preckel, T., Fung-Leung, W. P., Cai, Z., Vitiello, A., Salter-Cid, L., Winqvist, O., . . . Yang, Y. 
(1999). Impaired immunoproteasome assembly and immune responses in PA28-/- mice. 
Science, 286(5447), 2162-2165. doi:8078 [pii] 
Qian, M. X., Pang, Y., Liu, C. H., Haratake, K., Du, B. Y., Ji, D. Y., . . . Qiu, X. B. (2013). 
Acetylation-mediated proteasomal degradation of core histones during DNA repair and 
spermatogenesis. Cell, 153(5), 1012-1024. doi:10.1016/j.cell.2013.04.032S0092-
8674(13)00508-4 [pii] 
Rabl, J., Smith, D. M., Yu, Y., Chang, S. C., Goldberg, A. L., & Cheng, Y. (2008). Mechanism 
of gate opening in the 20S proteasome by the proteasomal ATPases. Mol Cell, 30(3), 
360-368. doi:S1097-2765(08)00175-5 [pii]10.1016/j.molcel.2008.03.004 
Raedler, L. (2015). Velcade (Bortezomib) Receives 2 New FDA Indications: For Retreatment of 
Patients with Multiple Myeloma and for First-Line Treatment of Patients with Mantle-
Cell Lymphoma. Am Health Drug Benefits, 8(Spec Feature), 135-140.  
Raedler, L. A. (2016). Ninlaro (Ixazomib): First Oral Proteasome Inhibitor Approved for the 
Treatment of Patients with Relapsed or Refractory Multiple Myeloma. Am Health Drug 
Benefits, 9(Spec Feature), 102-105.  
81 
 
Ramos, P. C., Hockendorff, J., Johnson, E. S., Varshavsky, A., & Dohmen, R. J. (1998). Ump1p 
is required for proper maturation of the 20S proteasome and becomes its substrate upon 
completion of the assembly. Cell, 92(4), 489-499. doi:S0092-8674(00)80942-3 [pii] 
Ramos, P. C., Marques, A. J., London, M. K., & Dohmen, R. J. (2004). Role of C-terminal 
extensions of subunits beta2 and beta7 in assembly and activity of eukaryotic 
proteasomes. J Biol Chem, 279(14), 14323-14330. doi:10.1074/jbc.M308757200 
Raule, M., Cerruti, F., & Cascio, P. (2014). Enhanced rate of degradation of basic proteins by 
26S immunoproteasomes. Biochim Biophys Acta, 1843(9), 1942-1947. 
doi:10.1016/j.bbamcr.2014.05.005 
Realini, C., Dubiel, W., Pratt, G., Ferrell, K., & Rechsteiner, M. (1994). Molecular cloning and 
expression of a gamma-interferon-inducible activator of the multicatalytic protease. J 
Biol Chem, 269(32), 20727-20732.  
Rechsteiner, M., Realini, C., & Ustrell, V. (2000). The proteasome activator 11 S REG (PA28) 
and class I antigen presentation. Biochem J, 345 Pt 1, 1-15. reference, T. i. a. p.  
Reuter, C. J., Kaczowka, S. J., & Maupin-Furlow, J. A. (2004). Differential regulation of the 
PanA and PanB proteasome-activating nucleotidase and 20S proteasomal proteins of the 
haloarchaeon Haloferax volcanii. J Bacteriol, 186(22), 7763-7772. 
doi:10.1128/JB.186.22.7763-7772.2004 
Richardson, P. G., & Anderson, K. C. (2003). Bortezomib: a novel therapy approved for multiple 
myeloma. Clin Adv Hematol Oncol, 1(10), 596-600.  
Rock, K. L., & Goldberg, A. L. (1999). Degradation of cell proteins and the generation of MHC 
class I-presented peptides. Annu Rev Immunol, 17, 739-779. 
doi:10.1146/annurev.immunol.17.1.739 
Roelofs, J., Park, S., Haas, W., Tian, G., McAllister, F. E., Huo, Y., . . . Finley, D. (2009). 
Chaperone-mediated pathway of proteasome regulatory particle assembly. Nature, 
459(7248), 861-865. doi:10.1038/nature08063 
Sa-Moura, B., Funakoshi, M., Tomko, R. J., Jr., Dohmen, R. J., Wu, Z., Peng, J., & Hochstrasser, 
M. (2013). A conserved protein with AN1 zinc finger and ubiquitin-like domains 
modulates Cdc48 (p97) function in the ubiquitin-proteasome pathway. J Biol Chem, 
288(47), 33682-33696. doi:10.1074/jbc.M113.521088 
Sa-Moura, B., Simoes, A. M., Fraga, J., Fernandes, H., Abreu, I. A., Botelho, H. M., . . . 
Macedo-Ribeiro, S. (2013). Biochemical and biophysical characterization of recombinant 
yeast proteasome maturation factor ump1. Comput Struct Biotechnol J, 7, e201304006. 
doi:10.5936/csbj.201304006 
Sadre-Bazzaz, K., Whitby, F. G., Robinson, H., Formosa, T., & Hill, C. P. (2010). Structure of a 
Blm10 complex reveals common mechanisms for proteasome binding and gate opening. 
Mol Cell, 37(5), 728-735. doi:10.1016/j.molcel.2010.02.002 
Saeki, Y., Sone, T., Toh-e, A., & Yokosawa, H. (2002). Identification of ubiquitin-like protein-
binding subunits of the 26S proteasome. Biochem Biophys Res Commun, 296(4), 813-819.  
Saeki, Y., & Tanaka, K. (2007). Unlocking the proteasome door. Mol Cell, 27(6), 865-867. 
doi:S1097-2765(07)00585-0 [pii]10.1016/j.molcel.2007.09.001 
Saeki, Y., Toh, E. A., Kudo, T., Kawamura, H., & Tanaka, K. (2009). Multiple proteasome-
interacting proteins assist the assembly of the yeast 19S regulatory particle. Cell, 137(5), 
900-913. doi:S0092-8674(09)00528-5 [pii]10.1016/j.cell.2009.05.005 
82 
 
Samanovic, M. I., & Darwin, K. H. (2016). Game of 'Somes: Protein Destruction for 
Mycobacterium tuberculosis Pathogenesis. Trends Microbiol, 24(1), 26-34. 
doi:10.1016/j.tim.2015.10.001 
Sasaki, K., Hamazaki, J., Koike, M., Hirano, Y., Komatsu, M., Uchiyama, Y., . . . Murata, S. 
(2010). PAC1 gene knockout reveals an essential role of chaperone-mediated 20S 
proteasome biogenesis and latent 20S proteasomes in cellular homeostasis. Mol Cell Biol, 
30(15), 3864-3874. doi:MCB.00216-10 [pii]10.1128/MCB.00216-10 
Schmidt, M., & Finley, D. (2014). Regulation of proteasome activity in health and disease. 
Biochim Biophys Acta, 1843(1), 13-25. doi:10.1016/j.bbamcr.2013.08.012 
Schmidt, M., Haas, W., Crosas, B., Santamaria, P. G., Gygi, S. P., Walz, T., & Finley, D. (2005). 
The HEAT repeat protein Blm10 regulates the yeast proteasome by capping the core 
particle. Nat Struct Mol Biol, 12(4), 294-303. doi:10.1038/nsmb914 
Schmidtke, G., Schmidt, M., & Kloetzel, P. M. (1997). Maturation of mammalian 20 S 
proteasome: purification and characterization of 13 S and 16 S proteasome precursor 
complexes. J Mol Biol, 268(1), 95-106. doi:10.1006/jmbi.1997.0947 
Schweitzer, A., Aufderheide, A., Rudack, T., Beck, F., Pfeifer, G., Plitzko, J. M., . . . Baumeister, 
W. (2016). Structure of the human 26S proteasome at a resolution of 3.9 A. Proc Natl 
Acad Sci U S A, 113(28), 7816-7821. doi:10.1073/pnas.1608050113 
Shah, J., Niesvizky, R., Stadtmauer, E., Rifkin, R. M., Berenson, J., Berdeja, J. G., . . . Usmani, S. 
(2015). Oprozomib, Pomalidomide, and Dexamethasone (OPomd) in Patients (Pts) with 
Relapsed and/or Refractory Multiple Myeloma (RRMM): Initial Results of a Phase 1b 
Study (<a href="pending:yes" l:ref-type="CLINTRIALGOV" 
l:ref="NCT01999335">NCT01999335</a>). Blood, 126(23), 378-378.  
Shah, S. A., Potter, M. W., McDade, T. P., Ricciardi, R., Perugini, R. A., Elliott, P. J., . . . 
Callery, M. P. (2001). 26S proteasome inhibition induces apoptosis and limits growth of 
human pancreatic cancer. J Cell Biochem, 82(1), 110-122.  
Sharon, M., Witt, S., Glasmacher, E., Baumeister, W., & Robinson, C. V. (2007). Mass 
spectrometry reveals the missing links in the assembly pathway of the bacterial 20 S 
proteasome. J Biol Chem, 282(25), 18448-18457. doi:10.1074/jbc.M701534200 
Shiber, A., Breuer, W., Brandeis, M., & Ravid, T. (2013). Ubiquitin conjugation triggers 
misfolded protein sequestration into quality control foci when Hsp70 chaperone levels 
are limiting. Mol Biol Cell, 24(13), 2076-2087. doi:10.1091/mbc.E13-01-0010 
Shiber, A., & Ravid, T. (2014). Chaperoning proteins for destruction: diverse roles of Hsp70 
chaperones and their co-chaperones in targeting misfolded proteins to the proteasome. 
Biomolecules, 4(3), 704-724. doi:10.3390/biom4030704 
Shimizu, N., Ueno, K., Kurita, E., Shin, S. W., Nishihara, T., Amano, T., . . . Matsumoto, K. 
(2014). Possible role of ZPAC, zygote-specific proteasome assembly chaperone, during 
spermatogenesis in the mouse. J Reprod Dev, 60(3), 179-186.  
Shin, S. W., Shimizu, N., Tokoro, M., Nishikawa, S., Hatanaka, Y., Anzai, M., . . . Matsumoto, 
K. (2013). Mouse zygote-specific proteasome assembly chaperone important for 
maternal-to-zygotic transition. Biol Open, 2(2), 170-182. doi:10.1242/bio.20123020 
Siegel, D. (2012). Initial success, frequent recurrence: tomorrow's multiple myeloma treatments 
and the value of subtype analysis. Interview with David Siegel. Am J Manag Care, 18(5 
Spec No.), SP226-227, cover.  
83 
 
Sikdar, A., Satoh, T., Kawasaki, M., & Kato, K. (2014). Crystal structure of archaeal homolog of 
proteasome-assembly chaperone PbaA. Biochem Biophys Res Commun, 453(3), 493-497. 
doi:10.1016/j.bbrc.2014.09.114 
Smith, D. M., Chang, S. C., Park, S., Finley, D., Cheng, Y., & Goldberg, A. L. (2007). Docking 
of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens 
the gate for substrate entry. Mol Cell, 27(5), 731-744. doi:S1097-2765(07)00445-5 
[pii]10.1016/j.molcel.2007.06.033 
Smith, D. M., Kafri, G., Cheng, Y., Ng, D., Walz, T., & Goldberg, A. L. (2005). ATP binding to 
PAN or the 26S ATPases causes association with the 20S proteasome, gate opening, and 
translocation of unfolded proteins. Mol Cell, 20(5), 687-698. 
doi:10.1016/j.molcel.2005.10.019 
Stadtmueller, B. M., Kish-Trier, E., Ferrell, K., Petersen, C. N., Robinson, H., Myszka, D. G., . . . 
Hill, C. P. (2012). Structure of a proteasome Pba1-Pba2 complex: implications for 
proteasome assembly, activation, and biological function. J Biol Chem, 287(44), 37371-
37382. doi:10.1074/jbc.M112.367003 
Striebel, F., Hunkeler, M., Summer, H., & Weber-Ban, E. (2010). The mycobacterial Mpa-
proteasome unfolds and degrades pupylated substrates by engaging Pup's N-terminus. 
EMBO J, 29(7), 1262-1271. doi:10.1038/emboj.2010.23 
Striebel, F., Imkamp, F., Sutter, M., Steiner, M., Mamedov, A., & Weber-Ban, E. (2009). 
Bacterial ubiquitin-like modifier Pup is deamidated and conjugated to substrates by 
distinct but homologous enzymes. Nat Struct Mol Biol, 16(6), 647-651. 
doi:10.1038/nsmb.1597 
Su, H., Yang, J. R., Xu, T., Huang, J., Xu, L., Yuan, Y., & Zhuang, S. M. (2009). MicroRNA-
101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses 
tumorigenicity. Cancer Res, 69(3), 1135-1142. doi:10.1158/0008-5472.CAN-08-2886 
Summer, H., Bruderer, R., & Weber-Ban, E. (2006). Characterization of a new AAA+ protein 
from archaea. J Struct Biol, 156(1), 120-129. doi:10.1016/j.jsb.2006.01.010 
Sun, G., & Anderson, V. E. (2004). Prevention of artifactual protein oxidation generated during 
sodium dodecyl sulfate-gel electrophoresis. Electrophoresis, 25(7-8), 959-965. 
doi:10.1002/elps.200305800 
Takagi, K., Saeki, Y., Yashiroda, H., Yagi, H., Kaiho, A., Murata, S., . . . Kato, K. (2014). Pba3-
Pba4 heterodimer acts as a molecular matchmaker in proteasome alpha-ring formation. 
Biochem Biophys Res Commun, 450(2), 1110-1114. doi:10.1016/j.bbrc.2014.06.119 
Tamura, T., Nagy, I., Lupas, A., Lottspeich, F., Cejka, Z., Schoofs, G., . . . Baumeister, W. 
(1995). The first characterization of a eubacterial proteasome: the 20S complex of 
Rhodococcus. Curr Biol, 5(7), 766-774. doi:S0960-9822(95)00153-9 [pii] 
Tanahashi, N., Murakami, Y., Minami, Y., Shimbara, N., Hendil, K. B., & Tanaka, K. (2000). 
Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent 
proteolysis. J Biol Chem, 275(19), 14336-14345.  
Tanaka, K. (1994). Role of proteasomes modified by interferon-gamma in antigen processing. J 
Leukoc Biol, 56(5), 571-575.  
Thompson, J. L. (2013). Carfilzomib: a second-generation proteasome inhibitor for the treatment 
of relapsed and refractory multiple myeloma. Ann Pharmacother, 47(1), 56-62. 
doi:10.1345/aph.1R561 
84 
 
Tian, G., Park, S., Lee, M. J., Huck, B., McAllister, F., Hill, C. P., . . . Finley, D. (2011). An 
asymmetric interface between the regulatory and core particles of the proteasome. Nat 
Struct Mol Biol, 18(11), 1259-1267. doi:10.1038/nsmb.2147nsmb.2147 [pii] 
To, W. Y., & Wang, C. C. (1997). Identification and characterization of an activated 20S 
proteasome in Trypanosoma brucei. FEBS Lett, 404(2-3), 253-262.  
Tomko, R. J., Jr., Funakoshi, M., Schneider, K., Wang, J., & Hochstrasser, M. (2010). 
Heterohexameric ring arrangement of the eukaryotic proteasomal ATPases: implications 
for proteasome structure and assembly. Mol Cell, 38(3), 393-403. 
doi:10.1016/j.molcel.2010.02.035 
Tomko, R. J., Jr., & Hochstrasser, M. (2011). Incorporation of the Rpn12 subunit couples 
completion of proteasome regulatory particle lid assembly to lid-base joining. Mol Cell, 
44(6), 907-917. doi:10.1016/j.molcel.2011.11.020 
Tomko, R. J., Jr., & Hochstrasser, M. (2013). Molecular architecture and assembly of the 
eukaryotic proteasome. Annu Rev Biochem, 82, 415-445. doi:10.1146/annurev-biochem-
060410-150257 
Uechi, H., Hamazaki, J., & Murata, S. (2014). Characterization of the testis-specific proteasome 
subunit alpha4s in mammals. J Biol Chem, 289(18), 12365-12374. 
doi:10.1074/jbc.M114.558866 
Uekusa, Y., Okawa, K., Yagi-Utsumi, M., Serve, O., Nakagawa, Y., Mizushima, T., . . . Kato, K. 
(2013). Backbone H, C, and N assignments of yeast Ump1, an intrinsically disordered 
protein that functions as a proteasome assembly chaperone. Biomol NMR Assign. 
doi:10.1007/s12104-013-9523-1 
Ustrell, V., Hoffman, L., Pratt, G., & Rechsteiner, M. (2002). PA200, a nuclear proteasome 
activator involved in DNA repair. EMBO J, 21(13), 3516-3525. 
doi:10.1093/emboj/cdf333 
Valas, R. E., & Bourne, P. E. (2008). Rethinking proteasome evolution: two novel bacterial 
proteasomes. J Mol Evol, 66(5), 494-504. doi:10.1007/s00239-008-9075-7 
Varambally, S., Cao, Q., Mani, R. S., Shankar, S., Wang, X., Ateeq, B., . . . Chinnaiyan, A. M. 
(2008). Genomic loss of microRNA-101 leads to overexpression of histone 
methyltransferase EZH2 in cancer. Science, 322(5908), 1695-1699. 
doi:10.1126/science.1165395 
Velichutina, I., Connerly, P. L., Arendt, C. S., Li, X., & Hochstrasser, M. (2004). Plasticity in 
eucaryotic 20S proteasome ring assembly revealed by a subunit deletion in yeast. EMBO 
J, 23(3), 500-510. doi:10.1038/sj.emboj.76000597600059 [pii] 
Verma, R., Aravind, L., Oania, R., McDonald, W. H., Yates, J. R., 3rd, Koonin, E. V., & 
Deshaies, R. J. (2002). Role of Rpn11 metalloprotease in deubiquitination and 
degradation by the 26S proteasome. Science, 298(5593), 611-615. 
doi:10.1126/science.1075898 
Verma, R., Chen, S., Feldman, R., Schieltz, D., Yates, J., Dohmen, J., & Deshaies, R. J. (2000). 
Proteasomal proteomics: identification of nucleotide-sensitive proteasome-interacting 
proteins by mass spectrometric analysis of affinity-purified proteasomes. Mol Biol Cell, 
11(10), 3425-3439.  
Voges, D., Zwickl, P., & Baumeister, W. (1999). The 26S proteasome: a molecular machine 
designed for controlled proteolysis. Annu Rev Biochem, 68, 1015-1068. 
doi:10.1146/annurev.biochem.68.1.1015 
85 
 
Volker, C., & Lupas, A. N. (2002). Molecular evolution of proteasomes. Curr Top Microbiol 
Immunol, 268, 1-22.  
Wang, C. H., Liu, C. Y., Lin, H. C., Yu, C. T., Chung, K. F., & Kuo, H. P. (1998). Increased 
exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase 
upregulation in alveolar macrophages. Eur Respir J, 11(4), 809-815.  
Wani, P. S., Rowland, M. A., Ondracek, A., Deeds, E. J., & Roelofs, J. (2015). Maturation of the 
proteasome core particle induces an affinity switch that controls regulatory particle 
association. Nat Commun, 6, 6384. doi:10.1038/ncomms7384 
Wilk, S., Chen, W. E., & Magnusson, R. P. (2000). Properties of the beta subunit of the 
proteasome activator PA28 (11S REG). Arch Biochem Biophys, 384(1), 174-180. 
doi:10.1006/abbi.2000.2112 
Wilson, H. L., Ou, M. S., Aldrich, H. C., & Maupin-Furlow, J. (2000). Biochemical and physical 
properties of the Methanococcus jannaschii 20S proteasome and PAN, a homolog of the 
ATPase (Rpt) subunits of the eucaryal 26S proteasome. J Bacteriol, 182(6), 1680-1692.  
Witt, E., Zantopf, D., Schmidt, M., Kraft, R., Kloetzel, P. M., & Kruger, E. (2000). 
Characterisation of the newly identified human Ump1 homologue POMP and analysis of 
LMP7(beta 5i) incorporation into 20 S proteasomes. J Mol Biol, 301(1), 1-9. 
doi:10.1006/jmbi.2000.3959 
Wolf, S., Nagy, I., Lupas, A., Pfeifer, G., Cejka, Z., Muller, S. A., . . . Baumeister, W. (1998). 
Characterization of ARC, a divergent member of the AAA ATPase family from 
Rhodococcus erythropolis. J Mol Biol, 277(1), 13-25. doi:10.1006/jmbi.1997.1589 
Xie, Y., & Varshavsky, A. (2001). RPN4 is a ligand, substrate, and transcriptional regulator of 
the 26S proteasome: a negative feedback circuit. Proc Natl Acad Sci U S A, 98(6), 3056-
3061. doi:10.1073/pnas.07102229898/6/3056 [pii] 
Xu, P., Duong, D. M., Seyfried, N. T., Cheng, D., Xie, Y., Robert, J., . . . Peng, J. (2009). 
Quantitative proteomics reveals the function of unconventional ubiquitin chains in 
proteasomal degradation. Cell, 137(1), 133-145. doi:S0092-8674(09)00089-0 
[pii]10.1016/j.cell.2009.01.041 
Yamano, T., Mizukami, S., Murata, S., Chiba, T., Tanaka, K., & Udono, H. (2008). Hsp90-
mediated assembly of the 26 S proteasome is involved in major histocompatibility 
complex class I antigen processing. J Biol Chem, 283(42), 28060-28065. 
doi:10.1074/jbc.M803077200 
Yao, T., & Cohen, R. E. (2002). A cryptic protease couples deubiquitination and degradation by 
the proteasome. Nature, 419(6905), 403-407. doi:10.1038/nature01071 
Yao, Y., Huang, L., Krutchinsky, A., Wong, M. L., Standing, K. G., Burlingame, A. L., & Wang, 
C. C. (1999). Structural and functional characterizations of the proteasome-activating 
protein PA26 from Trypanosoma brucei. J Biol Chem, 274(48), 33921-33930.  
Yao, Y., Toth, C. R., Huang, L., Wong, M. L., Dias, P., Burlingame, A. L., . . . Wang, C. C. 
(1999). alpha5 subunit in Trypanosoma brucei proteasome can self-assemble to form a 
cylinder of four stacked heptamer rings. Biochem J, 344 Pt 2, 349-358.  
Yashiroda, H., Mizushima, T., Okamoto, K., Kameyama, T., Hayashi, H., Kishimoto, T., . . . 
Tanaka, K. (2008). Crystal structure of a chaperone complex that contributes to the 
assembly of yeast 20S proteasomes. Nat Struct Mol Biol, 15(3), 228-236. doi:nsmb.1386 
[pii]10.1038/nsmb.1386 
86 
 
Yashiroda, H., Toda, Y., Otsu, S., Takagi, K., Mizushima, T., & Murata, S. (2015). N-terminal 
alpha7 deletion of the proteasome 20S core particle substitutes for yeast PI31 function. 
Mol Cell Biol, 35(1), 141-152. doi:10.1128/MCB.00582-14 
Yu, Y., Smith, D. M., Kim, H. M., Rodriguez, V., Goldberg, A. L., & Cheng, Y. (2010). 
Interactions of PAN's C-termini with archaeal 20S proteasome and implications for the 
eukaryotic proteasome-ATPase interactions. EMBO J, 29(3), 692-702. 
doi:10.1038/emboj.2009.382 
Zhang, H., Xu, X., Gajewiak, J., Tsukahara, R., Fujiwara, Y., Liu, J., . . . Prestwich, G. D. (2009). 
Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces 
breast cancer cell migration in vitro and causes tumor regression in vivo. Cancer Res, 
69(13), 5441-5449. doi:10.1158/0008-5472.CAN-09-0302 
Zhang, X., Schulz, R., Edmunds, S., Kruger, E., Markert, E., Gaedcke, J., . . . Dobbelstein, M. 
(2015). MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an 
Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP. 
Mol Cell, 59(2), 243-257. doi:10.1016/j.molcel.2015.05.036 
Zhang, Z., Krutchinsky, A., Endicott, S., Realini, C., Rechsteiner, M., & Standing, K. G. (1999). 
Proteasome activator 11S REG or PA28: recombinant REG alpha/REG beta hetero-
oligomers are heptamers. Biochemistry, 38(17), 5651-5658. doi:10.1021/bi990056+ 
Zhang, Z., & Zhang, R. (2008). Proteasome activator PA28 gamma regulates p53 by enhancing 
its MDM2-mediated degradation. EMBO J, 27(6), 852-864. doi:10.1038/emboj.2008.25 
Zhong, L., & Belote, J. M. (2007). The testis-specific proteasome subunit Prosalpha6T of D. 
melanogaster is required for individualization and nuclear maturation during 
spermatogenesis. Development, 134(19), 3517-3525. doi:dev.004770 
[pii]10.1242/dev.004770 
Zuhl, F., Seemuller, E., Golbik, R., & Baumeister, W. (1997). Dissecting the assembly pathway 
of the 20S proteasome. FEBS Lett, 418(1-2), 189-194. doi:S0014-5793(97)01370-7 [pii] 
Zwickl, P., Grziwa, A., Puhler, G., Dahlmann, B., Lottspeich, F., & Baumeister, W. (1992). 
Primary structure of the Thermoplasma proteasome and its implications for the structure, 
function, and evolution of the multicatalytic proteinase. Biochemistry, 31(4), 964-972.  
Zwickl, P., Kleinz, J., & Baumeister, W. (1994). Critical elements in proteasome assembly. Nat 
Struct Biol, 1(11), 765-770.  
Zwickl, P., Ng, D., Woo, K. M., Klenk, H. P., & Goldberg, A. L. (1999). An archaebacterial 
ATPase, homologous to ATPases in the eukaryotic 26 S proteasome, activates protein 
breakdown by 20 S proteasomes. J Biol Chem, 274(37), 26008-26014.  
Zwickl, P., Voges, D., & Baumeister, W. (1999). The proteasome: a macromolecular assembly 
designed for controlled proteolysis. Philos Trans R Soc Lond B Biol Sci, 354(1389), 
1501-1511. doi:10.1098/rstb.1999.0494 
  
87 
 
APPENDIX A. SUPPLEMENTARY FOR CHAPTER 2 
Supplementary Note 
 
 In the Discussion section of the main-text, we argue that α4 HMWCs may not be as 
stable on native PAGE as other CP-related species, requiring the presence of α4CC to visualize 
them (Figure 3 and Supplementary Figure 8). It deserves mention that although CuCl2-induced 
crosslinking was used to observe the α4 HMWCs by non-reducing SDS-PAGE in Figure 1B, it 
was not used prior to analysis of the same samples by native PAGE (Figure 2A). The primary 
reason for this is that following CuCl2 treatment, the species migrating faster than the CP appear 
as a uniform smear on native PAGE (not shown). This treatment is too oxidizing for the multi-
protein species to resolve into distinct bands on the native gel and would have resulted in us not 
being able to identify the α4 HMWCs.  
 However, we have shown before that experimental conditions during lysis, especially 
protracted periods of purification, are sufficiently oxidizing to enable (some) crosslinking to 
occur (Panfair et al., 2015). This is clearly seen in Figure 4A, whereby the his flow through 
samples following the lengthy depletion analysis exhibited essentially complete crosslinking of 
α4CC, even in the absence of CuCl2. Contrast this with Figure 1B, which shows the sample after 
a much shorter protocol (Flag purification only, no depletion) and requires CuCl2 for 
visualization of the slow migrating α4 species. Finally, the process of electrophoresis is itself 
oxidizing to proteins ((Sun & Anderson, 2004) and references therein), and the native PAGE 
here is carried out over a period of 10 hours. This also should provide considerable time for 
(some) crosslinking to occur. Therefore, even if the efficiency of crosslinking does not approach 
100% in the absence of exogenously added CuCl2 (as may be the case following Flag purification 
only), enough crosslinking is likely taking place during electrophoresis that a homomeric ring 
(such as the α4 HMWC) can be stabilized and thus survive native PAGE.  
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Supplementary Table 1: Yeast Strains used in Chapter 2 
              
Name   Genotype                             
AKY889 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre6∆::HIS3 [pRS315 pre6-Flag] 
AKY892 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre9∆::HIS3 pre6∆::HIS3 [pRS315 pre6N79C,I155C-Flag] 
AKY893 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre6∆::HIS3 [pRS315 pre6N79C,I155C-Flag] 
AKY1145 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre9∆::HIS3 pre6∆::HIS3 [pRS315 pre6N79C,I155C-Flag] 
AKY1066 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre8-HF(URA) 
AKY1100 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre8-HF(URA) pre9∆::HIS3 pre6∆::HIS3 [pRS315 pre6N79C,I155C-Flag] 
AKY1168 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre9∆::HIS3 pre6∆::HIS3 [pRS315 pre6-Flag] 
 
All strains generated in this study. 
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Supplementary Figure 1. Yeast lysates from the indicated strains were bound to Flag resin  
The Flag-purified CP was subjected to native PAGE and substrate overlay assay. The gel was 
stained with Gelcode blue and the migration of molecular size standards is indicated at left. CP 
denotes migration of the core particle. Asterisk denotes migration of CP-Blm10 complexes. 
Faster migrating species, likely containing CP assembly intermediates, is denoted by the bracket. 
This figure demonstrates the requirement for loading of excess protein onto native PAGE in 
order to better visualize the faster migrating species of interest. 
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Supplementary Figure 2. Composition of Band 1 from Figure 2.2 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate and/or 
CP-subunit-derived species present (right). 
 
 
 
Supplementary Figure 3. Composition of Band 2 from Figure 2.2 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate and/or 
CP-subunit-derived species present (right). 
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Supplementary Figure 4. Composition of Band 3 from Figure 2.2 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate and/or 
CP-subunit-derived species present (right). 
 
 
 
 
Supplementary Figure 5. Composition of Band 4 from Figure 2.2 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate and/or 
CP-subunit-derived species present (right). 
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Supplementary Figure 6. Composition of Band 5 from Figure 2.2 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate and/or 
CP-subunit-derived species present (right). 
 
 
Supplementary Figure 7. Composition of Band 6 from Figure 2.2 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate and/or CP-
subunit-derived species present (right). 
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Supplementary Figure 8. Analysis of putative α4-containing HMWCs by native PAGE  
This is essentially a repeat of the experiment described in Figure 2.2, except one additional 
sample (α4 α3∆) was included. Flag-purified CP from the indicated yeast strains was subjected 
to native PAGE on 4–15% gels followed by staining with Imperial Stain (top panel). To verify 
equal loading of proteins, aliquots of the material analyzed by native PAGE were withdrawn and 
subjected to SDS-PAGE on 12% gels, followed by staining with GelCode blue (middle panel). 
The position of molecular size standards for each gel is indicated on the left. Arrowheads denote 
migration of CP and of CP assembly intermediates. Bands 1 to 6 on this gel are equivalent to 
bands 1 to 6 on the native gel in Figure 2. To demonstrate this equivalence, the contents of the 
indicated bands was analyzed by LC-MS/MS following their excision from the gel, and the α 
and β subunit contents of the bands is shown (bottom panel). Red denotes the excess in PSMs for 
the α4 subunit, as observed in Figure 2. Bands 5, 6, and 0 are derived from α3∆ strains, and 
while bands 6 and 0 do not exhibit peptides derived from α3 (as expected), there are a few α3 
peptides in band 5 (asterisk). However, the low number of PSMs for α3, compared to the other 
CP subunits in this sample, argues that this is likely an experimental artifact.  
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Supplementary Figure 9. Depletion strategy 
Flag tag on subunits α4 and α2 enables the isolation of all CP and CP intermediates, as well as 
α4 HMWCs. Subjecting the Flag eluates to two rounds of ICAR binding depletes α2-containing 
species (CP and CP intermediates) because α2 also contains a His tag. For simplicity, the tags are 
shown on only one subunit at a time. Red denotes samples loaded on various gels in this study. 
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Supplementary Figure 10. Depletion requires more than one round of ICAR binding 
The Flag eluates from Figure 2.3C were subjected to depletion of his-tagged proteins by binding 
to ICAR. The bound material was eluted and subjected to SDS-PAGE (lanes 1-4). The unbound 
material (i.e. flow-through #1) was bound a second time to ICAR using fresh resin. This twice-
depleted material was eluted and subjected to SDS-PAGE (lanes 5-8). The gel was stained with 
Gelcode blue and the migration of molecular size standards is indicated at left.  
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APPENDIX B. SUPPLEMENTARY FOR CHAPTER 3 
Supplementary Notes 
 
On the recovery of Hsp70 proteins in previous high-throughput approaches versus this study. 
 As stated in the main text, previous high-throughput studies demonstrating physical 
association between Hsp70 proteins and the proteasome did not attempt to distinguish binding 
between fully assembled proteasomes and proteasome assembly intermediates (Gong et al., 
2009; Guerrero et al., 2008; Guerrero, Tagwerker, Kaiser, & Huang, 2006; Verma et al., 2000). 
Here, we clearly demonstrate the association of Ssa1/2 with CP assembly intermediates but not 
with fully assembled CP. However, not finding Ssa1/2 associated with fully assembled CP in this 
study does not imply that additional interactions between Ssa1/2 and the CP do not occur. Such 
interactions could simply be weak/transient enough to not survive our purification scheme 
(especially the rigorous depletion protocol) and/or electrophoresis on native PAGE. Also, in 
order to focus on the CP, our purifications omitted ATP which means that our biochemical 
analysis would not detect Hsp70 interactions with RP components. Hsp70 proteins like Ssa1/2 
likely play several roles in UPS function, including: enhancing ubiquitination; temporary triage 
of ubiquitinated substrates into soluble inclusions; substrate delivery to the proteasome; and this 
newly discovered role in CP assembly (Lee do, Sherman, & Goldberg, 2016; Luders, Demand, & 
Hohfeld, 2000; Shiber, Breuer, Brandeis, & Ravid, 2013).  
On suppression of CP mutants by high-copy Hsp70. 
 We observed suppression of CP assembly defects by overexpression of both SSA1 and 
SSB1 (Figure 3). Suppression of CP mutants by SSB1 had been observed previously, but the 
author failed to detect suppression by SSA1 (Ohba, 1994, 1997). We believe the discrepancy 
between our studies with regards to observing suppression with SSA1 might be attributed to 
protein levels. The earlier work relied on expression of SSA1 and SSB1 from their endogenous 
promoters (Ohba, 1997). Here, we express SSA1 and SSB1 from a strong heterologous promoter 
(TEF) that drives expression to higher levels (Mumberg, Muller, & Funk, 1995). 
On the recovery of CP-bound Ssa3/4 in ssa1∆ssa2∆ strains. 
 In the main text, Flag-purified CP from a wild type strain (α4-Flag) clearly shows a band 
corresponding to Ssa1/2 on SDS-PAGE (Figure 3.4A). By contrast, when CP is purified from an 
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ssa1∆ssa2∆ strain, the Ssa1/2 band is replaced by a doublet from which we recovered peptides 
corresponding to Kar2 and Ssa3/4. Kar2 is an ER-resident Hsp70; its recovery is likely an 
artifact of the lysis scheme (bead beating) which disrupts cellular membranes. By contrast, the 
cytoplasmic Ssa3 and Ssa4 proteins are normally repressed but become induced under stress 
conditions, or when both Ssa1 and Ssa2 are absent (Nelson, Heschl, & Craig, 1992). The 
recovery of Ssa3/4 in Flag-purified CP material in the absence of Ssa1/2 suggests that Ssa3/4 
may provide some redundancy in CP function/assembly. However, with respect to assembly, any 
redundancy provided by Ssa3/4 must be partial (at best). This is because levels of CP assembly 
intermediates are dramatically decreased in the ssa1∆ssa2∆ mutant, despite the induction of 
Ssa3/4. Clearly, Ssa3/4 cannot fully replace Ssa1/2 in CP assembly. 
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Supplementary Table 2: Yeast Strains used in Chapter 3  
 
              
Name  Alias  Genotype     Source     
 
AKY600  MHY500  MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2 (Chen & Hochstrasser, 1995) 
AKY601  MHY501  MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2 (Chen & Hochstrasser, 1995)  
AKY783    MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2 (Firestone et al., 2016) 
AKY784    MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 gal2 (Firestone et al., 2016) 
AKY207  MHY4299  MATα pba4∆::hphMX    (Kusmierczyk et al., 2008) 
AKY408    MATα pre9∆::hphMX    (Firestone et al., 2016) 
AKY417    MATa rpn4∆::hphMX 
AKY604  MHY1069  MATα pre9∆::HIS3    (Fu, Doelling, Arendt, Hochstrasser, & Vierstra, 
1998) 
AKY678  MHY4786  MATα sem1∆::HIS3     (Tomko & Hochstrasser, 2011) 
AKY698  MHY5279  MATa nas2∆::kanMX nas6∆::HIS3 rpn14∆::HIS3  (Funakoshi et al., 2009) 
AKY699  MHY5749  MATα rpn12-234∆::hphMX    (Tomko & Hochstrasser, 2011) 
AKY709  MHY6952  MATa PRE1-6xgly-3xFlag:kanMX4   (Sa-Moura, Simoes, et al., 2013) 
AKY789    MATα pre9∆::HIS3 
AKY808    MATa pre3∆::HIS3 pup1∆::leu2::HIS3 doa3∆::HIS3 PRE1-6xgly-3xFlag:kanMX4    
    [Ycplac22 pre3(T1A), pRS317 pup1(T1A), pRS315 DOA3-6xhis] 
AKY889    MATa pre6∆::HIS3 [pRS315 PRE6-Flag]  (Hammack & Kusmierczyk, 2017) 
AKY924    MATα ssa1∆::hphMX4 
AKY925    MATa ssa1∆::hphMX4 
AKY926    MATα ssb1∆::hphMX4 
AKY927    MATa ssb1∆::hphMX4 
AKY942    MATa pre3∆::HIS3 pup1∆::leu2::HIS3 doa3∆::HIS3 PRE1-6xgly-3xFlag:kanMX4    
     [Ycplac22 PRE3, pRS317 PUP1, pRS315 DOA3-6xhis] 
AKY985    MATa pre9∆::HIS3 PRE1-6xgly-3xFlag:kanMX4 
AKY1011    MATα pre9∆::HIS3 ssa1∆::hphMX4 
AKY1013    MATα sem1∆::HIS3 ssa1∆::hphMX4    
AKY1015    MATα nas2∆::kanMX nas6∆::HIS3 rpn14∆::HIS3 ssa1∆::hphMX4  
AKY1017    MATα pre9∆::HIS3 ssb1∆::hphMX4 
AKY1019    MATα sem1∆::HIS3 ssb1∆::hphMX4    
AKY1021    MATα nas2∆::kanMX nas6∆::HIS3 rpn14∆::HIS3 ssb1∆::hphMX4 
AKY1068    MATa ssa2∆::hphMX 
AKY1109    MATa pre9∆::HIS3 ssa2∆::hphMX 
AKY1113    MATa pre9∆::HIS3 ssa2∆::hphMX PRE1-6xgly-3xFlag:kanMX4 
AKY1116    MATa rpn12-234∆::hphMX ssa2∆::hphMX  
AKY1129    MATa rpn4∆::hphMX ssa2∆::hphMX  
AKY1132    MATa rpn4∆::hphMX ssa1∆::hphMX 
AKY1143    MATa pre3∆::HIS3 pup1∆::leu2::HIS3 doa3∆::HIS3 PRE1-6xgly-3xFlag:kanMX4    
    [Ycplac22 PRE3, pRS317 PUP1, pRS315 doa3(T1A) DOA3-6xhis] 
AKY1293    MATa pre6∆::HIS3 ssa1∆::natMX4 ssa2∆::kanMX4 [pRS315 PRE6-Flag] 
              
 
AKY600, AKY601, AKY783 and AKY784 are wild type strains and remaining strains are congenic with these four. All strains are from this study, except as noted in 
the table. 
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Supplementary Table 3: Plasmids used in Chapter 3 
 
              
Name Genotype/Alias Description           Source      
 
AKB323 p416TEF  Empty vector          (Mumberg et al., 1995; Pfund, Huang, Lopez-Hoyo, & Craig, 2001) 
AKB324 p416TEF His-SSA1 Construct for overexpression of SSA1 from TEF promoter  (Pfund et al., 2001) 
AKB325 p416TEF His-SSB1 Construct for overexpression of SSB1 from TEF promoter  (Pfund et al., 2001) 
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Supplementary Figure 11. The genotypes of all three depleted strains are shown  
The PHP is normally a short-lived species. To enrich its formation, we employed β subunit 
mutants that were incapable of maturation due to substitution of their active site threonines with 
alanine (T1A mutants). Yeast tolerate β1 (T1A) and β2 (T1A) mutations well (Arendt & 
Hochstrasser, 1997) and the PHP strain contained both of these mutations as the only copies of 
b1 and b2 in the cell. However, since β5 activity is essential (Chen & Hochstrasser, 1996), we 
had to engineer the PHP strain to retain functional β5 while also allowing expression of a β5 
(T1A) variant. To this end we generated a centromeric plasmid containing both wild type β5 and 
β5 (T1A) mutant, each expressed from its endogenous promoter and containing its endogenous 
terminator regions. This should help ensure more equitable expression of these two variants. The 
2/3-PHP was similar to the PHP strain except only a wild type copy of β5 was present. We refer 
to it as the “two-thirds preholoproteasome” because it looks like a PHP in which two out of three 
active sites are incapable of full maturation. The wild type strain only contains wild type versions 
of all β subunits. In all cases, the wild type β5 allele encodes a C-terminal hexahistidine tag (his-
tag) to enable depletion analysis. 
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Supplementary Figure 12. Depletion analysis activity assay 
The native gel in Figure 1A of the main text was subjected to a substrate overlay assay using  
the fluorogenic peptide substrate Suc-LLVY-AMC prior to staining with Imperial stain. CP 
denotes migration of the core particle. Asterisk denotes migration of CP-Blm10 complexes. 
Migration of band 4 in the PHP sample (see main text) is indicated. 
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Supplementary Figure 13. Composition of PHP band 1 from Figure 3.1 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate (right). 
 
 
Supplementary Figure 14. Composition of PHP band 2 from Figure 3.1 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate (right). 
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Supplementary Figure 15. Composition of PHP band 3 from Figure 3.1 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate (right). 
 
Supplementary Figure 16. Composition of PHP band 4 from Figure 3.1 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediates (right). 
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Supplementary Figure 17. Composition of 2/3-PHP band 1 from Figure 3.1 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate (right). 
 
 
Supplementary Figure 18. Composition of 2/3-PHP band 2 from Figure 3.1 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate (right). 
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Supplementary Figure 19. Composition of WT band 1 from Figure 3.1. 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate (right). 
 
 
Supplementary Figure 20. Composition of WT band 2 from Figure 3.1 
Results of LC-MS/MS analysis (left) and the identity of the likely CP intermediate (right). 
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Supplementary Figure 21. Likely composition of PHP band 4 
The PHP strain contains mutant (T1A) versions of all three catalytic b subunits, plus a wild type 
copy of the β5 subunit that is also his-tagged. Assuming β5 (T1A) and β5-his incorporate with 
equal efficiency during assembly, equal amounts of two types of half-proteasome will be 
produced, one containing β5 (T1A) and one containing β5-his. Assuming also that there is no 
difference in how these two half-proteasomes dimerize, three possible CP species will be 
produced in the idealized ratios shown above. Of course, the two species containing β5-his 
should be depleted during ICAR, but we have observed that the depletion is not complete (see 
main text Figure). So it is likely that some of each of the two β5-his containing species will 
persist in the second ICAR flow-through. This is confirmed by the residual activity of the PHP 
band 4 (Supplementary Figure 12). This could help account for the presence of three bands in 
observed in band 4. 
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Supplementary Figure 22. Genetic analysis of Hsp70 mutants 
(A) Dilution series showing no genetic interactions between mutations that affect proteasome  
assembly and deletion of the Hsp70 gene, SSB1. (B) Dilution series showing a genetic  
interaction between an assembly mutant of the RP base and deletion of SSA1. Four separate 
quadruple mutants, each from a different spore following tetrad dissection, are shown.  
(C) Representative Western blot with anti-Express antibody for the suppression experiments  
in main text Figure 3 to verify expression of plasmid-encoded Hsp70 proteins (arrowhead).  
A non-specific band serves as an internal loading control (asterisk). (D) Indicated yeast strains  
were struck out onto YPD plates and incubated as shown. No obvious genetic interaction is  
observed between deletion of SSA1 alone, or SSA2 alone, and deletion of RPN4. 
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Supplementary Figure 23. Composition of WT band 5 from Figure 3.4 
Results of LC-MS/MS analysis (left) and the identity of the species (right). For simplicity, only 
proteasome-related proteins and Hsp70 family members are shown. Ssa1/2 are highlighted. 
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Supplementary Figure 24. Composition of WT band 6 from Figure 3.4 
Results of LC-MS/MS analysis (left) and the identity of the species (right). For simplicity, only 
proteasome-related proteins and Hsp70 family members are shown. Ssa1/2 are highlighted. 
 
Supplementary Figure 25. Composition of WT band 7 from Figure 3.4 
Results of LC-MS/MS analysis (left) and the identity of the likely species (right). 
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Supplementary Figure 26. Composition of ssa1∆ssa2∆ band 8 from Figure 3.4 
Results of LC-MS/MS analysis (left) and the identity of the likely species (right). 
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Supplementary Figure 27. Likely β2 propeptide processing defect in ssa1∆ssa2∆ cells 
(Top) Peptide coverage maps for the β2 subunits in each of the 4 bands from Figure 3.4 analyzed 
by LC-MS/MS. Maps were prepared with the program Scaffold. Red ovals denote the N-terminal 
threonine nucleophile (Thr1) which becomes exposed following removal of the propeptide. 
Propeptide sequences recovered in the LC-MS/MS analysis are those highlighted in yellow and 
to the left of Thr1. Green denotes oxidized methionines identified by LC-MS/MS..  
(Bottom) Number of peptide spectral matches (PSMs) for the various β2 propeptide-derived 
peptides recovered from each of the 4 bands referenced above. Thr1 is shown in red. 
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APPENDIX C. SUPPLEMENTARY FOR CHAPTER 4 
Supplementary Table 4: Yeast Strains used in Chapter 4 
              
Name Genotype          Source                  
AKY709 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 PRE1-6XGLY-3XFlag::kanMX6   (Sa-Moura, Funakoshi, et al., 2013) 
AKY889 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre6∆::HIS3 [pRS315 pre6-Flag]   (Hammack & Kusmierczyk, 2017) 
AKY1066 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre8-HF(URA)    (Hammack & Kusmierczyk, 2017) 
AKY1368 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1- pre6∆::HIS3 rpn4∆::hphMX6 [pRS315 pre6-Flag] 
AKY1346 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre6∆::HIS3 DOA5-HF::hphMX6 [pRS315 pre6-Flag] 
AKY1347 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre6∆::HIS3 doa5∆::HIS3 [pRS315 pre6-Flag] [Ycplac22 doa5-1] 
AKY1375 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre8-HF(URA) rpn4∆::hphMX6  
AKY1377 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 DOA5-HF::hphMX6 rpn4∆::hphMX6 pre6∆::HIS3 
AKY1379  MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 DOA5-HF::hphMX6 PRE1-6XGLY-3XFlag::kanMX6 
AKY1402 MATa his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 pre8-HF(URA) doa5∆::HIS3 [Ycplac22 doa5-1] 
 
Unless otherwise indicated strains were generated in this study. 
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Supplementary Figure 28. Substrate overlay and loading control for Figure 4.1 
(A) SUC-LLVY-AMC substrate overlay of native gel (20 µg load) prior to staining. 
(B) 12% SDS-PAGE loading control for native PAGE. 
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Supplementary Figure 29. Native PAGE heavy load of Figure 4.1 
To better visualize intermediates and high molecular weight species in β4-Flag lane 
(*) 30 µg of purified protein was analyzed via native PAGE. 
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Supplementary Figure 30. Depletion strategy for isolating sub-13S 
First yeast lysate is Flag-purified. The Flag purification is followed by two rounds of ICAR. If 
sub-13S is a gel artifact, the sub-13S species will be absent from the depletion strain. Results for 
this strategy are depicted in Figure 4.2. 
 
